Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	20.1	11.6	12.4	15.0	18.1	10.7	22.0	6.7	16.0	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18.0	10.8	14.2	17.0	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5.0	2.4	2.6	1.6	7.2	16.1	17.2	20.8	25.3	30.9	6.3	12.7	19.9	14.9	12.6	12.6	9.4	11.9	7.3	16.8	15.3	14.0	8.7	11.7	11.0	7.4	5.4	7.8	27.4	10.7	17.3	11.9	10.9	22.5	12.9	26.6	16.5	20.8	20.6	15.4	43.5	9.5	18.1	13.7	15.1	9.8	19.1	11.3	11.9	17.5	22.3	12.8	15.1	8.5	16.1	20.1	21.3	8.3	10.2	10.5	16.2	11.0	23.6	57.2	14.8	21.8	19.9	2.9	6.8	15.9	23.5	9.9	18.1	0.2	2.1	1.1	2.0	1.2	2.6	3.1	2.0	1.9	2.0	1.4	1.9	1.7	0.2	2.4	5.0	3.1	0.9	1.6	12.4	18.1	6.7	16.0	10.3	8.4	24.1	9.4	17.1	21.2	8.9	9.9	4.2	6.4	8.1	6.2	5.8	12.7	5.3	5.7	14.0	11.8	11.3	1.7	12.6	3.1	14.3	15.4	0.0	9.5	3.5	27.8	8.1	2.3	13.4	13.7	9.5	21.2	20.3	13.7	7.4	25.9	6.5	5.0	3.6	15.7	15.7	14.3	20.3	24.1	8.4	9.7	19.4	21.0	11.9	13.6	5.9	12.7	7.9	19.1	6.4
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 32.3;TIME: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4.0	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2.0	3.8	1.2	1.8	2.2	0.6	10.1	5.6	3.7	2.5	3.2	7.4	2.3	11.3	9.3	13.9	10.1	4.1	3.1	5.9	8.4	8.0	9.6	5.1	5.4	3.8	19.8	3.7	4.9	2.8	5.1	2.0	5.9	3.1	0.9	6.8	5.0	19.8	32.3	6.0	15.4	3.0	6.7	1.7	18.1	2.7	2.5	1.7	3.6	2.0	1.8	3.7	6.3	2.9	4.7	1.6	2.3	5.2	9.4	3.0	23.2	5.9	2.7	2.6	30.1	14.5	10.8	6.9	18.1	3.1	3.9	6.1	6.8	1.8	13.9	3.8	1.2	0.4	2.2	0.4	1.0	1.8	1.4	1.4	0.9	2.8	1.9	2.0	2.6	1.8	0.5	2.0	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6	20.8	26.6	12.4	33.8	41.7	36.0	7.0	17.8	6.7	10.3	10.4	157.1	7.7	10.0	12.7	14.0	46.7	9.7	0.0	11.9	6.7	36.0	32.7	16.2	14.5	21.0	23.8	25.9	33.7	32.7	21.4	14.1	36.5	65.8	12.6	9.6	9.8	30.1	14.4	12.7	8.4	34.1	6.5	29.3	18.2	26.3	33.5	8.7	10.1	13.9	20.7
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 913.9;Late spermatids: 1666.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.8	26.6	41.5	22.8	18.8	18.8	33.7	21.7	23.1	21.7	19.2	36.5	18.0	11.2	16.9	20.3	28.5	17.5	40.3	23.6	19.6	27.3	41.0	32.8	24.1	79.8	26.1	37.2	18.9	19.2	21.5	20.3	25.2	23.0	24.6	42.0	33.1	21.9	25.6	24.2	40.0	36.0	50.1	47.2	30.0	26.6	42.1	25.6	33.9	25.5	45.3	44.8	13.5	32.0	43.4	28.3	18.9	19.9	20.3	23.9	15.9	19.7	32.7	29.8	59.1	34.9	28.3	32.2	28.1	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2	41.7	88.5	101.3	80.3	70.3	51.3	74.2	109.5	129.8	67.1	64.6	7.9	179.7	228.8	194.3	913.9	64.7	84.9	163.5	146.5	234.8	71.9	111.0	68.2	112.0	123.7	27.0	79.2	50.3	57.7	1666.6	87.5	74.7	77.6	116.4	107.9	64.8	155.5	108.7	86.7	241.7	43.6	90.5	79.3	111.8	121.7	79.7	157.0	93.8	114.3	108.3
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	14.3	8.5	2.3	10.9	4.6	2.5	14.8	1.2	2.4	7.1	6.2	4.7	14.6	1.9	7.9	6.2	5.0	5.4	6.6	8.4	2.3	2.4	5.1	5.5	17.4	18.9	3.7	2.7	3.6	11.9	8.1	2.8	23.0	4.0	6.3	3.9	6.8	6.5	14.5	19.7	3.1	6.4	8.8	4.7	13.6	5.1	4.1	3.6	5.3	7.4	5.8	12.0	7.1	6.9	8.2	8.0	13.3	13.0	3.4	9.6	4.9	1.6	2.0	0.5	0.0	1.7	1.9	0.0	1.4	0.3	1.2	1.6	0.6	1.3	0.4	0.6	2.1	0.0	0.1	1.4	0.0	1.2	16.0	0.1	11.5	0.2	0.0	2.8	0.0	13.0	2.8	0.0	0.6	0.0	0.5	5.0	0.0	1.0	17.6	7.6	0.5	0.0	2.7	4.8	0.1	4.0	0.0	5.7	0.7	0.7	0.6	0.3	0.0	0.0	0.1	4.3	0.7	3.1	7.2	4.1	0.0	0.8	3.2	0.3	17.2	3.8	0.0	2.1	0.0	3.1	7.8	13.0	13.3	0.6	12.0	0.6	8.2	1.4	1.3	8.0	4.9	0.2	0.6	0.4	3.4	9.2	7.0	9.6	4.9	2.3	4.6	1.2	2.4	2.3	2.4	3.7	2.7	4.0	3.6	8.9	7.5	4.5	0.7	0.7	0.6	4.1	2.5	2.7	4.5	3.5	3.9	4.8	1.7	2.2	0.8	8.4	0.0	0.0	2.9	3.2	1.1	0.9	10.4	1.3	8.4	0.0	0.0	5.5	9.4	0.4	0.3	10.6	1.7	7.2	0.1	0.8	2.4	0.0	2.8	0.8	4.6	0.0	2.9	0.5	0.2	0.6	9.8	1.3	0.0	0.1
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1;pituitary gland: 17.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 36.6;Late spermatids: 30.9"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2.0	0.0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0.0	1.6	0.0	0.3	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	3.6	0.0	0.0	0.1	0.3	27.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	4.1	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Kupffer cells: 104.4;Sertoli cells: 207.0;Smooth muscle cells: 341.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 8.8;plasmacytoid DC: 18.3"	"Group enriched"	"Detected in many"	14	"dendritic cells: 18.3;NK-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 67.0;U-251 MG: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	61000000	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	38.0	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28.0	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13.0	20.0	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12.0	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	53.3	21.4	1.3	0.1	4.8	4.9	0.0	42.3	38.1	62.2	38.6	1.1	25.1	0.0	17.2	67.0	32.5	4.5	0.0	28.5	53.6	0.0	0.0	0.0	14.2	0.8	17.6	0.0	0.0	3.7	0.5	36.6	56.9	35.3	23.0	0.0	2.0	0.0	38.5	0.0	0.0	0.0	0.5	0.1	10.3	0.0	22.7	0.0	27.8	0.0	0.0	0.0	10.9	0.0	0.2	8.2	0.1	0.9	47.2	44.1	30.1	42.1	71.7	0.0	0.1	0.1	29.4	0.0	32.8	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4	8.9	2.2	0.5	72.4	37.1	0.0	4.2	0.0	4.0	5.7	5.2	0.0	2.3	0.0	4.0	8.6	2.9	0.0	0.0	0.2	1.7	91.1	28.0	0.0	0.0	26.7	1.6	0.0	13.5	104.4	2.7	57.0	49.8	25.3	4.6	0.0	28.7	8.9	0.0	75.0	0.0	1.1	207.0	341.9	0.5	2.1	25.5	9.6	2.5	0.0	26.4
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8"	"Cell type enriched"	"Detected in some"	52	"B-cells: 93.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 47.8;naive B-cell: 33.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 47.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 44.0;REH: 11.9;RPMI-8226: 14.5;U-698: 21.5;U-87 MG: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.3	2.4	0.0	0.1	0.1	23.5	0.0	0.1	31.9	1.4	0.2	0.0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0.0	0.0	9.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.9	0.0	14.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.3	3.8	21.5	9.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.8	47.8	0.3	1.1	0.0	33.9	0.2	0.1	0.1	0.0	0.0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	93.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Group enriched"	"Detected in some"	9	"Endothelial cells: 18.5;Ito cells: 51.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1	0.0	1.4	0.0	0.5	0.3	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.1	0.0	4.1	51.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell type enhanced"	"Detected in some"	19	"B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	16.4	147.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	11.5	0.2	0.0	0.0	12.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	14.0	0.0	21.4	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3	3.0	12.8	86.8	0.1	0.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.2	0.6	0.0	23.3	0.0	0.4	0.5	0.0	203.6	0.0	50.3	0.0	0.0	1.3	53.4	0.0	0.3	53.0	3.3	52.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.4	1.6	0.3	1.6	0.8	0.0	0.1
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 165.7;Late spermatids: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.9	6.7	2.2	1.6	4.1	2.9	1.9	2.9	2.3	6.2	1.9	1.1	2.1	1.7	2.3	1.7	4.0	1.6	2.9	2.3	9.9	4.0	1.7	2.0	0.8	5.4	7.1	1.3	0.4	3.1	1.0	1.4	5.1	2.4	30.6	3.5	4.2	1.0	4.3	6.0	3.6	1.4	2.3	4.7	7.6	1.1	2.0	5.1	1.1	1.9	3.0	2.9	4.0	3.0	1.3	7.0	2.2	1.6	3.6	2.7	1.7	1.7	0.6	1.7	1.9	5.0	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7	3.0	5.6	2.2	4.2	3.3	0.2	5.3	0.0	28.1	5.7	1.8	3.9	1.7	0.0	2.7	165.7	9.3	12.8	0.0	1.7	0.8	4.7	6.6	14.0	1.5	2.3	0.0	4.6	6.2	4.6	161.3	4.6	4.3	5.0	5.4	4.7	9.1	2.5	8.7	0.7	1.7	3.6	0.0	2.8	1.9	3.0	2.0	1.8	10.2	2.7	2.3
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619830	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.9"	"Lineage enhanced"	"Detected in many"		"granulocytes: 9.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;ASC TERT1: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013312, HPA064747"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013312: AB_1846354, HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	7.3	6.2	6.8	3.0	7.5	4.4	15.7	2.4	6.6	5.3	5.0	14.8	7.1	4.5	4.0	3.7	3.5	7.1	5.9	8.2	6.0	4.6	9.1	16.0	4.9	1.8	9.5	4.0	5.8	7.3	17.1	5.2	3.4	7.1	5.7	5.4	8.3	3.8	7.2	2.2	3.3	7.7	4.2	9.3	2.2	9.3	16.9	8.2	0.2	13.6	2.2	2.1	10.4	10.3	1.6	0.0	9.9	0.0	0.1	2.9	0.8	5.2	2.9	3.1	3.2	15.2	22.8	8.5	3.8	5.1	2.5	4.1	9.9	8.3	0.0	3.7	8.0	6.2	5.9	4.4	3.0	3.0	1.3	4.1	0.8	1.0	7.8	2.5	0.0	0.1	9.4	1.5	2.7	2.5	3.0	0.5	0.0	3.0	0.6	3.5	2.5	0.0	0.8	5.8	5.9	2.5	0.0	1.9	0.1	4.0	8.1	0.9	4.9	2.7	0.8	1.5	11.0	0.7	1.7	1.5	2.5	3.0	6.6	2.8	0.1	0.0	0.0	2.7	0.0	6.0	9.9	0.0	3.1	2.9	0.0	1.6	1.6	1.3	2.3	0.0	0.8	2.3	1.4	0.0	0.1	0.0	0.0	1.6	0.8	6.8	7.5	2.4	6.6	6.0	4.6	9.5	4.0	7.1	8.2	6.0	9.1	2.4	7.4	8.0	6.4	14.5	10.2	16.0	14.8	8.7	7.9	5.3	6.6	4.8	28.7	4.7	8.5	0.0	5.7	2.5	9.3	10.2	13.9	27.2	8.6	7.9	2.4	8.0	1.0	27.6	8.3	4.1	8.5	3.6	7.6	10.9	6.9	6.5	11.0	14.1	11.7	25.8	22.0	3.7	5.5	6.8	2.9	5.0	7.2	8.1
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 106.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4.0	13.4	10.9	16.4	4.0	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5.0	17.0	23.1	12.1	7.2	4.1	25.6	16.0	26.4	7.0	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12.0	4.0	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	106.0	0.0	0.0	0.0	0.0	2.0	1.9	0.0	0.5	14.7	0.1	0.3	0.0	0.8	5.7	0.5	0.4	0.0	0.2	2.5	0.0	1.2	1.3	0.3	22.9	1.4	0.0	0.0	0.0	1.5	0.5	0.9	0.0	1.8	0.2	0.4	0.0	0.4	15.8	13.7	0.0	0.2	0.0	3.2	0.3
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	12.1	8.7	15.1	27.7	23.3	26.0	28.8	49.6	21.1	13.0	14.7	12.8	4.6	14.9	17.0	10.3	11.7	13.0	18.6	7.5	15.7	12.5	13.3	11.0	33.0	42.8	21.9	12.5	17.3	5.7	7.5	21.0	30.3	13.8	11.0	12.0	7.7	7.4	10.2	6.2	19.8	16.8	14.8	14.7	24.5	14.1	6.3	22.3	33.3	18.7	20.8	31.6	15.3	16.3	4.5	1.3	1.5	1.8	9.3	15.5	5.9	29.0	62.7	8.4	13.9	10.3	10.1	4.2	14.4	21.6	24.1	18.0	10.9	42.1	20.3	6.2	14.7	59.6	42.5	11.3	23.9	11.4	7.8	12.2	10.9	20.1	13.1	41.2	8.4	5.6	9.9	19.2	22.3	26.4	8.2	13.3	10.2	7.0	53.5	14.2	23.3	26.3	12.3	6.2	19.9	26.8	13.8	23.8	14.5	16.4	2.7	6.0	13.1	34.1	32.6	16.7	7.5	11.0	4.4	11.0	12.9	15.7	23.4	19.0	13.1	20.6	8.2	6.6	8.3	12.4	1.5	1.4	0.0	13.6	1.8	12.7	3.5	13.6	13.7	1.3	4.5	11.4	13.2	0.1	9.3	0.9	0.7	15.5	5.9	15.1	23.3	49.6	21.1	15.7	12.5	21.9	12.5	13.8	22.3	8.9	23.7	9.0	5.5	10.0	13.9	6.8	7.6	0.0	3.4	7.0	2.0	5.3	0.0	7.8	0.5	24.0	3.8	23.3	4.2	14.2	13.6	4.7	1.1	11.6	24.4	3.2	7.5	12.9	11.6	1.0	6.6	10.6	16.9	5.4	7.9	8.3	10.4	2.9	8.5	9.4	2.4	0.0	11.3	1.0	11.5	9.8	3.0	25.4	3.5	3.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.3	5.6	18.8	14.5	0.4	1.9	4.7	8.1	8.7	18.4	25.4	13.5	26.0	6.2	6.8	4.9	20.2	7.3	15.5	12.4	17.8	5.1	10.6	4.7	7.6	10.0	0.1	3.2	4.9	0.4	0.5	10.9	9.0	1.9	11.8	13.5	6.9	12.3	11.2	7.4	8.7	8.1	4.8	10.6	6.1	5.7	17.2	7.3	3.2	4.1	9.5	5.9	18.1	5.5	8.6	17.3	9.2	6.7	3.5	10.2	8.6	7.0	12.9	7.5	6.1	6.1	4.0	6.8	7.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	32.9	0.0	0.3	0.0	0.0	5.7	0.2	0.3	0.0	0.2	2.2	0.0	0.0	0.0	0.3	35.1	1.7	1.2	0.0	1.0	0.6	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	36.3	8.3	0.4	1.1	0.0	1.6	0.1
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 2056.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16.0	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16.0	52.7	32.6	11.9	13.8	15.3	26.4	2.0	17.2	9.8	1.2	1.0	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14.0	5.7	54.1	46.0	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0.0	0.0	0.8	3.1	8.2	1.4	9.3	0.0	0.0	1.2	1.8	2.0	9.8	0.0	2.8	2056.4	2.0	2.9	256.9	2.1	27.0	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2.0	6.2	9.9	1.7	2.3	0.0	2.1	159.2	36.4	5.6	3.4	7.0	12.8	1.4
CHMP4A	"C14orf123, HSPC134, VPS32A"	ENSG00000254505	"Charged multivesicular body protein 4A"	Q9BY43	14	24209583-24213869	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA068473	Approved					NA	NA		2600000			"HPA068473: AB_2685994"	"unprognostic (4.33e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.74e-4)"	"unprognostic (2.02e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.90e-2)"	31.6	24.7	37.0	25.1	36.5	21.0	24.2	11.6	28.2	18.6	32.3	23.8	23.6	20.8	18.8	34.5	30.0	22.3	21.5	24.6	29.9	26.7	24.4	26.2	19.3	36.5	39.8	26.6	16.0	23.6	36.9	14.5	18.8	34.2	26.1	32.6	16.8	25.3	32.4	26.3	26.8	22.5	42.7	35.4	28.9	24.7	9.8	28.9	27.5	21.7	15.5	42.7	32.0	24.2	41.8	45.1	30.1	44.3	30.8	41.8	35.9	11.0	20.2	9.6	9.8	10.2	11.1	15.2	13.3	11.4	9.9	11.7	9.8	24.0	19.3	12.0	14.2	8.9	11.4	9.8	18.0	10.0	35.8	5.6	15.6	19.3	40.0	25.5	24.8	16.6	12.4	22.0	8.1	30.0	8.9	15.5	19.8	15.8	25.9	19.9	24.1	24.0	18.7	6.5	18.0	18.6	16.6	9.3	18.1	15.7	27.3	6.4	8.2	30.6	18.0	14.6	10.5	13.4	17.8	12.5	5.4	9.0	9.3	10.1	27.9	34.0	22.4	6.1	16.8	12.8	30.1	37.0	24.4	31.9	44.3	33.5	41.8	34.2	35.1	42.3	37.3	27.4	28.6	11.3	30.8	41.8	45.1	41.8	35.9	37.0	36.5	11.6	28.2	29.9	26.7	39.8	26.6	34.2	28.9	14.9	32.3	103.3	71.5	46.8	29.5	1.4	109.5	45.5	36.4	59.3	60.9	78.7	82.9	96.5	7.6	64.9	46.5	70.0	70.9	69.9	44.6	61.2	71.9	55.0	143.3	23.8	37.8	66.9	78.0	13.7	61.9	99.2	65.8	249.7	67.2	51.5	82.2	70.2	45.6	130.2	23.5	97.0	73.1	18.6	11.9	68.9	100.9	113.3	76.8	60.0
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	26.3	55.1	27.8	30.5	43.4	97.6	40.2	40.1	40.7	42.2	23.0	19.9	39.1	12.9	29.1	34.5	26.3	19.1	35.8	26.7	31.0	21.9	21.8	35.3	28.2	30.1	56.0	23.1	48.1	20.9	36.6	41.5	40.0	34.4	34.3	16.5	13.7	25.6	37.1	27.3	32.1	14.9	36.8	55.2	32.4	15.1	12.4	52.6	25.0	30.4	20.2	25.6	51.2	71.8	13.2	9.8	26.2	6.2	6.5	14.4	7.4	8.2	6.2	10.4	3.2	11.9	13.1	8.2	9.0	12.8	9.1	12.2	11.6	5.4	2.8	6.1	5.6	5.3	8.9	13.1	4.1	18.7	12.5	11.6	8.5	15.7	14.3	7.1	8.8	14.4	6.0	18.9	11.4	20.2	10.9	5.3	4.5	10.2	37.3	12.9	5.6	10.4	26.8	6.6	5.2	14.2	10.6	12.4	14.8	6.3	5.4	10.5	8.3	7.8	2.9	13.0	6.5	2.4	6.1	8.1	10.2	7.0	9.8	9.8	22.0	9.1	6.5	6.5	7.2	6.9	26.2	6.2	13.3	13.6	4.4	13.1	13.2	12.8	12.1	4.1	10.1	14.4	11.4	12.7	6.5	4.2	9.8	13.0	7.4	27.8	43.4	40.1	40.7	31.0	21.9	56.0	23.1	34.4	52.6	41.7	97.6	120.6	205.3	149.9	55.8	85.6	28.1	76.3	79.6	26.2	94.2	37.9	16.6	25.9	1.9	110.1	100.8	23.3	23.3	39.1	151.1	171.5	133.9	37.6	51.4	49.3	128.8	78.0	91.9	5.1	86.0	167.5	146.8	47.7	56.3	46.1	27.4	66.6	71.1	11.1	91.9	109.9	142.2	31.2	22.0	132.6	75.5	146.6	44.8	153.2
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	5.9	5.1	18.7	5.7	9.4	5.1	16.0	5.3	6.5	4.1	4.2	5.4	4.3	13.0	7.4	3.6	2.2	8.6	9.3	6.9	3.9	9.4	7.3	10.3	5.4	6.9	8.1	12.8	10.4	4.1	6.4	6.0	12.2	11.9	7.2	11.1	14.5	9.0	6.2	10.3	8.7	7.6	12.2	15.0	7.3	9.7	11.3	13.9	10.5	13.4	8.9	12.7	2.0	6.4	4.9	14.7	9.8	15.7	4.7	2.5	6.8	4.6	4.4	17.2	14.7	11.8	5.1	9.2	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3	14.9	22.4	4.8	4.8	4.0	5.8	13.3	12.7	4.0	18.2	7.0	3.9	6.8	0.0	5.2	6.3	8.3	4.3	0.0	3.8	7.3	7.2	3.9	9.3	5.8	6.0	4.8	6.4	8.0	10.5	5.4	7.2	5.8	3.3	7.2	7.9	5.4	4.4	3.5	2.8	2.8	5.7	6.5	3.3	8.3	3.8	4.0	10.4	4.4	6.3	4.3
CLK3	clk3	ENSG00000179335	"CDC like kinase 3"	P49761	15	74598500-74645414	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046817: AB_10964124"	"unprognostic (4.10e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (2.05e-6)"	"unprognostic (1.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.14e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-2)"	20.9	17.2	15.7	24.7	22.5	62.7	31.1	23.4	18.8	24.9	24.6	23.1	16.4	18.6	24.1	17.7	25.3	17.3	21.2	16.4	17.8	13.5	17.2	16.0	19.6	21.9	29.3	14.5	23.7	21.8	19.0	19.9	27.9	16.7	20.6	14.4	19.9	24.8	20.9	28.4	24.1	20.7	19.8	19.2	23.8	19.6	31.5	23.3	28.8	21.0	12.0	23.7	23.2	19.8	38.9	36.0	60.7	46.0	43.6	43.4	39.7	22.3	14.2	18.8	10.5	24.2	18.6	14.9	15.3	24.2	21.9	26.9	19.3	14.8	20.4	11.4	13.6	30.6	15.8	35.0	14.7	14.3	29.0	19.2	25.0	21.1	13.3	38.5	6.7	19.4	23.2	29.4	28.8	24.0	26.8	24.0	20.8	12.2	14.9	12.7	15.8	19.9	22.7	12.0	22.2	10.1	16.1	9.0	13.4	17.1	16.3	10.6	12.5	12.2	13.6	13.5	15.1	12.9	13.5	11.0	13.0	10.0	8.1	20.0	24.5	19.6	16.8	11.4	33.1	16.4	32.9	34.4	45.0	38.5	37.4	37.4	37.7	41.1	39.7	31.9	38.9	42.1	40.1	60.7	43.6	46.0	36.0	43.4	39.7	15.7	22.5	23.4	18.8	17.8	13.5	29.3	14.5	16.7	23.3	6.0	35.5	20.9	38.8	40.0	34.9	14.9	20.4	17.4	18.2	12.2	53.0	22.9	26.6	29.6	59.6	28.3	37.1	23.3	21.0	31.4	22.7	32.5	20.8	10.9	24.3	27.0	28.2	17.2	24.0	14.8	25.6	28.5	27.0	32.5	24.6	17.7	28.8	28.1	19.1	14.2	42.2	12.9	24.4	37.1	17.5	36.6	49.0	39.2	22.6	53.1
CLK4		ENSG00000113240	"CDC like kinase 4"	Q9HAZ1	5	178602664-178630615	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 288.4;Late spermatids: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043746	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA043746: AB_2678650"	"unprognostic (9.46e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-3)"	12.2	16.4	17.0	17.4	18.4	11.4	17.3	53.8	24.1	17.9	12.2	11.9	18.3	12.4	17.0	16.4	10.5	11.0	13.1	11.4	15.9	9.5	11.8	16.0	10.9	20.3	21.2	12.7	17.4	16.2	15.4	20.2	13.9	16.3	16.7	8.9	10.8	14.4	17.0	20.6	19.5	11.3	11.3	25.8	17.0	11.0	15.7	22.0	15.0	15.8	9.7	12.7	11.4	18.0	13.2	7.8	16.1	6.1	7.7	13.8	5.2	6.7	6.3	5.8	8.4	17.5	14.7	9.7	6.7	7.5	4.0	7.4	6.7	5.5	3.9	5.4	2.8	4.5	9.0	7.5	5.4	6.6	14.1	5.9	1.5	11.8	8.1	6.5	3.1	4.9	6.7	7.8	6.4	8.6	13.2	2.7	2.7	3.5	11.6	5.1	2.8	4.0	11.4	3.0	4.6	3.9	4.0	5.2	5.7	3.9	2.1	6.5	4.4	7.5	4.0	6.9	3.4	4.3	6.6	5.6	8.2	2.9	4.2	7.1	7.6	2.8	3.0	5.9	7.6	4.1	6.5	6.1	12.0	10.0	4.1	13.2	13.2	10.3	8.9	5.9	10.4	13.8	10.6	16.1	7.7	4.4	7.8	9.5	5.2	17.0	18.4	53.8	24.1	15.9	9.5	21.2	12.7	16.3	22.0	14.9	26.7	50.0	37.2	28.3	66.4	19.3	7.6	32.1	23.9	14.0	37.3	16.5	5.0	7.3	288.4	24.8	13.5	23.3	4.1	13.0	20.8	26.1	27.6	11.9	8.8	27.0	5.8	17.2	13.1	350.8	28.4	23.8	15.1	12.6	10.7	34.6	6.5	11.8	27.6	7.7	76.4	19.4	36.0	23.2	17.7	21.5	13.3	34.8	9.1	22.2
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Group enriched"	"Detected in some"	5	"BEWO: 51.8;SK-BR-3: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	51.8	0.1	0.0	0.0	0.0	1.5	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.8	0.0	7.4	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0	0.0	6.7	0.5	0.0	2.5	0.0	2.8	5.1	1.4	0.0	0.0	0.0	2.9	0.0	0.0	3.7	2.2	0.0	0.0	0.0	97.9	3.3	0.0	2.3	0.8	277.3	0.0	0.0	4.9	200.7	3.5	1.7	125.7	3.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	12.9	1.3	0.5	0.2	1.1	22.1	2.2	0.0	0.0
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 91.8;Kupffer cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.9	18.3	9.0	14.7	8.6	6.6	7.7	8.7	8.4	16.6	11.8	16.7	12.0	58.0	11.5	7.8	15.4	13.5	18.8	17.5	4.7	28.1	23.2	49.1	6.7	16.7	11.9	25.6	62.6	9.3	8.7	11.8	10.6	8.3	12.5	27.4	14.1	20.2	9.8	21.9	18.4	15.1	11.1	11.7	13.1	20.5	7.7	42.3	7.6	28.8	14.9	10.3	11.3	23.7	15.1	6.0	16.3	37.8	10.8	20.1	10.6	15.7	15.0	10.8	21.8	59.2	10.4	49.0	13.6	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6	3.0	11.6	91.8	7.2	8.2	16.5	8.1	12.7	5.3	6.8	8.7	5.9	6.3	1.7	8.5	10.0	11.5	27.7	0.0	12.0	11.0	7.6	9.3	25.5	25.0	46.4	27.0	9.1	12.3	77.9	2.1	8.3	44.5	8.5	36.9	25.3	6.5	15.2	17.3	7.8	6.8	4.1	6.5	8.5	3.8	11.3	8.0	4.7	60.9	22.8	10.5
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.7	6.5	9.2	1.9	0.6	0.9	5.7	0.5	0.1	0.3	0.0	8.7	10.5	0.1	11.0	1.7	9.6	31.8	2.0	24.5	0.1	10.9	3.5	0.0	6.0	2.3	1.8	0.0	0.4	1.2	12.7	0.1	0.2	5.8	0.7	0.5	5.7	0.2	1.4	12.5	0.7	0.0	1.6	10.9	1.3	1.3	6.9	0.7	4.7	32.5	1.6	0.9	1.8	14.7	7.1	3.2	36.5	0.2	1.5	4.6	4.3	0.4	4.6	0.2	0.0	0.8	3.0	0.0	4.0	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0	32.8	24.0	2.2	62.3	47.2	5.2	19.9	38.2	33.5	31.8	85.5	0.0	53.4	5.0	115.9	10.8	4.9	88.3	23.3	66.9	19.7	6.5	54.7	1.1	0.4	5.4	6.4	44.4	1.8	0.8	16.6	7.8	2.2	15.1	22.6	55.1	145.4	62.4	74.8	4.9	5.6	7.4	6.5	8.9	0.7	4.5	45.4	38.9	0.0	54.4	76.8
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Supported	"Plasma membrane,Actin filaments"		Yes	No		850000	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9.0	18.6	3.3	24.2	17.7	25.0	13.4	16.6	15.4	7.9	4.7	4.0	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4.0	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0.0	8.6	12.8	4.1	29.0	18.3	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	16.3	61.7	61.0	0.2	24.0	45.1	10.5	15.1	0.0	0.0	0.0	0.0	32.3	2.1	0.0	0.0	0.1	14.4	12.9	0.1	0.0	0.1	0.0	26.8	0.0	0.0	43.3	0.1	18.5	0.5	17.0	12.1	0.1	0.1	5.1	9.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	6.9	0.1	0.0	0.0	0.0	9.9	0.0	0.0	0.8	0.9	0.0	0.0	0.6	16.8	3.7	8.5	3.3	0.7	1.3	0.0	15.2	0.0	17.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5	3.0	2.9	0.0	2.4	11.2	3.1	23.3	2.5	4.0	1.2	0.0	0.0	0.5	0.0	0.5	6.9	21.3	2.0	0.0	1.5	0.4	84.7	4.1	1.1	3.0	1.1	0.0	1.2	24.5	2.1	4.0	58.4	1.5	21.9	0.0	0.7	19.0	1.5	1.7	83.1	0.9	2.9	38.8	68.4	0.9	0.9	7.5	0.8	1.3	0.6	3.3
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.2;HEL: 56.7;K-562: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	1.0	0.0	1.6	0.8	0.2	8.4	7.1	11.6	11.7	11.5	0.9	0.1	3.4	0.6	2.9	2.9	0.9	5.1	1.1	9.2	21.2	2.4	56.7	1.9	0.2	0.0	1.9	1.4	1.0	0.8	1.1	5.0	2.2	0.2	2.8	22.0	0.4	2.4	0.6	0.7	0.0	2.3	0.0	0.8	0.0	1.7	0.1	8.9	0.0	14.2	9.7	4.1	5.6	1.9	14.1	2.7	0.1	2.2	1.7	1.2	0.2	2.0	2.1	1.4	1.0	4.8	1.4	2.9	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1	0.0	0.3	0.0	0.2	1.1	29.6	26.1	0.0	0.0	0.0	0.0	13.7	4.8	1.7	0.8	1.8	0.7	0.0	23.3	0.6	1.9	1.7	1.3	0.0	0.0	1.1	49.3	6.9	0.0	0.0	1.4	0.0	0.8	6.8	1.8	1.3	3.1	0.4	0.0	0.0	5.9	21.6	0.0	2.3	1.0	2.3	0.3	6.2	0.0	0.5	0.1
DUPD1	DUSP27	ENSG00000188716	"Dual specificity phosphatase and pro isomerase domain containing 1"	Q68J44	10	75037836-75058514	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"skeletal muscle: 38.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042964	Uncertain					NA	NA					"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.5	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 43.7;hTCEpi: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.5	1.7	2.4	38.1	22.3	2.9	35.4	10.3	23.8	9.6	6.0	2.6	0.7	10.3	24.8	27.4	0.9	1.7	8.7	11.2	19.4	4.7	0.4	12.0	2.5	43.7	0.2	0.8	21.3	76.4	10.8	17.6	12.4	7.4	1.5	1.8	13.9	15.3	2.5	1.1	1.0	1.5	1.6	1.6	41.1	3.2	6.4	16.9	1.1	7.5	3.1	9.6	16.3	1.2	7.6	1.4	0.4	19.5	16.9	8.4	16.4	2.7	2.9	1.6	0.6	15.1	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7	381.2	398.8	474.0	769.9	1136.9	64.0	181.6	236.9	45.5	126.3	200.7	25.5	239.6	48.0	361.0	67.1	510.4	567.7	46.7	76.6	355.3	824.5	763.6	295.5	297.9	967.3	46.1	687.8	403.9	1172.3	21.1	356.4	1745.4	514.5	55.9	830.1	603.1	188.6	648.8	292.4	25.4	177.1	756.7	886.8	11.8	23.0	1710.3	486.7	546.6	309.1	534.2
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 35.4"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;HaCaT: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	7.4	4.7	6.0	7.1	11.2	23.2	8.2	5.9	11.1	5.7	10.8	21.1	0.3	2.1	4.9	2.7	7.0	8.5	7.6	3.8	7.2	4.0	2.8	35.4	8.0	9.0	14.0	5.6	2.8	18.3	1.8	2.5	4.5	8.4	3.6	4.9	8.5	9.5	1.7	21.0	8.0	6.2	9.7	10.1	6.4	4.5	3.9	14.1	5.6	5.3	10.6	8.6	8.5	4.1	0.8	5.4	4.6	4.2	15.1	12.7	1.6	6.1	2.6	0.2	0.2	19.2	9.9	0.2	4.1	10.8	6.9	5.3	0.1	1.7	4.8	1.4	10.7	5.0	42.3	0.9	4.0	6.0	12.3	0.5	8.2	1.2	0.7	4.5	3.6	5.6	13.8	2.9	7.4	7.5	3.2	0.2	1.2	0.8	1.7	6.5	0.1	0.7	2.8	0.6	1.3	0.3	0.4	11.7	0.3	2.3	3.7	15.8	1.2	0.5	0.5	17.5	2.5	0.9	2.1	1.5	3.5	0.9	5.3	5.1	2.9	2.0	2.6	5.4	1.6	3.6	4.6	4.2	0.2	3.6	3.7	3.3	0.7	2.5	2.5	5.4	0.8	0.8	1.5	0.3	15.1	1.4	0.2	12.7	1.6	6.0	11.2	5.9	11.1	7.2	4.0	14.0	5.6	8.4	14.1	0.0	1.7	1.9	12.6	45.2	4.5	3.3	10.2	8.1	6.8	3.5	19.6	2.2	0.0	27.3	29.1	6.3	1.0	0.0	7.8	2.7	8.3	10.9	135.7	50.4	22.0	1.6	42.1	1.8	11.0	2.7	23.0	23.9	21.9	13.6	9.9	13.5	21.9	0.0	12.0	0.7	32.3	0.0	5.1	3.8	2.0	36.1	2.9	29.9	2.2	14.4
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	19.6	16.1	15.1	15.1	17.9	29.5	21.4	31.8	21.5	23.1	16.8	16.4	16.2	16.3	29.9	19.8	38.7	37.4	15.2	15.2	17.2	13.9	19.3	16.5	17.2	21.5	12.7	15.8	26.4	14.9	11.6	28.2	19.1	14.0	18.2	16.8	16.5	22.3	20.3	16.2	27.9	19.7	18.9	13.4	21.5	15.4	19.7	13.8	28.7	16.8	16.2	29.3	20.4	27.3	29.9	20.9	42.6	19.1	28.0	37.6	29.2	19.4	8.4	9.1	9.6	16.5	20.7	16.3	14.3	18.7	18.6	19.1	12.1	14.8	25.3	9.2	15.4	16.7	13.6	11.2	28.8	18.0	17.4	11.7	15.5	6.4	18.5	17.3	17.4	14.6	16.7	35.0	16.6	23.1	16.2	20.6	12.4	16.4	14.9	20.6	10.8	16.7	18.6	14.6	18.3	11.7	6.7	24.5	22.7	15.0	16.2	13.5	7.3	13.2	15.8	16.8	11.4	8.4	9.3	11.7	13.3	16.4	15.2	16.8	15.9	12.6	33.4	12.3	17.7	12.9	24.7	19.1	42.6	26.8	16.9	34.6	29.9	31.7	31.6	20.9	28.1	33.9	31.8	29.1	28.0	16.9	15.9	37.6	29.2	15.1	17.9	31.8	21.5	17.2	13.9	12.7	15.8	14.0	13.8	8.9	11.8	34.3	47.9	73.8	9.4	6.9	33.1	26.8	22.7	12.2	3.9	27.8	43.1	24.2	5.9	29.2	13.5	23.3	24.2	35.1	26.6	23.0	41.4	12.9	27.5	4.8	11.5	29.4	22.3	5.6	26.7	20.5	21.9	42.3	19.0	9.3	22.5	17.8	24.1	38.5	13.9	6.5	22.8	23.6	31.8	72.5	32.3	32.4	17.2	54.2
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	15.6	12.1	15.0	16.0	17.2	37.8	21.2	27.2	20.3	14.0	14.2	13.9	16.6	11.7	19.5	14.0	12.7	15.6	12.1	11.9	12.6	12.7	14.0	11.4	14.1	18.5	18.6	13.1	18.4	16.7	10.7	18.7	16.4	14.7	13.6	16.0	15.2	13.8	15.1	8.6	12.6	14.4	16.5	12.0	17.4	13.8	8.2	19.4	11.1	15.9	9.4	18.4	14.4	14.1	16.0	17.8	18.7	15.4	23.1	19.4	10.6	18.2	17.3	18.9	12.7	10.1	11.0	17.9	14.6	19.1	22.6	17.5	24.5	16.1	11.1	15.3	17.7	14.2	13.2	14.7	17.9	22.0	14.5	13.0	9.9	15.7	15.9	21.4	21.1	9.9	14.8	19.7	19.6	35.3	12.8	15.7	15.6	17.6	12.2	16.2	17.0	12.3	24.0	30.2	19.4	25.1	18.1	18.5	18.2	12.7	22.5	12.1	25.7	12.4	20.8	24.2	21.7	18.1	24.4	10.9	19.5	18.2	15.2	31.1	20.6	17.0	26.5	12.1	21.4	19.2	18.7	13.9	10.2	16.1	15.4	19.4	15.5	18.1	15.3	17.8	16.0	17.5	19.1	5.5	23.1	9.2	8.2	15.3	10.6	15.0	17.2	27.2	20.3	12.6	12.7	18.6	13.1	14.7	19.4	17.9	10.9	26.6	12.4	12.0	14.1	4.4	7.6	4.0	12.5	7.0	7.9	18.4	18.3	17.8	3.2	19.6	5.3	0.0	21.0	18.7	16.5	15.2	17.4	6.6	17.6	9.5	10.9	16.5	25.1	0.5	8.1	14.3	10.1	19.0	9.7	11.1	16.9	5.8	16.6	14.6	15.6	0.0	20.0	10.6	12.0	11.4	14.8	20.1	11.8	10.7
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 75.2;testis: 18.6;tongue: 26.0"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 345.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 5.9;Hep G2: 12.2;K-562: 4.7;LHCN-M2: 10.9;RH-30: 9.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	1.2	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	75.2	0.1	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	1.0	26.0	1.9	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	12.2	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	10.9	0.6	0.0	0.0	0.7	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	345.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	54.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.6	2.7	1.8	2.5	0.0	0.0	0.1
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 152.9;Basal keratinocytes: 159.6;Cytotrophoblasts: 141.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.7;HBF TERT88: 18.3;U-138 MG: 8.7;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.2	6.2	10.9	12.7	0.9	1.9	0.1	0.7	5.9	0.1	1.4	0.1	4.8	18.3	0.1	0.6	0.0	1.1	2.0	0.8	0.4	1.3	4.8	2.9	3.8	2.0	0.6	0.2	0.2	0.4	0.0	8.0	0.3	0.8	0.2	0.2	0.0	0.0	0.7	0.5	0.2	2.7	0.7	1.3	0.1	0.4	0.7	1.2	3.2	0.6	1.0	0.8	8.7	2.0	0.1	4.1	0.0	0.2	0.1	0.0	0.0	10.5	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5											6.0	4.8	5.9	152.9	159.6	6.2	14.2	5.1	52.2	26.1	7.0	7.9	141.3	24.9	33.6	35.0	22.7	0.0	0.0	13.2	71.8	47.7	52.8	87.4	10.2	17.0	14.3	2.4	14.7	2.8	40.7	12.7	10.4	59.1	43.3	1.0	9.0	46.1	1.1	5.6	11.8	18.7	0.0	52.6	28.9	29.2	80.9	56.8	6.4	0.8	72.6
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 75.1"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3"					"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.1	2.1	2.8	0.6	4.0	0.5	1.3	1.2	3.7	1.6	0.8	4.2	6.9	0.9	1.4	10.4	0.6	0.7	1.1	2.7	2.8	3.1	15.4	0.6	0.8	1.0	4.9	2.3	2.1	1.8	10.6	2.7	1.1	5.9	1.9	0.5	5.3	2.1	9.3	2.4	0.7	1.0	2.3	5.2	1.0	1.1	75.1	1.4	0.0	3.5	0.1	0.6	0.7	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	5.4	0.1	1.1	2.2	0.3	3.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	3.8	0.7	0.0	0.0	17.7	2.1	0.1	0.0	0.0	2.5	5.1	2.9	0.0	4.4	0.2	1.3	1.1	0.0	0.0	4.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.0	1.2	3.7	2.8	3.1	4.9	2.3	5.9	1.4	0.0	0.0	0.0	1.0	0.6	0.5	2.0	2.5	0.0	0.0	17.4	3.9	0.0	232.1	1.7	237.5	0.7	0.0	0.0	0.9	0.1	2.4	0.7	0.0	0.0	0.5	6.4	1.7	3.1	0.0	743.6	8.1	0.8	6.8	1.0	0.0	2.7	0.9	0.0	10.3	33.5	0.2	0.0	1.0	85.0	5.2	0.1	0.1	0.0	0.0	0.1
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12474210-12562383	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 56.3;Intestinal endocrine cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 6.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 23.7;RT4: 21.6;SuSa: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	6.4	32.8	6.3	14.8	7.5	3.4	12.5	16.4	7.1	8.8	13.1	6.7	9.5	13.6	11.0	9.1	9.5	6.8	12.3	5.8	6.7	5.4	6.6	34.2	17.0	13.2	8.0	3.6	8.5	13.9	11.6	31.4	21.3	7.7	13.9	11.7	9.2	17.4	9.5	8.3	7.9	20.1	5.7	9.1	12.2	9.9	8.6	9.2	40.7	10.8	6.8	16.7	10.9	13.4	0.1	0.2	1.4	0.1	0.1	6.9	0.5	2.7	4.0	5.1	2.7	1.8	2.3	8.5	1.6	3.7	4.1	5.9	11.9	5.2	0.2	0.9	1.8	7.2	1.8	9.0	1.5	5.8	8.7	4.5	0.4	4.3	13.3	3.8	0.8	1.8	1.8	4.5	3.3	10.7	4.6	3.1	4.6	2.3	7.3	0.3	5.9	1.0	0.6	23.7	7.1	1.3	1.2	1.7	4.9	2.5	21.6	7.8	7.4	6.5	8.7	4.3	19.7	3.3	1.5	2.8	1.8	5.4	1.1	1.9	5.2	6.0	0.9	2.5	1.8	2.5	0.0	0.0	0.0	1.1	0.1	4.6	0.1	3.2	1.5	0.2	0.1	1.1	0.7	1.4	0.1	0.0	0.0	6.9	0.5	6.3	7.5	16.4	7.1	6.7	5.4	8.0	3.6	7.7	9.2	26.8	56.3	2.9	13.7	2.5	4.2	11.2	17.8	16.0	14.8	3.5	2.0	8.1	0.0	11.0	1.1	6.3	28.9	0.0	21.0	2.7	4.1	30.4	23.1	28.4	4.4	6.4	47.6	6.7	8.3	2.0	5.5	2.6	5.0	4.6	7.1	37.1	19.9	17.6	6.3	4.1	4.8	0.0	3.1	1.6	5.8	1.6	25.2	13.4	16.1	12.8
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667890	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 103.5;Late spermatids: 252.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	5.2	3.9	10.1	7.1	9.7	4.9	5.3	4.1	8.3	5.6	10.1	11.4	4.6	7.8	6.1	8.4	7.5	18.5	8.0	3.8	8.7	7.8	5.5	2.3	9.9	7.2	8.4	3.9	4.4	6.6	5.2	19.5	3.6	9.5	4.6	11.5	4.7	6.1	4.3	2.0	7.9	11.0	6.4	9.0	6.9	8.3	30.8	10.2	8.0	5.8	3.4	7.6	6.0	6.1	6.4	11.2	21.7	13.9	4.3	8.1	4.7	5.3	5.8	2.6	6.5	6.6	13.1	2.5	5.1	5.9	5.2	5.6	3.1	5.7	3.5	3.6	6.4	6.6	4.0	1.6	4.1	5.8	10.0	6.4	1.8	2.0	2.0	2.8	7.5	5.9	3.7	5.8	8.6	3.1	5.8	15.9	4.3	1.8	3.2	5.6	4.6	4.1	1.8	1.0	6.6	3.5	3.0	1.7	1.3	6.3	3.7	6.7	3.8	5.3	2.1	3.7	3.6	4.7	2.1	11.4	10.7	5.8	2.7	2.9	2.3	2.7	1.8	12.1	1.3	5.4	18.3	10.4	19.4	5.9	12.5	4.6	6.4	6.8	5.4	11.2	6.2	4.6	5.5	21.7	4.3	13.9	6.4	8.1	4.7	10.1	9.7	4.1	8.3	8.7	7.8	8.4	3.9	9.5	10.2	17.9	4.8	6.0	10.2	19.1	2.6	1.9	7.6	64.3	11.4	5.2	43.2	1.0	3.3	7.4	103.5	9.0	14.8	0.0	8.2	3.0	9.3	7.5	6.9	0.9	7.3	1.6	34.1	9.8	12.7	252.1	7.8	16.2	8.5	6.4	18.0	9.2	7.0	14.0	6.3	3.0	16.3	6.5	7.2	68.7	18.8	18.6	0.8	8.6	18.5	6.4
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100005	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 20.1;Early spermatids: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	2.8	4.6	9.2	2.0	16.3	1.0	3.0	2.9	9.6	3.4	4.7	2.2	3.8	3.5	6.8	9.2	4.2	8.4	3.5	7.4	17.4	3.4	4.7	3.0	3.4	2.3	3.3	6.8	4.4	4.3	7.7	10.6	2.7	3.7	4.2	3.0	3.0	2.8	5.4	3.8	3.4	3.0	8.6	2.9	4.0	9.1	10.4	4.7	6.2	4.6	1.1	1.9	4.0	2.7	4.1	1.5	2.0	0.8	2.2	3.2	1.3	0.1	2.4	2.9	1.4	3.9	2.2	0.0	1.1	1.8	4.6	1.6	2.3	3.0	1.0	6.0	1.2	3.3	0.3	5.7	0.8	3.5	5.8	3.2	10.6	1.8	1.6	1.7	2.6	6.5	1.7	0.5	2.3	1.1	2.9	2.6	0.0	3.1	1.6	2.7	1.0	5.0	2.5	2.4	1.0	2.0	4.9	4.5	0.3	1.0	1.1	3.6	1.5	4.0	1.7	2.9	0.2	0.8	1.0	2.0	2.5	2.1	1.7	0.9	2.0	2.4	0.1	3.1	0.4	3.7	2.0	0.5	1.9	2.3	0.8	2.3	4.1	2.1	3.1	0.6	2.2	2.7	2.7	1.3	2.2	0.4	1.5	3.2	1.3	9.2	16.3	2.9	9.6	17.4	3.4	3.3	6.8	3.7	4.7	0.0	2.7	1.7	1.2	0.9	1.7	6.5	2.5	20.1	2.3	1.8	2.0	2.0	5.0	0.6	10.4	1.0	1.6	0.0	0.6	1.2	1.3	0.9	1.1	1.0	0.6	1.6	2.4	1.8	0.6	4.6	1.7	0.1	0.0	1.8	2.0	4.5	0.5	2.5	2.5	2.3	1.0	0.0	1.4	4.7	3.1	1.4	0.6	0.0	2.1	1.3
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143166-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 151.1"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 136.7;T-cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 46.1"	"Group enriched"	"Detected in all"	10	"NK-cells: 29.6;T-cells: 46.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	6.4	3.1	2.0	13.1	4.3	51.3	2.9	1.3	4.3	4.8	3.9	1.9	7.9	0.8	4.3	18.3	4.1	3.0	8.8	7.4	3.0	1.4	5.5	3.4	15.9	19.0	1.8	0.8	3.0	1.7	0.4	14.6	0.6	2.0	10.7	1.1	2.8	2.0	151.1	1.8	9.8	4.7	3.7	1.6	16.4	2.1	3.3	0.7	43.4	2.4	2.6	12.2	24.6	14.1	3.9	2.3	1.4	2.2	29.6	46.1	7.5	1.5	0.0	0.1	0.1	0.2	0.3	2.3	1.9	0.0	2.8	2.7	4.4	0.3	15.3	5.6	2.1	0.0	1.1	3.8	0.0	0.5	0.2	0.0	0.3	13.9	0.0	1.0	6.3	1.3	0.5	1.0	0.4	0.0	0.0	0.0	14.2	0.0	17.5	0.1	2.6	12.5	14.5	3.4	0.4	5.4	0.0	0.2	12.1	0.1	17.4	15.5	0.8	0.7	0.2	2.8	0.0	1.0	7.2	0.0	0.0	4.1	0.0	0.9	1.2	1.8	21.0	0.0	6.9	0.1	0.5	0.9	0.2	46.1	2.2	22.6	3.9	11.4	41.4	2.3	2.6	7.8	23.9	1.4	29.6	1.8	0.6	3.4	7.5	2.0	4.3	1.3	4.3	3.0	1.4	1.8	0.8	2.0	0.7	0.0	10.6	47.7	90.1	86.0	22.1	33.5	2.5	0.0	1.2	8.7	21.6	0.8	1.7	0.9	0.7	8.2	3.3	0.0	1.2	1.1	24.2	63.5	105.8	2.8	75.6	0.0	84.2	8.6	27.5	0.7	1.7	90.7	136.7	0.0	12.3	1.3	0.9	2.9	1.8	1.0	2.5	0.0	35.3	0.5	4.3	95.9	1.4	346.4	21.8	28.5
DUSP21		ENSG00000189037	"Dual specificity phosphatase 21"	Q9H596	X	44844004-44844888	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 15.9"	"Group enriched"	"Detected in some"	54	"Early spermatids: 58.8;Late spermatids: 167.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 1.7;K-562: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (5.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 71.9;U-266/70: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	24.8	13.1	22.0	24.6	31.3	19.4	28.7	12.1	27.5	18.1	29.0	29.8	18.8	21.2	20.6	25.2	29.8	15.0	20.4	31.0	22.6	17.4	16.0	20.3	24.6	27.4	33.5	16.1	13.9	27.9	10.8	14.8	25.9	25.5	16.1	15.9	16.9	20.9	15.5	32.0	30.6	21.8	23.4	29.2	30.0	21.4	41.3	30.0	9.2	19.9	19.0	27.9	22.8	27.4	21.6	18.0	16.3	17.5	2.9	8.2	9.8	3.6	2.2	4.8	7.2	5.6	6.2	6.4	2.7	2.2	2.4	2.9	2.4	4.1	7.7	6.6	2.8	5.1	2.5	6.0	5.0	1.7	18.4	6.9	5.2	1.8	6.6	2.8	1.8	6.8	4.6	15.2	1.7	3.2	4.0	6.8	6.6	4.8	25.7	2.0	2.1	2.7	6.7	2.9	2.7	5.2	5.4	3.3	71.9	4.5	1.6	8.3	3.2	2.3	0.9	7.9	11.0	4.9	2.4	9.3	2.2	2.9	2.2	1.6	36.6	25.8	10.7	0.8	5.1	4.9	16.3	17.5	6.9	5.0	14.0	3.5	21.6	3.9	5.1	18.0	17.5	3.6	5.1	12.0	2.9	12.6	15.4	8.2	9.8	22.0	31.3	12.1	27.5	22.6	17.4	33.5	16.1	25.5	30.0	14.9	17.6	38.7	19.8	23.6	5.2	35.3	10.2	26.8	25.0	5.2	0.0	9.1	18.3	21.3	11.0	33.7	13.8	0.0	45.0	6.9	17.8	14.6	32.3	22.1	25.5	0.0	9.1	22.7	40.0	14.8	14.4	35.8	43.9	83.8	13.0	9.8	28.3	14.0	8.9	14.6	2.6	25.8	27.2	30.7	73.7	32.4	5.5	15.0	14.5	23.5
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.0"	"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	25.0	28.0	7.6	9.3	10.5	11.2	27.3	4.4	9.0	15.5	15.9	5.9	6.6	17.2	12.2	15.0	21.2	10.9	12.6	14.9	7.8	5.2	88.0	80.8	12.1	15.4	8.5	4.6	12.3	21.5	12.5	4.3	7.4	9.6	18.0	9.1	9.5	37.8	10.9	32.8	15.8	16.1	7.7	9.6	8.7	11.0	9.7	7.3	5.7	27.0	17.4	11.4	10.5	19.1	13.6	59.7	49.9	43.2	21.3	24.0	24.0	12.2	13.2	0.1	0.0	12.9	11.1	0.1	5.0	4.1	5.9	4.6	5.4	14.1	0.0	30.0	5.5	1.3	0.5	3.4	4.5	3.2	3.0	1.5	16.9	4.8	0.0	19.3	10.2	13.0	46.8	12.3	3.8	13.9	4.3	22.6	0.0	7.7	6.2	8.3	22.2	1.0	0.4	22.9	22.1	18.9	0.0	0.0	5.8	7.2	2.1	5.8	12.8	9.1	20.0	23.4	2.4	12.9	16.0	16.5	4.9	0.2	0.6	0.0	4.4	10.3	0.1	8.3	8.2	3.7	20.0	43.2	49.9	24.0	33.4	13.3	13.6	18.1	22.5	59.7	9.8	11.0	16.4	43.2	21.3	22.1	13.6	15.7	24.0	7.6	10.5	4.4	9.0	7.8	5.2	8.5	4.6	9.6	7.3	38.7	65.7	25.0	97.5	66.2	8.4	26.4	94.3	38.8	83.0	48.8	5.9	13.5	222.2	148.8	39.6	154.1	106.2	0.0	394.0	20.1	31.9	94.9	53.1	219.9	155.2	1.6	34.0	66.3	86.6	5.5	24.5	94.8	40.5	32.5	101.6	59.7	258.6	101.7	14.9	620.9	7.1	12.9	32.0	3.2	13.0	65.1	4.8	43.7	91.6	102.1
DUSP26	"DUSP24, MGC1136"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591332-33600106	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 147.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 76.1;Cardiomyocytes: 54.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 58.5"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	1.3	9.3	11.5	1.4	13.1	1.1	1.2	18.2	14.8	1.1	1.7	4.2	0.0	2.4	1.5	3.4	3.0	2.3	1.5	20.1	9.1	15.9	1.6	1.0	1.7	1.1	10.6	8.8	15.1	2.2	1.0	14.0	1.0	7.6	2.6	1.5	4.4	1.5	1.3	147.1	1.0	1.9	2.0	10.0	1.2	2.6	1.6	3.8	0.0	1.1	27.0	1.3	1.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.2	11.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.1	18.2	14.8	9.1	15.9	10.6	8.8	7.6	3.8	0.0	0.0	0.0	0.2	0.0	76.1	54.3	0.0	0.0	0.0	0.0	39.3	0.0	18.3	0.3	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	23.8	24.6	0.0	0.0	4.4	0.0	0.0	1.7	0.0	0.0	13.3	1.6	0.0	5.6	0.8	58.5	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 131.1"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 18.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	131.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.6	1.4	0.8	2.4	1.9	1.2	1.5	1.1	1.0	4.5	2.7	1.0	1.2	2.3	5.1	1.7	0.7	1.6	3.4	6.4	3.9	3.4	2.5	1.0	2.5	6.7	1.7	1.8	1.0	1.3	2.9	0.7	3.9	2.7	3.3	1.3	1.9	3.1	4.0	1.4	2.6	1.4	3.8	4.8	3.6	1.1	2.9	4.9	2.7	1.8	1.9	2.2	1.4	2.4	4.4	1.7	3.5	2.9	2.2	1.7	13.2	3.8	4.4	2.2	1.9	2.8	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3	0.0	5.0	5.1	6.9	3.3	6.3	12.9	12.7	6.7	1.2	12.2	3.9	6.4	13.3	4.1	27.6	3.1	11.8	0.0	5.1	4.0	4.1	8.4	6.9	6.6	10.0	7.9	8.1	2.5	10.3	29.8	2.8	7.0	6.8	8.2	8.1	7.4	3.9	11.8	1.4	11.2	6.6	6.5	5.6	41.1	17.6	4.6	5.8	12.5	10.1	6.8
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 242.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.5	19.2	7.4	7.9	21.6	11.6	6.3	8.0	19.2	18.8	22.8	18.4	7.1	1.6	12.7	15.0	39.0	9.2	11.4	9.8	19.9	3.6	8.7	5.3	8.8	15.0	26.4	0.6	5.6	10.7	17.8	14.5	12.6	20.6	13.1	5.4	4.8	1.8	21.9	7.6	2.7	2.7	3.4	15.1	14.0	3.4	22.3	4.0	26.1	11.2	4.1	7.5	9.4	6.3	23.6	21.3	28.1	14.9	13.6	21.3	14.5	30.2	13.2	9.8	13.0	0.4	25.3	7.5	7.1	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8	23.8	16.8	7.2	42.9	19.9	16.3	242.3	48.4	14.7	9.1	40.1	23.6	14.4	34.9	42.9	73.8	32.1	42.0	0.0	50.5	17.5	18.4	41.2	38.1	99.4	73.0	19.1	34.9	27.6	34.5	128.1	13.6	40.3	10.1	32.5	17.6	14.8	50.2	28.1	24.8	69.4	16.6	32.3	35.5	2.4	2.9	25.2	37.6	6.4	14.6	32.8
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 94.6;monocytes: 131.7;Pancreatic endocrine cells: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"A549: 29.9;OE19: 27.1;SK-MEL-30: 46.1;WM-115: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	29.9	17.8	0.8	2.2	0.0	1.5	2.3	12.7	7.0	3.1	0.3	5.7	0.0	6.3	1.0	4.9	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.1	13.1	15.4	5.7	0.1	0.1	1.3	14.0	12.6	0.0	2.0	3.1	27.1	18.4	0.3	0.5	2.3	16.1	5.9	0.1	9.8	3.2	15.2	46.1	0.3	3.2	0.3	16.0	5.1	0.0	0.0	1.6	3.5	0.4	0.0	15.6	2.6	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2	0.0	3.2	1.4	94.6	10.8	34.2	1.9	28.1	29.4	15.9	0.0	11.8	2.7	0.0	64.0	3.5	10.8	0.4	0.0	66.9	37.5	8.4	20.9	5.8	0.0	19.5	41.3	93.8	19.6	5.0	19.7	0.3	25.0	62.4	131.7	7.6	0.9	166.3	0.0	0.0	0.0	2.8	12.9	12.2	0.6	0.4	10.5	14.9	8.5	2.2	92.0
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497838-110511544	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal glandular cells: 372.8;Urothelial cells: 958.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.4;non-classical monocyte: 8.8;plasmacytoid DC: 13.3"	"Group enriched"	"Detected in many"	19	"dendritic cells: 13.3;monocytes: 8.8;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 87.7;Karpas-707: 34.0;U-266/70: 48.5"	"Region enhanced"	"Detected in many"		"cerebellum: 68.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.9"							NA	NA						"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	13.7	11.0	2.8	12.4	5.1	14.5	11.2	19.8	5.2	15.1	12.5	3.3	7.7	5.4	9.1	8.8	55.5	5.6	24.2	11.3	5.2	3.3	9.1	13.1	12.1	9.3	2.9	2.8	6.5	3.9	5.5	8.0	45.1	5.6	15.6	12.4	21.0	9.4	10.0	1.8	6.5	17.6	10.3	7.1	11.4	10.2	13.1	2.1	4.8	7.8	21.9	47.8	31.6	14.3	0.2	13.3	0.4	8.8	0.0	3.4	0.5	4.4	3.0	0.6	1.5	2.4	10.2	2.2	10.6	24.0	5.7	6.9	1.9	6.0	0.5	2.0	2.5	12.2	1.4	0.6	5.5	9.3	12.7	0.3	2.4	0.5	1.1	9.1	0.6	3.2	3.9	7.6	18.2	87.7	2.5	3.5	0.2	0.4	34.0	17.0	1.2	0.1	1.8	2.0	0.4	4.6	0.0	1.3	7.8	19.5	8.7	0.3	0.8	0.7	1.7	3.5	5.7	0.9	0.7	5.5	1.9	1.3	4.6	5.0	48.5	8.6	1.2	7.5	3.3	1.3	0.4	0.2	0.0	3.4	2.0	1.2	0.2	1.8	1.0	0.9	0.0	0.0	1.1	0.1	0.0	8.8	13.3	0.0	0.5	2.8	5.1	19.8	5.2	5.2	3.3	2.9	2.8	5.6	2.1	3.0	8.5	17.2	372.8	58.6	8.2	28.2	7.6	0.0	18.2	33.2	5.9	30.4	5.0	26.2	1.0	35.0	36.5	0.0	4.2	9.9	26.3	104.8	3.5	4.0	9.3	0.0	46.8	165.1	18.3	1.9	1.4	20.8	150.1	76.7	7.8	2.5	31.7	14.0	0.7	0.3	10.6	0.0	31.1	1.0	9.1	89.1	114.9	25.9	7.6	958.4
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 82.0;NB-4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.4	82.0	21.1	18.0	0.0	8.8	11.2	1.8	1.3	7.2	1.3	0.0	2.1	3.7	3.4	9.4	0.1	22.0	2.5	0.1	0.1	3.6	0.2	11.4	15.0	15.7	40.2	3.5	7.7	15.5	14.5	18.4	40.7	0.4	0.0	3.8	5.6	0.5	0.5	58.8	14.8	28.0	20.0	40.0	3.0	1.5	25.2	23.7	0.4	17.4	0.2	0.1	46.7	8.7	1.2	8.8	10.9	6.0	0.1	1.1	4.2	0.6	3.2	0.1	24.9	11.1	38.0	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4	95.3	270.1	20.5	66.1	80.7	1.2	8.1	53.5	22.7	111.5	171.0	31.4	63.9	14.9	10.9	1.1	97.2	31.9	0.0	11.9	2.9	29.6	20.6	438.5	128.2	43.3	1.6	18.4	173.1	216.2	1.4	1.4	140.4	11.8	1.8	11.0	9.0	12.3	7.4	3.2	23.5	2.0	25.8	8.5	1.2	1.1	21.7	41.2	18.5	12.8	23.4
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056550	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 104.2;Suprabasal keratinocytes: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 41.4;hTERT-HME1: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073007	Approved					NA	NA					"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	5.5	5.9	7.8	4.3	8.5	1.6	3.7	6.5	19.2	8.6	2.9	15.3	3.4	2.4	5.6	2.4	22.0	4.4	5.3	8.3	7.3	4.8	3.6	2.5	7.0	5.6	9.9	10.0	4.7	4.3	3.9	3.8	8.9	4.9	4.0	2.3	4.6	5.2	5.3	11.4	24.1	3.5	4.2	4.8	10.7	3.7	5.4	9.2	3.2	3.4	15.0	8.6	5.8	14.7	1.0	7.5	1.7	10.7	2.3	8.2	1.7	7.6	1.6	1.9	4.4	6.3	5.5	2.3	7.7	14.8	7.7	5.6	2.1	3.9	2.1	2.1	11.4	3.9	9.0	7.4	28.0	5.3	1.8	3.0	10.0	3.9	3.7	5.1	8.9	6.1	5.7	41.4	9.9	35.3	5.3	7.3	6.2	5.7	6.1	6.1	2.1	6.6	12.7	4.8	2.1	14.0	5.6	1.7	5.6	3.2	3.3	2.4	7.2	3.4	3.2	5.4	1.6	1.1	21.6	9.5	14.9	9.6	15.6	23.5	2.9	2.7	3.4	8.2	15.1	4.7	0.9	3.9	1.7	6.0	10.7	8.2	1.0	7.2	4.3	5.0	0.6	5.3	4.8	1.4	2.3	10.0	7.5	4.6	1.7	7.8	8.5	6.5	19.2	7.3	4.8	9.9	10.0	4.9	9.2	8.9	0.6	1.5	23.5	104.2	4.7	15.3	0.0	1.4	5.7	0.0	0.0	0.4	1.7	3.3	1.1	11.3	0.7	0.0	2.3	3.4	9.0	3.2	0.0	0.4	6.7	0.0	2.4	28.3	10.7	0.0	8.1	8.3	20.3	0.0	2.9	0.9	7.4	0.0	4.6	0.9	1.0	25.8	15.1	3.2	4.3	118.3	1.0	4.5	2.9	24.4
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554044-1571920	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.3	2.2	18.8	3.2	18.8	7.5	3.5	20.0	30.2	1.9	4.3	4.2	1.4	1.7	5.9	4.8	3.5	4.0	5.4	5.7	16.6	9.3	2.6	3.7	3.6	3.5	5.5	11.2	2.2	12.7	1.7	10.8	2.8	5.1	3.0	4.1	2.7	5.1	2.7	6.1	3.2	6.3	9.3	3.6	6.3	4.3	2.4	5.1	0.0	2.6	2.2	2.3	2.7	1.6	0.1	0.1	0.0	0.0	0.0	0.7	0.0	1.8	0.8	1.0	0.1	0.0	0.1	2.2	0.1	1.2	0.4	1.2	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.4	0.0	0.1	0.1	0.0	1.8	0.0	6.2	0.0	0.4	0.0	0.0	1.9	0.1	0.1	0.7	0.0	0.2	0.0	5.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.0	2.3	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	18.8	18.8	20.0	30.2	16.6	9.3	5.5	11.2	5.1	5.1	3.0	0.6	0.0	5.6	8.8	101.5	5.2	5.1	0.0	0.0	12.2	45.2	0.1	1.7	6.9	0.2	2.2	22.7	0.0	9.6	0.4	4.5	12.8	0.0	0.4	0.4	85.8	40.5	1.3	0.0	0.0	0.6	0.3	5.0	1.8	20.2	16.0	9.8	17.5	0.4	1.1	36.7	6.5	5.1	0.2	0.4	4.3	4.9	1.3	16.8	9.8
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	20.0	18.5	19.2	23.4	20.0	49.7	19.9	31.6	24.6	23.7	23.0	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19.0	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31.0	25.1	25.0	14.0	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3.0	3.3	6.0	2.5	1.3	3.8	0.8	10.4	8.1	16.6	11.6	7.9	8.6	14.7	9.3	11.8	9.4	9.9	11.5	9.2	14.0	6.3	16.2	12.4	7.1	12.1	9.0	11.1	21.4	5.2	41.4	13.5	7.0	11.8	16.3	15.2	8.7	10.8	12.2	18.7	10.8	9.7	19.8	15.6	32.5	9.8	10.4	21.4	11.2	17.5	10.3	4.8	27.8	9.1	12.9	9.8	13.6	17.1	9.6	21.1	14.5	14.5	5.8	13.5	15.2	12.4	12.9	3.9	8.0	7.7	22.1	17.1	20.0	10.2	18.4	14.0	5.5	1.5	2.0	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3.0	3.8	3.7	6.0	1.3	2.5	3.3	3.1	0.8	19.2	20.0	31.6	24.6	18.8	17.9	15.5	17.8	14.0	16.3	17.9	21.0	14.9	21.8	33.3	28.8	68.6	17.8	18.7	21.6	10.4	25.5	8.2	0.0	11.5	21.3	24.8	20.2	23.3	12.6	9.6	20.6	24.7	24.3	15.3	13.8	44.5	20.5	28.3	24.3	15.3	15.0	20.8	23.6	6.4	16.5	15.6	16.7	20.4	18.4	8.1	19.4	12.9	24.5	15.8	14.0	27.7	12.8	30.6	13.6	28.3
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 145.5;Late spermatids: 469.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.4	5.9	4.8	4.5	0.7	2.7	1.7	2.5	2.3	0.8	3.3	1.3	10.6	3.2	0.1	2.9	1.2	1.9	2.2	4.9	7.3	0.6	5.4	0.8	4.0	0.3	1.8	6.1	1.2	0.8	2.8	8.2	0.6	3.3	1.4	1.9	0.4	4.3	1.9	0.8	2.0	2.5	2.0	0.9	0.1	0.6	5.4	2.1	12.2	13.8	4.2	4.2	0.2	4.7	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6	0.0	1.1	13.7	3.6	3.1	14.9	5.3	5.1	1.4	0.0	15.7	19.6	1.8	8.3	11.7	145.5	5.7	9.1	0.0	3.7	1.5	4.0	5.4	1.1	3.0	4.9	9.5	19.5	6.2	9.2	469.8	6.6	2.7	5.0	3.6	9.4	8.1	8.6	8.6	4.9	11.2	13.0	0.0	2.3	22.4	14.0	2.5	1.1	6.9	8.5	3.2
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 72.1;Horizontal cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.8	7.8	11.7	8.4	5.9	8.1	9.4	14.1	9.2	6.9	3.9	10.3	7.7	25.8	17.4	20.3	4.2	16.1	9.3	5.5	7.4	11.1	12.2	4.1	5.2	3.9	2.3	9.4	9.1	6.6	7.9	18.6	14.9	11.7	3.8	11.0	5.1	13.5	8.8	7.9	8.0	4.6	10.1	9.0	12.6	21.5	11.6	11.4	8.0	17.4	15.5	18.3	5.9	7.9	8.1	8.3	5.4	7.9	5.7	11.0	10.4	7.5	11.1	6.5	1.0	14.3	10.5	6.4	11.3	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9	8.9	12.2	6.4	9.1	10.1	17.2	33.5	22.9	12.0	10.3	1.8	21.6	2.7	0.0	17.2	0.4	10.5	72.1	0.0	15.8	6.4	18.2	11.3	5.7	4.7	14.1	76.3	23.6	6.2	11.6	1.6	10.6	9.8	8.5	6.4	50.5	15.3	15.6	48.2	12.4	7.5	21.9	12.9	21.1	2.5	8.7	14.2	3.8	21.0	26.7	28.1
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8.0	0.0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0.0	2.4	0.1	5.0	3.7	7.3	0.3	10.0	1.0	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1	3.0	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0.0	0.0	3.0	160.9	4.2	0.0	0.0	1.9	0.1	7.3	3.2	0.0	1.1	0.9	0.0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3.0	1.4	0.0	1.8	1.0	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0.0	0.2	3.5
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	9	"testis: 85.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 369.7;Late spermatids: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	1.6	2.1	2.3	2.1	1.8	1.6	2.8	1.9	2.3	2.6	2.1	2.2	2.3	1.7	2.5	9.1	1.6	2.0	1.7	1.7	1.8	1.8	1.9	2.0	2.2	2.5	1.9	2.5	2.2	2.3	2.9	2.7	2.9	2.3	2.3	2.7	2.4	2.3	3.4	1.6	1.9	2.4	2.1	2.7	4.3	1.7	85.9	2.1	1.6	4.3	1.6	2.0	2.4	1.6	7.6	2.7	1.3	5.2	1.1	1.6	1.6	1.9	3.0	3.8	4.1	5.8	7.2	4.6	2.3	4.6	5.3	5.8	0.6	3.1	5.7	0.3	6.5	3.6	4.0	2.9	4.3	4.2	4.3	6.6	4.0	0.8	3.3	16.4	3.4	3.2	4.9	9.2	3.7	12.2	9.9	7.4	6.3	1.6	6.5	4.7	4.0	3.2	8.5	5.2	1.0	1.7	0.7	2.7	2.4	6.4	1.8	0.0	1.5	0.4	2.3	3.3	8.7	1.8	3.1	0.5	6.2	4.9	0.6	2.9	1.9	2.3	3.4	3.3	5.4	3.2	0.6	2.8	1.3	1.0	2.2	1.1	7.6	1.5	1.6	2.7	5.8	1.6	1.6	0.1	1.1	5.2	1.4	1.1	1.6	2.3	1.8	1.9	2.3	1.8	1.8	1.9	2.5	2.3	2.1	11.9	14.4	11.1	13.1	7.9	20.7	19.4	5.1	12.0	13.6	15.7	9.8	12.9	26.6	22.0	369.7	9.3	4.0	0.0	23.8	10.1	17.5	12.6	17.3	9.2	41.7	12.7	5.2	9.2	15.7	289.4	14.1	15.9	15.1	18.0	47.3	16.6	22.1	15.8	29.7	28.1	17.0	6.5	15.6	20.0	31.5	6.6	8.2	17.3	15.6	9.8
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 104.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.5;HaCaT: 9.8;HBEC3-KT: 8.0;MCF7: 8.7;NTERA-2: 32.7"	"Not detected"	"Not detected"							CAB026144	Uncertain					NA	NA		24000000			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.4	0.4	0.0	2.0	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0.0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0.0	0.0	2.8	10.6	2.9	5.8	0.0	0.0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0.0	5.1	6.0	16.4	17.2	1.6	11.8	0.0	0.7	0.2	0.1	0.2	6.9	1.6	5.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	10.5	4.2	0.0	0.0	0.0	0.0	9.8	0.0	8.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.7	0.0	1.1	32.7	5.1	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	0.0	4.9	0.0	2.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	3.4	0.9	0.4	0.0	6.9	5.1	0.2	0.2	0.0	0.7	0.2	1.6	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	0.0	5.0	1.8	0.0	0.8	2.5	0.0	3.4	7.0	0.0	1.5	0.0	3.9	16.5	0.0	6.5	0.0	3.7	2.0	0.4	2.1	0.0	7.6	0.4	0.0	1.2	0.0	0.0	7.5	0.6	0.0	0.0	0.0	3.7	0.3	5.1	6.8	0.0	1.1	0.0	0.0	0.0	0.2	1.2	3.1	0.8	0.0	6.0	5.0
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	"EPH receptor A10"	Q5JZY3	1	37713880-37765133	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.6;intestine: 12.6;testis: 24.8"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 86.4;Early spermatids: 49.4;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.2;HDLM-2: 19.6;SCLC-21H: 9.1"									HPA027497	Uncertain				"Intracellular and membrane"	NA	NA					"HPA027497: AB_10601158"	"unprognostic (9.27e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.24e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (8.81e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	0.4	1.1	5.8	1.7	15.6	0.7	1.9	1.3	10.5	0.6	12.6	3.6	0.2	5.8	0.5	6.8	0.8	1.8	2.1	0.4	4.6	7.4	0.5	0.4	0.5	0.6	3.5	5.0	0.4	5.1	1.1	10.8	0.4	6.4	1.4	10.3	1.6	2.4	0.7	0.4	0.6	7.3	1.0	2.3	0.5	5.3	24.8	2.1	0.0	1.0	0.0	0.5	0.6	0.3	0.4	0.3	1.5	0.3	0.8	0.7	0.1	1.5	1.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.7	2.8	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.0	19.6	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.7	0.0	1.1	0.0	0.2	0.7	2.1	0.6	0.0	0.0	0.4	0.3	1.7	9.1	0.4	1.1	0.0	0.0	0.2	2.9	0.1	0.0	0.0	1.0	0.1	0.0	1.8	1.2	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.7	0.1	0.4	0.4	0.3	0.3	0.1	0.4	0.6	0.7	1.5	0.8	0.3	0.3	0.2	0.1	5.8	15.6	1.3	10.5	4.6	7.4	3.5	5.0	6.4	2.1	0.0	0.3	0.0	0.0	0.1	5.0	1.4	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.4	49.4	0.0	9.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	11.1	18.0	0.0	0.0	147.5	1.7	0.0	0.0	0.0	9.3	0.3	2.1	23.5	0.4	0.0	3.0	0.0	0.0	8.2	2.5	0.0	0.0	0.0	8.3	0.1
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 66.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.8	0.0	0.0	4.1	0.0	0.0	0.6	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.6	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0	0.0	0.0	0.0	0.3	0.5	1.5	2.1	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.1	12.2	0.1	0.0	0.0	0.1	19.1	0.0	0.6	0.0	1.3	2.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	0.0	16.9	6.5	20.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 25.0;Pancreatic endocrine cells: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 35.8;ASC diff: 15.8;CACO-2: 26.2;U-2197: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		8400000			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.1	1.8	8.1	1.9	18.3	3.5	5.2	14.7	29.6	4.9	5.9	3.1	3.2	1.1	6.5	3.1	5.0	6.6	3.3	16.7	19.9	4.4	5.2	0.9	3.7	2.5	2.4	16.4	11.7	1.2	2.0	1.2	1.7	4.9	5.9	4.7	0.8	3.7	6.7	3.1	12.8	4.1	8.2	2.1	3.3	4.0	11.4	2.6	0.5	9.8	3.7	3.2	4.6	4.9	2.5	0.2	3.0	0.0	6.0	5.0	0.7	1.1	1.1	35.8	0.0	15.8	9.8	0.0	8.5	3.7	7.7	2.8	26.2	0.4	0.0	0.0	11.8	0.0	3.1	5.5	0.0	3.2	4.2	3.0	0.0	0.3	0.0	0.4	0.0	0.6	3.9	1.9	2.4	0.0	4.8	7.2	0.0	0.0	0.0	2.0	4.2	0.1	0.0	2.5	2.6	0.8	0.0	3.9	0.0	12.0	1.9	6.3	0.0	2.8	0.6	0.6	3.0	1.3	0.0	0.0	0.8	1.5	17.5	0.4	0.0	0.0	0.0	3.2	0.0	1.6	3.0	0.0	0.0	3.4	0.0	3.4	2.5	5.0	3.3	0.0	1.8	1.9	0.3	0.2	6.0	0.0	0.2	2.1	0.7	8.1	18.3	14.7	29.6	19.9	4.4	2.4	16.4	4.9	2.6	0.0	5.4	0.8	0.4	5.5	10.2	25.0	7.6	1.4	3.4	8.7	0.0	0.0	6.6	0.2	2.0	11.7	0.1	0.0	0.2	0.0	3.9	1.2	1.1	0.0	0.3	1.6	3.4	12.3	0.0	4.3	1.1	0.2	6.8	0.0	14.0	6.3	18.0	0.0	8.1	1.5	2.7	0.0	7.2	6.7	1.3	10.9	0.0	1.0	6.8	1.8
EPHA5	"CEK7, EHK1, Hek7, TYRO4"	ENSG00000145242	"EPH receptor A5"	P54756	4	65319563-65670495	"Enzymes, Predicted membrane proteins"	Neurogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 12.1;Late spermatids: 12.5;Muller glia cells: 6.4"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.8;PC-3: 7.1;TIME: 9.5;U-138 MG: 19.9;U-2197: 12.1;U-251 MG: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.02e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.89e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.60e-1)"		"unprognostic (6.68e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.25e-2)"		"unprognostic (5.88e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.81e-3)"	0.9	2.7	17.6	1.0	9.0	0.8	0.8	1.9	25.5	5.9	1.2	1.5	1.8	0.9	1.9	0.9	1.1	1.0	0.9	2.7	17.3	6.8	0.9	0.8	1.1	0.9	5.4	13.2	6.2	0.8	0.8	6.5	2.7	10.2	4.2	1.1	2.6	1.2	4.1	0.8	1.2	0.9	1.4	17.7	1.5	1.1	2.2	0.7	0.0	3.0	0.0	0.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.3	0.0	0.3	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.2	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	19.9	2.5	12.1	15.3	0.0	0.0	0.0	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	9.0	1.9	24.7	17.3	6.8	5.4	13.2	10.2	0.7	0.0	0.0	0.0	0.0	0.5	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	1.6	0.0	0.0	0.0	12.5	0.9	0.0	3.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.0	0.2	0.1	0.0	0.0	0.0	0.0
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	67	"Early spermatids: 305.1;Late spermatids: 156.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 8.2;U-266/70: 24.9"	"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	8.2	0.0	2.1	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.9	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.3	2.8	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.4	0.6	0.2	0.0	0.1	3.4	2.3	0.0	0.1	0.0	0.0	0.0
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419547	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 110.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.1;Cardiomyocytes: 10.8;Early spermatids: 3.7;Horizontal cells: 11.1;Proximal tubular cells: 11.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.9;HEK 293: 25.5;RH-30: 24.4;THP-1: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		340000			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	1.3	1.3	6.0	1.7	24.6	1.2	2.2	21.6	8.6	2.4	24.6	0.0	0.1	2.5	2.0	7.5	14.7	1.7	3.1	4.2	13.8	2.9	6.9	1.3	1.5	1.3	2.4	5.8	3.0	1.3	110.4	5.6	1.6	6.7	17.9	3.6	0.4	8.2	1.9	1.3	1.4	6.5	20.2	4.8	4.7	14.9	2.1	4.4	0.0	1.3	0.0	1.3	9.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	25.5	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.5	0.0	0.6	4.5	24.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	20.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	24.6	21.6	8.6	13.8	2.9	2.4	5.8	6.7	4.4	0.0	0.0	0.0	0.4	0.3	14.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.7	0.7	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.1	11.1	0.0	0.0	0.0	2.1	0.9	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	11.5	0.9	0.0	0.8	0.2	0.7	0.9	0.0	0.0	0.0	0.0
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563564-22603594	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 5.2;Early spermatids: 2.5;Horizontal cells: 3.2;Late spermatids: 3.9;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 37.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 25.0"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.2	9.4	1.6	0.2	3.1	0.2	0.1	1.8	3.9	0.2	0.2	2.2	0.0	1.7	0.1	0.3	0.2	0.1	0.2	0.2	2.0	2.6	0.1	0.1	0.2	0.2	2.1	4.1	0.1	8.3	0.2	1.7	0.1	5.3	0.2	0.2	1.6	0.8	0.2	0.3	0.4	0.2	0.1	1.3	10.3	0.2	3.5	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	3.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.9	2.0	2.6	2.1	4.1	5.3	0.6	0.0	0.0	0.0	0.0	0.0	5.2	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	8.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	15.9	6.7	6.5	10.4	0.6	0.6	0.0	3.7	0.2	11.3	2.4	2.3	6.4	0.2	8.0	1.6	34.4	15.1	4.4	21.7	3.0	0.0	1.6	0.0	0.7	0.0	6.8	0.0	1.6	2.2	7.0	20.2	0.1	10.0	29.7	0.9	0.6	0.0	2.2	2.3	0.3	0.1	1.5	17.8	4.4	1.9	6.7	0.3	5.5	1.5	7.1	7.4	6.5	0.2	0.0	0.6	0.4	0.2	29.4	4.5	11.8	11.4	25.5	0.0	0.1	0.0	8.4	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3	3.0	0.0	0.0	1.5	0.7	11.6	1.2	12.7	1.4	3.4	0.0	0.0	0.4	0.0	42.3	2.3	0.5	6.8	0.0	6.8	2.2	1.5	1.4	0.0	0.5	9.1	6.4	46.8	0.6	7.5	0.4	0.9	3.7	0.0	0.0	53.6	20.9	38.4	3.5	0.7	0.0	1.7	0.0	1.7	0.5	2.6	0.4	0.9	0.0	82.9	1.0
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	"EPH receptor B3"	P54753	3	184561784-184582409	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Angiogenesis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 49.3"	"Cell type enhanced"	"Detected in many"	10	"Intestinal endocrine cells: 68.8;Mucus-secreting cells: 39.5;Suprabasal keratinocytes: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.1;myeloid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;HaCaT: 23.4;OE19: 16.1;SK-BR-3: 18.1;T-47d: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007698, HPA008184, CAB034350"	Enhanced					NA	NA		20000			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.10e-3)"	1.4	0.9	4.5	5.0	2.6	0.5	9.0	9.7	5.7	22.7	8.8	2.3	1.7	5.7	10.0	1.9	19.9	3.0	9.7	1.6	4.7	1.8	1.7	1.0	4.7	1.0	3.3	3.7	9.0	49.3	1.1	1.7	6.3	7.2	7.7	9.7	3.8	27.7	3.5	0.7	32.3	5.6	3.5	1.3	1.2	16.0	1.1	4.0	0.2	1.0	15.7	8.4	4.0	13.6	0.0	3.1	0.3	1.1	0.0	0.4	0.4	3.7	1.3	8.8	0.9	2.7	0.2	17.0	0.6	1.1	1.3	0.7	1.2	0.1	0.0	1.7	3.6	0.6	23.4	3.1	1.1	0.3	0.1	0.7	0.0	0.2	0.0	0.2	0.0	0.2	0.7	7.7	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.6	9.9	0.0	3.8	0.9	16.1	1.4	0.8	5.3	0.0	0.0	3.4	1.1	1.3	0.7	18.1	0.8	4.8	12.0	0.1	0.0	2.1	3.1	1.1	1.4	0.0	0.0	0.1	0.2	0.0	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.4	4.5	2.6	9.7	5.7	4.7	1.8	3.3	3.7	7.2	4.0	3.0	2.4	0.0	6.9	21.4	0.0	1.4	2.5	1.4	2.3	0.0	0.0	8.1	1.7	0.3	0.4	0.6	3.5	0.0	1.4	14.8	8.4	5.5	4.6	0.0	17.9	14.3	68.8	3.1	0.3	0.0	2.6	1.0	0.0	1.0	39.5	0.1	2.4	7.0	5.6	0.1	0.8	0.0	2.1	0.5	0.6	31.2	13.6	0.0	27.1	19.5
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827521	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 50.1;Endothelial cells: 43.5;Ito cells: 106.8;Syncytiotrophoblasts: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.6;neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013537	Uncertain					NA	NA		1000000			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	14.0	20.7	1.8	4.2	2.9	2.2	17.1	1.9	3.0	29.1	9.5	2.9	14.6	4.1	28.8	10.3	11.0	13.1	35.0	19.0	3.4	1.1	16.8	29.8	16.5	12.0	2.2	0.9	24.6	11.6	5.6	3.1	35.5	3.2	13.7	5.4	11.6	10.8	14.7	5.1	14.2	7.0	12.4	2.2	50.5	8.6	12.2	2.1	2.3	10.2	13.1	7.0	7.7	21.5	0.0	1.6	7.4	3.6	0.0	0.0	1.2	12.6	11.2	11.2	32.6	7.2	4.6	33.3	5.0	10.8	7.8	10.2	9.2	9.7	1.6	22.7	5.1	10.9	13.2	4.9	13.1	4.1	2.1	9.1	0.4	6.5	14.3	4.2	0.2	0.3	5.4	19.7	4.9	11.6	8.6	29.1	0.5	23.9	0.6	6.3	22.1	0.2	4.9	19.2	18.7	16.9	17.2	5.5	2.9	9.9	6.7	0.0	9.7	7.6	3.6	7.4	16.3	9.0	2.2	24.4	9.7	15.4	17.9	7.3	0.1	0.2	0.5	1.4	4.1	17.6	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	7.4	0.0	0.2	0.3	0.0	1.2	1.8	2.9	1.9	3.0	3.4	1.1	2.2	0.9	3.2	2.1	8.9	13.0	6.4	8.7	18.2	0.0	3.6	10.2	1.4	5.7	5.2	0.0	50.1	0.0	9.9	20.9	43.5	2.4	0.0	5.7	7.3	7.4	8.7	1.1	18.1	8.1	0.0	2.9	106.8	5.6	8.1	7.5	1.1	3.3	1.0	14.8	1.5	17.1	7.0	3.9	3.7	0.0	6.5	5.0	1.0	12.4	15.6	172.7	1.7	17.9	7.1
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1"	"Cell type enhanced"	"Detected in many"	16	"Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"MOLT-4: 18.2;RT4: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035784			Uncertain	"Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"		"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (4.68e-5)"	3.3	1.7	7.4	3.0	30.1	3.3	2.6	3.1	29.3	9.0	1.5	0.8	3.4	0.9	3.0	4.5	7.5	6.4	2.8	1.4	5.4	4.2	1.7	1.3	2.4	3.6	3.3	14.4	3.9	7.8	0.8	1.1	2.9	1.7	6.8	0.9	1.5	4.7	8.1	1.8	32.1	1.6	2.0	1.4	2.6	3.3	3.8	3.6	26.7	6.6	2.5	3.3	5.1	6.5	4.1	0.9	1.0	1.3	0.0	3.1	1.4	0.1	0.0	0.0	0.4	2.0	1.0	0.0	0.2	0.4	0.1	0.0	0.6	1.3	0.0	0.0	0.1	0.0	4.5	0.2	0.0	0.0	1.0	0.1	0.3	0.0	0.2	0.6	4.3	0.2	0.3	0.0	1.2	0.0	0.0	0.2	3.0	0.6	0.0	0.0	0.0	18.2	3.3	3.1	0.7	1.3	0.4	0.0	0.0	0.0	34.6	0.0	0.0	1.2	0.9	0.0	0.4	2.9	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.3	0.5	0.1	1.0	0.6	4.1	2.5	1.4	0.9	1.0	3.1	1.5	1.0	0.0	0.4	0.1	1.9	1.4	7.4	30.1	3.1	29.3	5.4	4.2	3.3	14.4	1.7	3.6	3.0	1.7	4.5	25.1	48.3	4.3	2.0	38.2	6.7	10.3	7.0	2.0	0.2	5.0	25.0	0.7	1.4	0.0	0.0	5.7	0.0	12.3	11.7	0.0	1.8	4.3	0.0	1.7	1.3	11.5	4.0	27.9	5.3	11.8	0.0	0.0	270.3	19.6	0.0	9.2	0.4	5.0	103.5	18.4	0.2	8.3	103.5	0.2	8.3	0.0	23.4
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.3"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.3	6.3	8.2	2.5	1.4	3.0	3.5	2.8	3.4	1.5	1.7	20.3	2.5	3.5	3.4	1.8	1.2	1.3	2.5	7.9	1.7	3.3	2.4	2.5	5.0	11.3	2.0	2.1	6.8	1.7	0.6	3.7	2.0	4.8	1.4	5.2	3.5	2.6	7.5	2.4	3.4	3.0	1.7	4.3	3.0	5.9	2.5	1.7	6.1	6.1	5.3	3.2	7.0	3.1	1.8	6.5	4.3	2.8	1.4	2.6	2.3	3.8	3.8	8.2	2.4	2.7	4.4	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1	6.0	1.0	3.2	0.8	0.8	7.9	23.5	5.1	2.7	3.4	1.8	5.9	0.7	10.0	0.9	28.2	1.5	0.3	0.0	2.0	0.6	1.2	1.3	2.3	5.8	2.0	28.6	1.2	1.3	1.5	14.1	2.8	3.1	6.8	0.0	1.5	7.5	1.1	1.1	2.1	6.3	6.7	0.0	2.0	1.6	1.3	0.4	0.3	0.0	1.0	0.3
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 129.1;Enterocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Group enriched"	"Detected in many"	41	"OE19: 366.2;SK-BR-3: 179.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	2.1	2.5	2.9	1.8	3.5	2.4	3.9	1.5	2.5	3.3	2.8	1.9	5.8	0.1	3.1	3.5	1.8	6.7	0.1	3.4	1.5	0.2	2.2	0.1	2.0	3.1	2.0	0.0	0.0	2.4	3.2	2.0	1.2	3.2	1.3	0.1	0.3	0.1	2.4	3.3	0.3	0.1	5.2	366.2	0.6	0.2	1.1	0.3	3.4	6.7	0.5	0.1	2.9	179.8	0.9	3.7	5.0	0.1	0.1	1.7	2.2	2.1	0.9	0.3	0.1	0.1	0.1	0.0	5.6	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7	38.7	34.4	1.3	21.0	12.5	4.3	13.5	30.6	10.7	15.9	129.1	11.8	9.7	6.6	27.1	0.3	4.6	93.2	0.0	22.3	75.4	11.0	33.4	0.0	10.4	3.5	6.4	15.0	12.3	2.4	0.7	17.0	1.8	10.1	1.0	56.6	30.9	26.2	42.1	21.5	20.7	5.9	0.0	10.3	7.1	5.3	16.6	19.0	2.2	63.0	28.1
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		420000	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312"	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.0	0.6	0.8	0.3	0.0	0.0	16.4	0.8	1.9	1.1	1.1	5.5	18.2	0.0	0.2	0.2	0.1	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	30.9	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.1	20.2	0.1	0.3	2.8	31.8	0.4	0.1	1.9	0.5	2.1	24.2	0.9	0.3	0.7	28.4	37.9	2.7	31.5	0.1	0.0	0.1	1.1	0.6	0.1	0.2	0.1	0.1	0.1	0.0	40.2	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8	110.2	61.2	1.3	13.0	16.3	1.5	1.4	180.9	21.4	61.4	33.2	2.0	44.4	1.7	41.9	0.9	2.2	163.1	0.0	77.1	73.6	2.7	83.4	1.1	83.9	5.5	0.0	89.5	6.7	1.9	0.0	1.4	1.7	52.3	2.8	134.3	11.3	75.9	165.5	0.0	31.8	1.1	6.5	1.7	2.4	2.3	32.2	84.1	1.5	124.3	62.5
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 11.2;Cardiomyocytes: 15.3;Ciliated cells: 26.8;Club cells: 17.0;Collecting duct cells: 12.2;Muller glia cells: 12.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;EFO-21: 7.2;HEK 293: 5.3;RPTEC TERT1: 7.8;SCLC-21H: 4.4;T-47d: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		140000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	1.6	1.9	15.1	1.2	15.0	1.0	13.4	18.6	14.1	7.8	1.1	7.6	8.8	1.1	1.5	1.2	1.3	24.5	1.2	7.0	14.3	6.5	11.9	1.1	2.9	1.2	7.8	10.7	1.3	2.4	10.8	5.1	1.3	8.8	1.7	1.1	2.0	9.7	18.1	3.8	1.8	1.2	1.1	7.3	1.2	1.5	7.6	12.0	0.0	4.5	1.1	1.2	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	7.2	1.0	0.0	0.4	0.2	0.0	0.0	0.1	5.3	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	7.8	0.4	4.4	0.2	0.0	0.1	0.1	0.1	7.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	18.6	14.1	14.3	6.5	7.8	10.7	8.8	12.0	0.0	9.3	0.0	0.8	0.6	11.2	15.3	0.0	26.8	17.0	12.2	0.0	0.0	5.0	0.4	4.1	0.1	0.0	0.0	0.4	0.1	0.2	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.7	0.0	3.3	0.0	0.0	12.4	0.0	0.0	0.4	0.0	1.4	6.5	3.1	1.9	1.5	1.1	0.0	0.0	0.0	1.0
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 7.5;Ciliated cells: 12.0;Club cells: 9.1;Early spermatids: 3.9;Late spermatids: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;RH-30: 13.0;SH-SY5Y: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.8	16.8	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	1.2	0.0	0.9	0.0	13.0	5.5	0.0	0.0	1.3	31.6	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	12.0	9.1	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	1.0	0.1	0.5	0.0	0.0	0.0
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 47.4"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 40.0;Club cells: 18.2;Cytotrophoblasts: 21.2;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 13.7;SCLC-21H: 20.9;SK-BR-3: 9.3;U-266/70: 38.9;U-266/84: 47.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	10.5	2.0	6.5	2.6	7.4	0.8	13.4	2.4	6.5	47.4	6.4	3.8	21.0	1.0	15.7	10.7	25.9	28.2	2.2	4.3	7.0	4.1	5.2	1.8	2.3	1.3	6.3	4.9	5.2	2.4	11.5	4.7	5.9	9.1	18.5	3.2	15.4	28.6	27.3	2.1	4.2	1.1	2.3	7.2	1.1	8.2	4.9	5.1	14.3	21.4	3.6	14.0	5.5	17.3	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.7	0.1	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	20.9	0.0	0.0	9.3	0.0	1.1	1.8	0.1	0.0	0.0	1.7	0.1	3.1	38.9	47.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	7.4	2.4	6.5	7.0	4.1	6.3	4.9	9.1	5.1	0.0	0.0	0.0	40.0	0.6	0.2	0.5	0.0	6.7	18.2	0.0	5.9	21.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.8	4.7	9.2	1.1	2.4	5.8	0.0	1.2	0.6	0.0	0.0	0.0	0.2	3.3	4.6	0.2	0.0	0.7	1.7	0.7	4.4	0.3	0.0	1.4	0.2	0.7	0.3	9.0	0.0	1.5	36.7
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088696	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	12.8	10.0	14.9	24.0	12.9	8.6	13.3	21.9	13.8	14.7	10.2	14.4	12.8	10.7	14.4	12.4	19.4	11.8	8.1	11.7	10.6	11.8	21.6	11.3	12.5	15.6	11.1	8.8	12.4	12.9	20.9	29.2	13.8	12.9	11.8	11.7	16.4	11.8	13.1	14.5	16.3	12.2	10.5	10.1	14.2	10.0	20.6	13.7	17.4	17.3	12.2	25.0	10.7	13.8	8.6	12.4	10.5	11.2	10.4	12.1	2.6	10.5	4.4	9.0	6.7	10.6	8.2	5.1	7.7	7.4	9.1	9.0	4.3	6.5	16.7	8.6	5.2	3.4	10.4	16.6	6.4	10.8	8.8	9.3	19.0	9.0	7.7	6.3	18.3	17.5	5.0	5.8	10.0	6.8	7.9	11.6	6.2	17.4	6.5	8.1	4.6	11.7	12.3	18.9	8.4	5.9	8.9	16.6	10.6	10.7	5.9	10.4	5.7	8.3	5.2	7.4	7.6	4.3	4.9	11.1	11.0	5.9	10.1	6.3	9.7	9.7	15.5	7.9	17.9	4.8	7.5	11.2	10.5	12.1	10.4	10.8	8.6	9.5	8.7	12.4	7.6	8.3	9.4	9.7	10.4	8.3	7.7	8.2	2.6	14.9	12.9	21.9	13.8	10.6	11.8	11.1	8.8	12.9	13.7	8.9	9.6	18.4	9.6	15.9	17.4	7.5	2.5	1.4	5.7	24.4	15.7	11.8	13.3	9.9	72.6	10.8	8.6	0.0	7.9	11.4	10.4	8.5	11.5	6.8	8.8	17.5	19.7	15.4	12.3	29.7	9.5	14.3	11.8	10.0	9.2	9.1	11.2	10.2	5.6	11.6	18.9	12.9	8.5	40.6	26.0	19.9	9.2	25.4	8.9	9.9
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	1.2	0.0	0.0	0.0	0.0	0.0	10.2	0.2	1.5	0.0	0.0	0.0	10.0	0.0	13.2	0.0	7.7	3.3	0.0	0.0	10.0	1.3	35.6	0.0	0.3	0.0	3.5	2.6	0.0	7.3	2.3	1.7	0.0	0.0	0.0	5.4	4.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	12.1	0.0	0.0	1.9	1.9	2.0	0.1	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	3.7	1.6	0.0	12.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4	11.9	2.6	0.0	0.1	0.1	0.0	13.7	0.0	0.0	3.4	43.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.7	0.6	1.3	2.0	0.6	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	6.6	0.0	0.0	0.0	0.0	0.1
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747822-109196841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 123.9;granulocytes: 91.4;Late spermatids: 142.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 45.1"	"Low region specificity"	"Detected in all"							"HPA007641, CAB022464"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	13.4	5.7	5.5	6.1	13.4	1.8	5.2	6.0	5.0	9.7	6.7	1.4	16.8	2.5	6.5	19.3	8.2	4.6	5.3	4.6	4.8	4.8	7.2	3.6	12.2	1.9	4.9	2.2	7.2	3.0	18.5	15.9	5.7	3.1	6.8	3.6	5.0	4.5	21.9	5.0	6.6	3.5	7.2	6.2	8.1	4.1	15.9	2.6	3.9	10.2	12.8	2.8	7.7	9.0	10.5	5.4	8.0	5.1	1.2	2.8	1.1	4.7	1.6	5.8	9.2	3.5	5.4	3.7	5.7	5.6	3.4	4.0	9.7	2.9	7.6	3.6	6.9	4.3	3.4	3.1	7.2	7.6	3.2	4.2	5.1	7.4	3.5	2.3	2.7	4.3	3.2	4.0	8.1	9.2	3.4	5.0	7.4	6.3	5.7	4.3	1.3	2.1	0.8	0.8	0.4	3.4	1.7	5.6	45.1	3.3	1.6	1.9	2.8	9.4	0.5	6.1	3.8	2.2	1.2	7.3	6.5	5.0	3.3	4.5	4.8	7.2	3.0	4.1	0.9	3.0	8.0	5.1	5.4	1.7	3.1	2.8	10.5	1.0	1.8	2.8	3.8	1.6	2.0	0.4	1.2	2.4	5.4	2.1	1.1	5.5	13.4	6.0	4.2	4.8	4.8	4.9	2.2	3.1	2.6	74.5	27.0	2.4	9.8	26.0	16.3	18.6	12.7	40.2	33.0	14.0	17.7	3.0	1.7	11.7	123.9	13.3	3.2	0.0	5.2	8.9	10.4	8.2	91.4	1.6	6.8	17.5	8.1	22.1	10.5	142.5	17.8	10.6	13.5	12.6	3.7	10.9	7.7	3.6	16.6	5.4	16.6	6.5	9.9	4.3	9.1	15.4	2.6	9.2	3.8	4.9
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.6	1.0	3.1	6.1	0.9	0.0	1.8	1.0	0.9	0.0	2.3	0.1	2.0	0.0	0.5	0.6	0.1	0.5	1.2	0.3	21.3	0.0	3.8	2.1	19.0	40.7	3.1	0.0	2.6	0.0	0.0	10.8	3.2	0.6	0.0	0.0	6.9	0.6	24.9	1.0	0.8	0.0	2.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.9	1.1	0.0	37.4	8.4	0.0	3.7	0.1	0.0	0.0	2.7	0.8	0.1	16.1	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7	3.0	8.0	6.4	4.7	3.4	0.0	2.5	5.1	0.0	0.0	1.8	0.0	4.5	3.3	4.8	1.1	24.5	0.4	0.0	3.9	3.8	6.2	4.0	28.8	8.2	40.6	0.0	2.9	22.7	93.1	4.7	8.3	37.3	6.8	27.1	2.1	2.3	2.0	0.0	9.6	1.3	1.9	12.9	7.2	3.5	9.1	2.5	3.8	10.2	2.6	5.2
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38411138-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 177.8;Muller glia cells: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 111.2;BJ hTERT+: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		120000000			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	41.1	8.6	12.5	14.5	12.2	7.2	39.5	45.0	10.5	36.0	31.5	10.1	11.6	5.5	29.3	20.6	22.9	29.4	32.4	31.7	12.8	10.1	11.8	5.4	18.6	9.7	11.4	14.3	42.0	51.2	11.5	22.3	28.4	20.0	28.2	10.8	35.8	14.0	31.6	12.0	12.9	14.4	52.4	15.6	4.5	16.4	16.4	8.5	11.3	12.6	13.0	9.8	39.6	41.2	1.6	0.7	1.8	1.1	0.8	5.7	0.7	2.4	9.4	41.1	111.2	25.5	18.2	27.1	25.3	50.7	17.6	18.4	6.1	1.4	0.3	7.0	24.2	22.6	0.0	19.4	1.2	20.4	6.6	4.3	0.0	1.6	6.0	14.4	5.9	0.1	16.5	0.1	14.3	2.9	9.5	16.9	1.4	2.3	0.1	8.3	2.9	17.4	2.0	28.9	0.3	3.9	16.0	4.3	0.0	8.5	0.0	1.6	3.6	4.5	0.2	1.0	21.5	2.3	1.1	10.6	11.5	6.4	31.8	6.0	0.4	0.8	0.0	13.6	0.3	6.0	1.4	1.1	0.4	5.7	0.3	3.9	0.7	2.7	3.7	0.1	1.6	1.5	4.1	1.8	0.8	0.5	0.7	2.2	0.7	12.5	12.2	45.0	10.5	12.8	10.1	11.4	14.3	20.0	8.5	3.0	12.0	0.0	68.4	27.9	1.3	48.2	17.8	1.4	9.1	8.7	3.9	6.5	0.0	23.4	14.2	57.3	0.0	0.0	56.3	69.1	85.6	80.3	8.1	0.9	19.7	20.6	24.0	47.3	3.2	9.3	177.8	7.5	32.1	2.8	0.0	106.2	29.8	0.0	93.7	8.0	2.4	12.9	68.0	1.4	11.3	17.2	8.7	6.4	0.4	8.4
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		670000	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.2	2.6	0.0	0.1	9.4	1.1	0.1	0.4	0.2	19.3	0.4	0.0	7.7	0.3	0.4	15.1	2.6	0.1	0.1	0.1	9.7	6.0	1.5	32.5	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.9	6.5	0.0	0.0	9.6	0.4	0.2	15.8	8.8	0.0	0.5	0.5	0.1	1.3	19.3	2.7	0.7	0.8	1.6	0.0	11.1	9.0	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6	0.0	23.8	2.4	3.6	92.2	0.0	2.0	94.3	0.0	21.6	14.0	0.0	0.4	0.0	4.8	5.4	0.9	20.6	0.0	0.6	9.2	7.0	3.3	0.0	27.0	0.5	0.0	4.1	14.7	1.2	0.4	0.6	1.2	11.8	1.0	20.7	0.2	0.4	17.3	0.4	7.5	0.6	0.0	2.8	0.4	17.9	77.5	0.7	0.0	13.0	11.8
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.6;kidney: 37.7;liver: 45.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 50.9;Hepatocytes: 23.7;Proximal tubular cells: 19.5;Sertoli cells: 19.4;Undifferentiated cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CACO-2: 43.0;Hep G2: 43.0;RH-30: 69.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1.0	13.6	26.0	0.0	0.7	1.3	0.8	4.0	3.7	2.0	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3.0	1.1	0.4	0.4	0.0	0.7	12.1	0.2	2.9	0.0	0.0	5.9	0.0	0.0	0.0	0.0	43.0	1.6	1.3	5.6	0.0	0.6	0.6	2.4	0.4	0.0	0.7	2.8	0.1	0.6	43.0	1.3	0.1	1.0	0.2	0.0	2.1	0.0	0.0	0.0	0.8	4.0	0.1	0.9	9.8	0.0	0.8	7.3	7.6	1.0	1.9	69.1	7.2	5.8	0.1	0.4	0.7	0.4	3.1	1.4	1.6	2.9	0.6	0.2	0.0	5.8	0.0	0.1	0.4	0.4	0.7	0.0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0.0	0.1	0.6	0.4	0.4	3.0	0.4	0.3	0.9	0.2	0.0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1.0	0.8	0.4	0.0	0.0	0.8	0.6	0.6	0.4	0.8	50.9	0.0	0.0	3.5	0.0	1.1	3.3	8.4	0.1	0.1	10.6	0.0	4.4	3.2	1.7	0.3	0.0	23.7	0.3	0.0	4.1	2.5	0.8	0.0	0.6	0.0	0.0	1.0	5.2	0.9	3.6	2.9	1.4	19.5	0.1	19.4	0.5	1.6	12.8	0.4	7.3	0.0	33.6	0.6
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 30.1;U-266/70: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	55.9	0.7	2.3	0.0	6.8	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1	6.0	30.7	12.5	0.5	2.5	0.0	1.6	2.5	2.7	10.3	1.8	0.0	0.4	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.5	1.4	0.3	12.7	0.9	58.9	0.0	0.0	4.3	187.9	0.4	0.3	86.1	1.7	7.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.5	1.0	0.8	45.8	0.0	0.9
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	54000	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.4	13.8	6.3	3.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	11.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.2	0.0	15.6	1.4	0.4	0.0	0.0	0.0	1.0	0.8	9.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.0	31.0	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2	0.0	8.9	2.2	0.5	3.7	5.9	12.6	5.1	2.7	1.2	0.0	3.9	155.4	1.7	0.0	116.6	192.1	0.0	0.0	0.0	778.4	17.5	1.1	1.1	2.1	28.1	1.6	0.0	284.2	16.1	130.7	17.3	5.3	0.0	0.0	0.0	172.0	0.0	0.0	45.6	0.0	7.3	90.5	6.6	12.9	2.8	4.3	942.6	2.9	0.0	0.5
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 31.7;Ito cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA		270000000	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.5	0.3	2.8	0.1	0.2	0.1	12.5	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	0.3	8.1	10.0	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.2	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	2.7	11.9	0.2	12.6	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0	0.0	1.7	0.9	0.2	0.8	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.2	9.2	0.0	0.0	0.0	31.7	0.6	0.2	2.3	0.4	1.1	0.0	0.0	65.1	5.7	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	4.3	1.0	0.8	0.7	0.0	0.1
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 73.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 19.0;RT4: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	2.5	4.2	0.7	1.0	0.3	0.3	0.8	0.6	0.2	0.0	0.1	3.3	4.1	1.1	3.9	0.6	0.6	6.1	0.3	1.2	0.1	3.5	0.4	1.4	3.6	2.8	0.2	1.0	0.9	0.3	1.7	0.4	0.4	0.5	0.2	0.7	0.7	2.6	1.0	1.4	0.8	0.6	1.1	19.0	0.7	1.2	3.7	1.3	5.2	8.0	0.9	1.0	0.9	5.4	0.5	1.1	1.6	0.8	1.0	1.2	1.2	0.9	0.6	4.0	2.8	1.8	1.2	0.7	0.8	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5	0.0	10.1	0.0	15.3	2.4	0.7	8.4	12.7	22.7	15.9	22.7	0.0	4.3	10.0	16.5	73.1	0.3	35.5	0.0	14.3	3.8	3.5	20.3	3.5	19.2	0.8	6.4	19.0	1.8	0.6	17.7	0.6	0.5	0.0	1.8	13.0	0.3	19.1	20.1	1.1	22.5	0.0	12.9	7.5	1.4	0.7	2.8	0.7	0.5	16.1	34.6
FRMPD2	"MGC35285, PDZD5C, PDZK5C"	ENSG00000170324	"FERM and PDZ domain containing 2"	Q68DX3	10	48153088-48274870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4"	"Cell type enhanced"	"Detected in some"	21	"Ciliated cells: 53.5;Cone photoreceptor cells: 271.0;Early spermatids: 94.0;Late spermatids: 95.9;Rod photoreceptor cells: 95.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.9;SK-BR-3: 2.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 7.6"							NA	NA						"unprognostic (1.53e-1)"	"unprognostic (3.08e-1)"		"unprognostic (7.88e-4)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.54e-3)"		"unprognostic (1.85e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.25e-12)"	"unprognostic (3.48e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.43e-5)"	0.4	0.4	5.6	0.4	12.0	0.4	2.1	7.3	4.1	1.4	0.6	12.7	0.0	0.4	0.9	7.9	0.4	11.1	0.4	6.3	6.4	4.0	1.1	0.4	1.5	0.4	3.1	1.3	0.8	0.7	0.4	0.5	0.7	14.2	1.8	1.0	11.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	0.4	0.4	1.5	6.5	0.0	2.3	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.9	0.2	0.0	2.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.0	7.3	1.7	6.4	4.0	3.1	1.3	14.2	6.5	0.0	0.3	0.0	0.4	0.1	28.7	2.6	0.0	53.5	5.7	3.5	271.0	0.2	0.0	0.0	94.0	0.0	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.1	3.2	2.9	0.0	0.0	95.9	0.3	0.0	0.0	0.0	0.5	4.8	0.3	0.0	0.4	0.3	95.6	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.6	0.3
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Proximal tubular cells: 145.7;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.3	34.9	5.8	26.7	16.4	0.6	5.5	17.5	4.7	8.5	0.2	0.3	3.9	3.6	10.7	4.1	0.2	4.9	7.6	9.2	0.1	12.8	10.7	2.6	0.5	15.8	3.6	3.7	15.8	11.6	17.7	15.2	12.4	19.2	19.2	0.9	27.3	16.8	0.2	17.1	3.3	5.0	0.6	3.5	5.4	4.7	0.2	0.0	1.7	24.5	9.9	1.0	0.4	23.3	8.1	0.2	10.8	12.2	14.3	2.6	105.3	3.5	3.9	3.5	6.0	26.9	8.4	24.8	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3	0.0	11.7	18.8	1.9	15.1	53.9	9.2	12.7	5.3	3.4	7.0	0.0	2.2	14.9	8.1	2.8	56.2	3.5	0.0	0.9	2.1	36.8	1.4	51.8	59.3	2.8	44.5	12.7	71.8	42.5	0.9	24.5	33.6	35.4	3.6	2.4	88.8	6.3	0.0	6.7	145.7	7.8	12.9	23.1	2.6	4.3	11.7	43.5	208.1	1.2	0.9
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Group enriched"	"Detected in some"	8	"THP-1: 23.1;U-937: 66.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"CAB005195: AB_631619, HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	3.4	0.0	66.3	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2	6.0	21.8	10.3	3.5	2.7	0.0	1.7	2.5	2.7	6.8	7.0	0.0	0.8	1.7	0.0	0.2	1.4	0.0	0.0	0.5	0.7	1.3	0.0	5.8	0.8	131.2	0.0	1.7	1.8	133.2	0.0	0.0	170.5	1.7	221.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	1.0	1.4	0.5	0.0	4.6
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648971-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.7;T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB010268, HPA045563"	Approved					NA	NA		36000			"CAB010268: AB_671792, HPA045563: AB_2679368"	"unprognostic (1.30e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	8.4	12.7	11.5	5.9	13.5	16.3	18.5	23.0	15.7	15.3	13.4	10.4	22.7	4.2	15.3	16.3	9.2	18.9	7.7	11.6	11.7	7.3	17.0	2.0	11.0	4.9	8.0	11.8	23.2	22.5	4.7	13.8	17.5	9.5	21.7	7.2	16.7	12.5	23.2	9.1	13.0	7.5	18.1	8.0	7.3	10.7	12.0	11.5	10.7	16.1	7.0	5.6	12.8	21.6	1.0	0.4	7.7	0.6	1.0	2.9	0.7	3.2	16.3	11.4	0.2	5.7	4.2	7.6	3.6	7.3	1.2	1.0	7.0	8.6	0.8	10.6	7.1	8.0	15.5	5.1	14.8	1.0	0.0	5.1	12.3	18.2	14.0	5.0	6.5	1.3	6.5	7.0	2.1	10.0	4.3	4.0	1.3	0.6	2.9	5.6	23.0	2.5	4.4	10.6	5.4	0.9	4.0	8.9	2.9	3.4	20.0	3.8	17.1	26.2	1.5	14.1	25.7	8.0	3.0	11.1	1.1	14.7	2.9	5.7	1.0	4.4	2.7	2.2	4.8	2.7	4.0	0.6	1.8	0.9	0.6	0.6	0.4	0.8	0.3	0.4	1.0	2.9	1.0	7.7	1.0	0.5	0.3	0.0	0.7	11.5	13.5	23.0	15.7	11.7	7.3	8.0	11.8	9.5	11.5	26.8	11.2	0.0	25.0	29.1	51.6	25.7	10.2	38.8	31.8	21.0	86.4	26.8	1.7	13.8	23.0	23.2	5.1	0.0	9.4	16.8	24.2	51.2	0.0	0.4	5.8	71.5	33.7	38.1	7.0	38.8	16.7	5.0	20.3	2.8	21.9	47.2	25.3	10.5	12.7	18.6	32.3	0.0	17.6	3.3	13.6	28.0	23.0	3.2	20.4	39.1
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Predicted secreted proteins"		Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 234.1"	"Group enriched"	"Detected in some"	68	"Leydig cells: 1148.3;Peritubular cells: 938.7"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.9;PC-3: 4.1;SCLC-21H: 8.2;SH-SY5Y: 7.4"									HPA028615	Enhanced				"Secreted to blood"	NA	NA	566000				"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.1	0.4	0.1	1.1	0.2	0.3	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.3	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	9.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	1.1	0.1	234.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.3	5.7	1.2	1.3	2.9	1.1	0.4	1.0	0.2	0.8	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.1	1.7	0.2	2.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.3	0.0	0.1	2.0	1.3	0.9	0.0	0.0	0.0	0.0	0.2	0.1	8.9	0.0	1.6	0.3	1.6	0.0	1.7	4.1	1.3	0.0	0.2	0.2	0.5	8.2	7.4	0.1	2.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.7	3.1	0.2	0.1	2.0	0.0	0.8	0.5	0.0	1.8	1.2	1.8	0.3	2.4	2.3	0.3	2.4	2.1	2.9	5.7	1.3	0.3	0.3	2.0	1.1	0.1	0.2	0.2	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	15.4	1148.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	938.7	0.0	0.0	0.0	0.0	2.6	4.7	0.0	0.5	0.0	0.0	0.0
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 64.5"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 230.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3;U-266/70: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		72000	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.9	14.7	7.1	3.5	8.2	4.5	12.0	12.0	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8.0	10.5	8.9	11.0	12.0	10.6	15.1	7.3	16.0	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5.0	3.2	11.3	16.0	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.8	2.1	2.0	3.0	10.9	3.8	6.5	2.2	2.0	1.2	1.2	5.4	4.4	4.8	5.4	3.9	2.6	1.0	4.7	1.0	0.7	0.0	3.8	0.0	1.5	11.8	4.7	2.2	3.9	5.9	2.4	0.1	2.8	2.4	2.2	2.7	5.9	31.3	0.9	1.7	1.7	3.9	1.8	2.0	3.4	16.7	1.1	4.2	0.1	15.8	3.7	2.9	3.9	2.1	2.1	3.7	1.0	11.0	2.0	2.3	1.4	4.9	2.8	23.1	12.6	11.2	2.6	3.9	0.0	2.0	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0.0	1.3	7.1	8.2	12.0	8.2	6.4	5.8	10.1	4.9	8.0	9.7	44.7	26.7	8.2	54.6	57.7	38.7	85.3	107.0	41.5	50.0	59.3	74.6	15.8	13.3	41.1	2.9	52.3	87.1	0.0	68.2	39.2	29.8	84.0	3.5	214.7	8.6	36.5	157.1	201.3	47.7	3.6	89.2	26.7	49.0	8.2	103.9	26.9	67.8	56.1	230.5	116.2	22.2	58.2	42.3	6.2	1.2	60.1	32.0	6.4	56.3	113.2
INSRR	IRR	ENSG00000027644	"Insulin receptor related receptor"	P14616	1	156840063-156859018	"Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.5;brain: 5.9;kidney: 8.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 1.3;Cardiomyocytes: 1.7;Early spermatids: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 5.5;SH-SY5Y: 19.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA025285	Uncertain					NA	NA					"HPA025285: AB_1851814"	"unprognostic (1.19e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.66e-2)"	0.9	5.5	0.0	0.3	5.9	0.1	0.8	1.9	1.4	1.9	0.1	0.0	0.0	0.1	2.7	0.1	0.1	0.6	0.3	1.9	0.5	1.3	8.3	0.1	0.1	0.4	0.8	0.6	0.3	0.9	0.1	1.7	0.4	5.6	2.7	0.1	2.1	0.6	0.5	0.4	0.1	0.2	0.3	0.0	0.2	3.0	4.2	0.4	0.3	0.3	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	19.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	1.4	0.5	1.3	0.8	0.6	5.6	0.4	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255191	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 28.0;lymphoid tissue: 60.5"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	28	"gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1"	"Group enriched"	"Detected in many"	29	"NK-cells: 9.2;T-cells: 28.0"	"Group enriched"	"Detected in some"	9	"JURKAT: 36.5;MOLT-4: 13.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	2.3	0.7	0.5	12.2	0.6	2.5	1.3	1.9	0.5	1.4	3.3	0.0	0.0	0.5	1.2	1.1	1.8	1.4	4.3	0.9	0.5	0.5	1.4	1.2	6.6	60.5	0.9	0.0	0.7	0.7	0.0	0.9	0.1	0.3	1.1	1.3	1.5	3.5	1.1	0.5	1.0	8.9	0.4	1.2	10.7	2.3	1.4	0.0	60.3	1.6	2.7	24.3	4.1	1.3	0.0	0.0	0.4	0.6	9.2	28.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	13.8	0.0	9.1	0.0	19.5	18.9	0.0	0.0	28.0	22.8	0.4	9.2	0.6	0.0	23.1	13.6	0.5	0.6	1.9	0.5	0.5	0.5	0.9	0.0	0.3	0.0	0.0	10.4	0.0	0.6	2.4	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	32.2	0.6	0.0	0.0	0.0	1.8	0.6	5.5	0.0	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	3.0	0.1	47.3	0.0	0.4
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-64966504	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved					NA	NA					"CAB013088: "	"prognostic favorable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	46.7	20.4	15.5	31.1	16.5	21.2	56.6	24.3	20.4	27.3	27.1	16.3	16.5	13.8	28.2	22.0	27.0	20.7	27.7	27.3	15.3	16.5	31.4	38.3	36.5	61.4	15.6	14.1	33.3	29.1	28.3	39.8	22.9	25.1	26.0	22.2	18.1	19.8	21.3	45.1	29.7	29.3	30.7	16.3	52.7	20.9	17.3	15.0	62.7	29.0	17.9	42.5	37.2	29.3	20.2	15.4	34.9	17.1	68.1	27.5	25.8	11.2	14.6	6.1	0.6	70.7	40.1	7.9	17.5	25.9	14.6	17.2	4.8	6.2	17.1	13.6	31.1	27.2	6.3	4.1	13.5	20.8	22.5	6.6	23.1	7.7	10.4	26.1	8.8	16.1	35.1	18.8	22.0	23.0	17.4	45.4	8.5	8.4	18.3	16.1	6.4	4.8	5.9	4.2	12.9	8.8	6.9	17.6	6.3	37.6	19.8	4.3	12.9	24.0	11.3	10.3	12.7	24.0	5.5	41.2	17.5	7.8	39.6	9.3	11.5	5.2	13.5	16.3	11.7	7.9	31.2	10.9	31.5	22.8	15.2	27.5	20.2	22.0	25.7	15.4	16.1	24.3	20.7	34.9	68.1	17.1	10.5	26.5	25.8	15.5	16.5	24.3	20.4	15.3	16.5	15.6	14.1	25.1	15.0	47.6	79.3	120.3	114.0	103.6	35.7	98.8	79.0	41.5	63.7	106.4	21.6	5.5	36.5	152.3	100.2	130.9	49.5	23.3	184.7	94.8	76.6	173.3	55.4	77.3	52.1	20.6	63.8	178.0	138.0	72.8	88.9	109.3	47.2	252.5	54.9	54.4	180.7	49.2	79.5	61.6	35.1	161.7	144.2	30.5	50.9	145.2	10.2	159.2	38.1	188.3
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Group enriched"	"Detected in many"	5	"ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.5	1.5	2.5	19.4	5.0	0.4	3.5	3.0	2.7	1.8	0.1	0.8	0.1	0.8	2.1	2.2	0.9	1.6	2.1	2.0	27.4	0.5	56.1	3.0	0.7	4.0	3.8	2.9	4.1	0.9	1.1	1.8	3.3	2.5	2.0	4.0	6.5	4.8	0.9	0.9	5.4	1.3	1.3	1.7	1.9	2.8	0.8	2.0	1.3	1.7	0.9	1.0	1.5	1.1	1.6	0.8	6.7	5.1	4.1	1.4	4.2	2.4	1.2	2.3	0.5	5.3	1.9	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0	14.9	6.4	6.9	2.8	8.7	7.4	22.0	0.0	5.3	7.9	7.0	7.9	1.8	1.7	3.0	7.4	8.7	3.9	23.3	3.4	0.8	7.0	1.7	13.9	1.6	11.9	7.9	2.9	4.9	36.0	5.3	21.9	27.7	5.0	16.2	4.2	12.2	5.4	14.4	31.5	2.5	11.1	0.0	5.0	14.9	5.7	7.3	2.9	5.0	3.3	4.1
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.1	0.4	1.5	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	2.0	0.4	0.3	0.1	0.0	0.2	0.0	20.6	0.0	9.2	0.0	0.8	0.7	0.0	9.4	5.1	0.2	0.0	0.0	0.0	0.2	2.1	0.0	24.0	0.0	0.4	3.6	0.0	0.2	0.5	0.7	4.7	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.1	2.0	1.4	0.4	0.0	0.4	0.0	0.0	9.3	13.8	2.5	0.1	14.0	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8	0.0	5.8	18.2	0.5	0.7	0.3	1.4	0.0	0.0	1.2	1.8	0.0	0.9	0.0	0.6	1.0	5.8	0.0	0.0	0.3	0.7	2.3	0.2	4.7	0.0	11.5	0.0	0.0	14.1	10.8	0.9	11.5	3.5	3.3	12.6	0.0	0.8	0.4	0.0	13.8	0.1	0.5	6.5	2.1	0.3	0.7	0.9	1.1	24.5	0.0	0.5
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 100.3;Ito cells: 200.7;Muller glia cells: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 32.5;TIME: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004028	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		7400000	"Plasma membrane"		"CAB004028: AB_2212507"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6.0	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6.0	8.1	8.0	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3.0	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20.0	5.3	3.0	4.4	12.0	0.1	0.1	0.7	0.0	0.2	0.2	0.1	0.0	0.0	1.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.2	0.2	32.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2	0.0	8.2	7.5	0.4	2.3	7.4	4.8	0.0	6.7	30.7	0.0	0.0	0.1	0.0	0.5	0.8	100.3	0.0	0.0	0.0	0.1	1.9	0.4	2.3	1.3	0.4	0.0	0.0	200.7	14.5	0.6	0.0	1.0	6.8	0.0	0.0	229.2	0.3	0.0	0.4	0.0	6.0	0.0	1.4	0.2	0.2	2.4	0.1	0.0	0.0	0.4
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 496.5;Melanocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Group enriched"	"Detected in some"	13	"HEL: 48.8;HMC-1: 102.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		48000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6	0.9	2.6	3.2	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.5	0.0	2.2	0.0	1.2	48.8	0.0	0.0	0.0	0.0	102.6	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.6	0.1	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.1	0.0	0.0	0.0	4.8	1.2	0.4	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5	6.0	34.8	1.4	1.1	12.7	0.0	0.4	5.1	0.0	5.7	3.5	0.0	0.0	3.3	0.8	0.0	2.4	0.0	0.0	0.0	0.1	1.3	0.5	496.5	0.0	0.3	0.0	5.2	1.8	0.3	0.0	1.1	3.1	200.8	0.0	0.3	2.4	0.0	0.0	0.0	0.6	0.3	0.0	0.5	0.0	8.2	3.3	0.2	2.2	0.3	0.3
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 112.2;lymphoid tissue: 153.0"	"Cell type enriched"	"Detected in many"	10	"T-cells: 207.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2"	"Group enriched"	"Detected in many"	13	"NK-cells: 42.8;T-cells: 112.2"	"Group enriched"	"Detected in some"	6	"JURKAT: 66.9;MOLT-4: 93.9;U-698: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	2.6	0.7	0.4	28.2	0.5	3.8	1.3	0.3	0.5	1.7	3.9	0.5	0.9	2.2	1.1	4.5	2.3	1.6	3.8	1.0	0.4	0.4	3.0	2.3	6.6	34.9	0.9	0.5	1.2	0.8	0.0	0.8	0.7	0.6	2.2	1.9	1.3	8.4	1.3	0.9	1.0	16.5	0.7	1.0	28.9	3.5	0.7	0.5	153.0	2.9	1.5	27.1	5.8	2.1	6.1	0.5	2.5	0.3	42.8	112.2	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	93.9	0.0	1.0	0.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	54.1	0.0	0.0	0.0	0.6	0.3	0.4	83.4	0.3	77.5	4.0	86.1	90.2	0.3	6.1	97.0	91.3	2.5	42.8	0.3	0.5	112.2	109.3	0.4	0.5	0.3	0.5	0.4	0.4	0.9	0.5	0.6	0.5	0.0	16.0	20.4	0.9	4.0	0.0	1.1	2.5	2.7	2.3	3.5	0.0	0.2	0.0	0.3	0.1	1.6	0.0	0.0	0.4	0.1	2.0	0.8	4.7	1.0	0.3	0.0	2.4	3.7	4.9	0.0	0.0	0.6	3.3	0.0	0.0	0.0	2.7	0.0	0.4	1.1	0.0	0.0	0.9	3.7	1.9	2.8	0.3	207.5	0.4	1.0
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	"Lemur tyrosine kinase 2"	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: AB_2677698"	"unprognostic (7.36e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.96e-1)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.38e-3)"	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11.0	10.1	10.1	8.5	10.0	5.1	7.5	18.9	8.0	21.0	22.2	10.0	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8.0	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.8	11.6	9.0	9.2	4.8	3.9	8.4	4.1	4.5	4.0	4.9	9.1	9.0	5.2	11.8	5.2	15.3	10.8	10.4	6.3	6.3	7.4	7.3	3.5	10.4	9.1	5.9	6.2	6.3	2.6	8.7	8.3	11.3	4.1	6.0	6.0	9.1	10.9	3.6	13.3	6.6	3.7	11.0	13.5	5.7	7.2	6.1	10.2	6.7	17.3	6.5	12.9	8.2	15.0	6.0	9.5	4.1	2.5	7.3	8.4	13.8	16.8	9.3	4.9	8.5	10.3	5.7	4.9	10.0	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11.0	10.1	7.5	18.9	13.2	6.9	26.8	10.5	0.0	4.2	8.7	14.0	18.7	17.8	10.7	9.1	1.8	13.7	2.3	1.7	5.0	0.8	3.1	26.2	0.0	7.9	1.6	3.5	6.2	2.3	6.8	1.8	6.4	11.5	3.1	2.6	2.1	1.7	2.3	1.7	0.0	13.5	5.8	8.6	13.1	4.2	2.4	9.9	0.0	3.8	6.3	4.7	9.5	2.5	2.9	12.6	13.2
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	1.3	4.4	19.8	2.3	28.6	2.0	2.0	20.0	38.1	2.0	1.5	6.0	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4.0	1.2	6.6	1.8	2.9	1.5	10.3	0.0	2.3	0.0	2.2	1.6	1.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	4.6	3.1	0.4	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.2	3.7	1.7	1.3	0.0	1.2	2.2	0.3	1.6	0.0	0.0	1.2	0.2	0.3	0.7	0.0	0.0	8.6	0.2	0.9	0.0	0.0	2.0	0.1	2.8	1.4	2.9	0.0	3.1	0.6	0.8	1.1	2.4	0.9	3.9	0.0	1.3	1.1	0.8	0.7	2.9	0.1	10.2	0.0	0.6	3.9	0.2	0.1	0.0	0.8	0.1	0.0	9.5	7.7	0.4	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	19.8	28.6	20.0	38.1	17.2	11.1	6.5	23.8	12.5	10.3	3.0	1.7	0.8	9.2	0.5	16.4	2.2	2.5	4.0	4.5	7.0	0.0	4.3	21.6	19.4	0.1	0.0	0.7	0.0	0.4	2.5	0.9	15.7	0.0	0.0	1.0	17.5	0.0	1.3	0.3	0.0	0.6	0.3	3.3	0.0	1.0	7.3	10.7	0.0	0.0	0.6	1.9	0.0	0.7	2.4	1.3	1.6	5.7	0.0	0.6	44.3
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503638-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 15.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 8.3;plasmacytoid DC: 7.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 7.0;T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1"	"Low region specificity"	"Detected in many"							HPA059545			Approved	Vesicles		NA	NA			Vesicles		"HPA059545: AB_2684057"	"unprognostic (9.47e-4)"	"unprognostic (5.52e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.36e-3)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	1.0	0.5	0.5	5.1	1.6	3.1	0.5	2.0	3.2	0.6	8.2	0.5	1.9	10.6	1.3	1.1	1.2	0.3	2.0	2.2	0.5	0.1	3.5	4.3	15.1	0.6	0.5	0.5	1.0	0.5	1.0	0.7	8.9	0.5	0.7	4.8	4.3	11.7	0.5	2.0	0.9	10.7	0.5	0.5	5.5	8.3	2.4	0.8	0.5	0.7	0.5	2.2	0.6	0.7	0.7	7.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.6	1.0	1.3	2.4	0.0	0.0	0.1	0.7	0.0	0.0	2.9	0.0	0.4	0.2	1.4	5.4	0.0	0.0	2.4	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	2.0	0.0	2.1	0.0	0.0	10.5	0.4	2.0	0.2	0.2	5.1	0.2	0.0	0.0	0.5	3.4	0.1	0.2	0.0	3.0	0.2	16.1	0.0	0.0	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.6	0.0	8.3	0.7	0.5	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.2	0.5	1.6	2.0	3.2	0.5	0.1	0.5	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	5.1	4.0	1.2	0.0	0.0	0.2	0.0	0.0	2.1	0.1	13.4	0.0	0.2	1.1	0.2	0.0	0.0	0.2	0.1	0.0	1.7	14.7	3.2	1.7	0.0	0.0	3.3	0.0	7.8	0.0	0.5	3.5	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.1	0.3	1.3	2.8	0.0
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 110.4;Kupffer cells: 161.3;Macrophages: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 57.7;HMC-1: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.8	7.7	1.8	0.3	0.1	0.0	13.9	9.8	14.5	6.2	4.4	5.3	4.4	12.4	4.4	3.9	4.8	6.0	7.2	7.3	5.3	20.1	7.2	57.7	2.3	1.9	1.9	5.8	58.6	0.3	2.5	0.1	4.5	3.6	8.3	0.0	30.5	26.9	0.9	0.7	0.0	6.1	11.1	20.2	0.9	0.9	2.8	1.5	4.0	6.1	1.2	22.3	4.9	0.0	2.0	13.8	1.1	13.6	9.7	0.0	2.9	0.0	4.4	9.0	3.3	28.1	0.6	11.5	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1	32.8	35.7	89.3	18.6	4.7	2.1	1.4	17.8	22.7	31.8	8.7	2.0	2.5	0.0	18.6	0.6	18.5	14.9	0.0	44.9	61.3	8.4	36.9	70.5	10.9	110.4	0.0	5.8	25.8	161.3	1.7	3.1	122.4	5.0	73.1	13.5	61.7	37.6	13.5	1.1	1.3	1.5	19.4	4.3	0.2	1.2	5.1	32.4	24.5	12.3	92.1
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	28.6	16.9	33.9	19.1	54.1	29.0	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10.0	11.8	16.5	22.0	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12.0	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.6	15.9	31.9	13.3	19.3	14.5	18.5	24.4	20.9	26.5	23.7	23.8	27.7	30.9	30.3	20.1	20.2	30.0	29.8	35.7	31.3	24.9	17.8	9.9	16.6	12.9	15.6	13.0	14.8	11.2	22.1	19.2	28.5	28.3	20.7	15.8	17.5	39.6	38.7	13.0	10.5	17.1	16.3	31.2	13.9	11.9	19.7	27.5	25.7	14.5	19.7	11.0	19.8	15.5	20.5	26.9	14.0	11.2	28.5	34.6	21.2	24.4	36.2	24.5	43.6	19.7	36.5	23.1	16.1	3.2	8.2	5.5	7.4	8.2	6.7	3.0	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6	26.8	21.9	30.2	40.5	73.6	8.5	16.9	38.2	6.7	13.6	24.4	13.7	40.9	39.7	65.3	10.2	19.0	20.0	46.7	20.4	39.4	31.3	59.4	9.2	116.5	44.9	9.5	20.8	17.2	91.3	18.3	20.8	67.7	50.6	88.4	17.0	33.9	70.1	21.0	20.5	28.5	5.6	6.5	53.6	16.3	44.5	58.8	43.3	40.5	16.8	65.5
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124129	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 596.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003835, HPA051993"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (4.39e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (2.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (5.43e-5)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.90e-2)"	23.9	33.0	35.6	27.6	36.1	46.7	30.2	31.2	43.4	22.6	38.8	24.6	27.0	70.9	21.8	23.2	32.8	21.7	27.9	41.4	33.1	31.0	22.7	42.0	24.1	44.5	34.4	29.2	30.8	46.0	18.9	29.7	21.3	26.1	25.7	24.3	21.7	41.5	24.0	134.9	27.4	56.7	19.0	25.2	25.9	28.3	42.0	20.9	44.1	26.2	42.2	29.1	20.0	26.9	11.4	10.7	28.3	10.6	11.3	12.1	4.5	36.8	40.7	22.3	31.3	30.9	37.3	22.3	24.3	32.6	33.3	30.2	35.2	20.0	31.6	23.0	27.7	26.8	26.6	17.4	26.0	25.8	26.8	21.2	11.5	22.2	38.9	47.3	21.1	24.3	41.1	25.3	23.4	31.2	44.6	29.4	28.8	22.0	62.4	28.0	46.3	41.8	29.7	25.5	27.2	29.6	32.0	14.7	36.1	29.1	23.7	30.3	30.2	22.3	30.9	75.8	26.9	23.8	36.4	25.9	27.3	23.8	69.8	37.4	62.8	38.0	22.1	42.4	38.2	46.8	15.2	9.1	28.3	11.9	10.6	9.7	8.9	9.7	12.1	10.7	11.4	8.9	11.6	14.4	11.3	8.7	6.0	9.2	4.5	35.6	36.1	31.2	43.4	33.1	31.0	34.4	29.2	26.1	20.9	8.9	38.8	57.0	73.8	31.5	79.0	54.9	17.8	10.7	19.4	38.4	39.3	23.7	124.3	17.7	223.1	33.7	242.0	0.0	38.5	28.5	33.0	88.2	19.6	43.1	46.2	114.4	60.6	34.4	35.6	596.7	33.1	29.7	40.5	12.6	77.6	82.3	41.7	90.9	21.5	75.0	82.4	25.8	32.5	25.9	14.5	55.8	29.7	45.4	69.4	97.8
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.4	21.7	2.9	13.2	17.6	11.3	11.0	33.2	36.1	26.5	24.4	24.1	13.8	19.4	13.6	52.0	22.4	21.3	9.2	29.5	18.9	20.1	16.8	11.2	12.5	21.8	5.5	14.7	23.1	8.7	8.4	36.1	10.9	8.3	11.8	11.4	2.1	9.7	22.1	21.3	7.4	14.0	8.3	38.6	12.5	15.3	18.7	14.3	15.0	22.6	7.9	2.8	12.3	13.3	23.1	30.1	6.6	5.0	10.8	25.2	20.6	26.9	21.4	12.1	6.1	25.0	24.3	12.7	13.0	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1	35.7	59.6	38.8	149.8	229.1	5.9	17.0	45.9	29.4	45.5	21.0	3.9	51.1	63.0	81.6	1.1	21.1	72.0	210.2	69.2	75.4	38.0	143.0	94.4	63.8	45.6	17.5	115.4	21.5	64.9	0.7	11.2	56.1	82.7	15.4	50.2	16.4	93.5	56.1	15.6	27.9	6.9	0.0	70.0	0.9	4.4	190.7	56.1	56.1	31.9	222.1
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	10.6	9.2	12.1	6.2	6.7	8.7	7.7	7.3	9.6	8.3	8.0	5.4	3.7	4.4	5.9	11.3	5.4	7.1	10.5	10.1	12.5	7.8	12.3	4.9	5.4	10.2	7.9	4.7	7.4	7.2	10.0	9.7	10.2	8.6	7.5	6.3	5.2	2.6	10.4	3.9	5.6	4.4	7.0	11.5	4.5	7.0	13.6	3.0	11.4	6.9	2.4	7.2	8.4	4.5	7.0	67.1	5.7	3.4	6.8	4.1	6.3	5.6	8.6	5.1	5.7	3.5	7.7	3.7	5.9	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8	8.9	14.2	10.8	26.3	36.9	14.2	21.2	10.2	2.7	21.6	14.0	7.9	10.7	21.6	11.2	6.3	8.7	11.8	0.0	12.4	8.6	12.9	32.3	1.1	16.3	10.2	17.5	11.5	10.4	17.7	5.8	10.9	11.7	11.8	19.0	13.8	10.3	14.7	11.5	12.0	17.7	9.7	12.9	12.0	7.9	8.1	34.4	21.2	9.5	10.6	40.3
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 115.1;Late spermatids: 149.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules		NA	NA			"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25.0	25.4	17.0	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29.0	21.0	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15.0	19.4	17.2	13.0	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17.0	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.3	14.2	8.5	10.0	12.6	22.2	6.7	5.4	10.9	10.1	11.1	5.7	9.6	8.8	11.4	8.9	11.0	8.1	14.5	8.6	8.4	12.8	14.5	12.0	10.6	6.1	15.9	7.2	7.5	15.2	11.3	7.3	16.6	22.3	13.3	20.5	10.5	14.8	8.3	6.9	11.8	8.6	12.0	6.2	6.9	11.7	9.9	14.7	6.1	9.8	5.4	8.4	6.0	8.9	21.4	15.4	11.2	14.2	11.0	10.5	6.9	7.2	7.2	21.0	24.6	10.3	14.0	16.6	7.5	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9.0	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25.0	25.4	17.1	16.4	12.6	11.5	22.2	16.2	6.0	4.3	4.2	7.5	6.2	10.0	8.0	2.5	1.4	1.2	5.2	9.8	10.3	6.6	7.7	115.1	7.0	8.8	0.0	7.4	9.1	7.1	4.5	2.3	6.8	8.8	4.8	9.1	9.8	9.2	149.4	11.5	5.3	10.1	2.8	8.4	16.0	6.9	10.5	11.0	6.8	7.2	0.0	5.1	10.4	8.2	7.2	8.2	8.7	9.4	2.7
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 43.8;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	24.4	11.0	13.3	4.7	2.6	1.6	0.1	3.6	1.0	1.5	0.7	1.1	0.6	9.0	0.5	0.8	1.2	3.8	0.5	0.3	0.8	2.0	0.1	6.9	6.8	4.7	1.0	1.0	12.1	0.3	0.3	0.0	1.0	17.5	3.3	0.0	1.7	0.0	0.1	12.7	0.5	7.8	0.5	4.5	4.6	1.1	0.3	4.9	3.4	4.9	7.4	1.0	0.9	2.2	6.1	3.4	1.3	3.1	1.3	1.6	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4	3.0	7.9	4.7	3.2	2.4	4.9	1.4	2.5	6.7	5.7	0.0	2.0	7.5	19.9	1.2	8.5	2.4	17.0	0.0	3.6	5.4	2.8	1.9	1.1	2.0	5.1	3.2	43.8	4.9	8.9	1.9	4.0	7.0	3.3	0.0	22.4	32.9	1.2	8.6	3.5	1.1	3.8	0.0	3.1	0.0	0.2	3.8	0.7	11.5	23.7	2.3
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.9	7.4	6.4	10.6	5.2	5.0	12.1	8.5	4.2	5.8	6.0	10.7	7.9	15.4	13.8	4.5	5.7	11.9	5.6	6.5	2.3	12.2	27.8	10.8	9.8	7.9	6.7	10.1	13.8	5.8	8.5	4.6	5.2	7.7	5.2	11.3	15.8	20.3	3.3	6.8	14.3	24.5	11.4	6.9	16.7	14.3	7.0	15.6	5.2	10.8	11.9	11.9	5.8	10.2	11.8	4.0	11.0	11.5	7.8	17.7	10.1	12.4	11.5	29.4	13.6	14.5	8.9	14.9	7.1	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5	23.8	21.5	21.9	31.0	34.3	50.6	12.6	22.9	9.4	5.7	19.2	72.6	23.2	11.6	19.1	3.8	18.7	26.2	0.0	16.4	25.3	18.1	32.9	10.4	17.4	16.3	54.0	35.1	19.0	12.4	8.6	26.7	15.7	30.4	16.2	23.6	25.8	19.2	21.0	11.7	14.7	70.3	32.3	26.9	14.2	26.4	37.3	41.2	28.0	24.2	25.2
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.3;bone marrow: 19.1;brain: 27.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 19.4;NK-cell: 29.3"	"Group enriched"	"Detected in many"	54	"NK-cells: 29.3;T-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0.0	7.0	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10.0	1.1	2.8	7.3	9.6	7.0	11.0	1.0	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1.0	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0.0	4.5	2.4	0.7	0.4	0.3	0.4	0.0	29.3	19.4	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.4	4.2	5.5	0.1	0.0	0.0	7.2	4.6	0.5	1.1	0.0	41.6	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	13.5	0.1	29.0	3.4	3.5	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.4	0.0	10.9	1.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	13.2	0.0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0.0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10.0	7.0	11.0	6.1	1.3	0.0	1.4	2.4	0.0	0.3	1.7	1.1	0.0	1.4	0.0	0.0	11.8	0.2	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.3	0.5	0.1	44.9	0.8	58.6	0.0	6.8	11.6	3.5	4.0	0.0	7.2	1.7	1.0	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	2.7	1.0	0.2	105.8	0.1	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ito cells: 36.8;Kupffer cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		NA	NA		29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.4	10.0	0.2	0.1	7.1	0.0	0.1	0.5	1.0	21.3	1.3	0.1	4.7	0.0	4.6	0.1	5.8	0.0	0.8	0.8	3.1	3.8	0.0	22.1	0.1	0.1	0.9	0.2	0.0	5.1	0.3	2.3	22.0	0.8	1.2	2.0	1.7	1.0	0.0	5.0	2.7	0.6	3.4	1.4	1.2	1.7	11.2	13.1	0.1	4.2	0.1	0.3	1.7	1.6	0.0	0.2	3.3	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8	3.0	20.1	0.8	2.9	1.4	0.6	2.1	5.1	1.4	11.4	0.0	2.0	2.6	1.7	0.8	1.6	7.1	1.6	0.0	0.8	1.0	4.1	2.0	0.0	8.9	23.6	0.0	0.0	36.8	92.6	1.5	4.6	11.0	0.0	0.0	2.3	8.6	1.7	1.9	6.3	1.9	9.2	6.5	11.3	0.5	1.5	1.1	15.8	0.8	1.8	1.4
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.9	5.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.9	0.5	3.1	0.2	0.0	19.8	0.0	21.6	0.0	0.3	0.3	0.0	8.5	0.3	0.3	0.0	0.4	0.1	30.3	0.1	4.3	0.1	0.0	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.1	11.6	10.5	0.9	0.0	0.3	13.3	23.1	0.3	0.0	3.6	8.4	0.0	0.0	6.6	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4	23.8	10.1	0.0	2.2	7.8	0.0	1.2	0.0	2.7	9.1	0.0	0.0	0.1	0.0	5.2	13.7	0.0	29.1	0.0	8.7	0.4	0.4	1.7	0.0	0.0	0.1	0.0	4.1	0.0	0.0	7.9	0.3	0.0	0.0	1.0	21.5	0.0	19.7	20.4	0.0	0.0	0.0	0.0	0.4	1.6	0.8	4.1	0.0	0.0	12.4	4.6
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883155-30030866	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	15.8	17.2	15.7	12.6	20.6	66.7	16.0	24.2	18.0	13.7	12.6	18.9	14.8	10.6	18.8	13.5	20.1	16.7	13.0	14.4	13.0	11.7	12.4	9.9	18.3	12.6	14.7	11.4	20.3	15.8	22.1	20.6	20.6	15.8	15.1	12.9	18.1	15.9	14.7	30.7	22.5	13.1	16.0	17.0	20.7	14.1	23.7	14.6	14.0	16.6	11.9	14.9	14.0	19.3	2.6	3.9	16.5	6.6	3.9	4.1	3.5	8.5	6.7	11.7	12.4	11.8	8.6	8.6	7.6	11.6	10.5	12.2	6.3	5.2	6.5	5.1	14.7	8.4	10.6	12.3	9.7	10.6	12.9	10.2	11.8	6.8	6.7	10.9	10.0	30.2	9.1	16.1	10.2	18.6	10.3	10.5	7.1	7.3	11.8	6.5	10.7	6.7	7.3	4.3	9.2	5.0	8.0	15.8	6.6	9.9	16.0	12.9	8.9	14.7	13.3	7.9	10.3	7.4	10.1	11.1	17.2	11.7	3.5	5.4	10.2	6.9	6.1	7.5	5.0	7.9	6.4	6.6	10.0	3.1	4.6	4.1	2.2	2.5	3.4	3.9	2.6	3.1	2.7	16.5	3.9	4.7	1.5	2.7	3.5	15.7	20.6	24.2	18.0	13.0	11.7	14.7	11.4	15.8	14.6	3.0	11.3	4.3	8.7	14.8	0.0	2.8	10.2	6.7	14.8	12.2	0.0	10.4	1.7	9.3	11.6	8.9	12.4	0.0	7.6	5.5	9.4	14.8	7.0	8.5	9.8	0.0	12.0	13.5	24.0	12.1	12.7	12.9	13.5	2.8	11.1	0.0	9.9	8.6	10.6	5.7	0.0	6.5	5.0	20.9	24.0	12.0	11.4	7.0	9.3	11.6
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 50.0"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 2.7;Late spermatids: 3.3;Leydig cells: 4.9;Peritubular cells: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"LHCN-M2: 19.8;RH-30: 20.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Not detected"	"Not detected"									NA	NA						"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	7.5	0.3	0.6	5.8	0.7	0.0	0.2	0.1	0.2	0.3	6.8	0.0	0.0	2.3	0.2	4.0	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0.0	0.2	0.6	0.3	1.9	5.3	0.0	0.4	0.0	50.0	0.3	5.0	3.0	0.3	0.2	2.6	5.9	0.0	0.0	0.3	1.4	3.9	3.6	2.9	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	20.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Group enriched"	"Detected in some"	8	"granulocytes: 56.4;Horizontal cells: 54.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 42.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	6.8	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5	0.0	2.2	0.0	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	56.4	0.0	0.1	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	2.5	0.1	0.0	0.0	0.0	0.0
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell type enhanced"	"Detected in many"	12	"Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Approved	Cytosol		NA	NA		13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	11.7	0.8	0.9	13.4	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1	0.0	0.3	0.0	1.0	50.4	24.4	8.7	0.0	2.7	0.0	8.7	5.9	0.0	23.2	26.5	1.5	4.5	0.0	0.0	0.6	0.1	10.6	0.9	0.0	0.0	0.2	228.8	0.0	5.5	0.0	1.7	96.4	1.2	16.9	1.0	0.0	248.1	0.5	7.2	45.3	7.9	9.1	122.9	96.9	0.7	1.1	21.5	0.0	0.0	5.4	0.8
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		11000000	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	6.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	48.6	0.9	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7	0.0	0.0	0.0	5.9	0.5	58.9	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	85.5	0.7	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.9	1.6	0.0	1.8	0.0	103.3	3.1	0.2	0.0	0.0	0.0	8.9	0.0	0.0	25.8	0.0	2.7	51.8	37.7	8.8	1.9	0.1	0.1	0.0	0.0	0.1
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.5	0.0	4.6	0.4	0.4	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	4.9	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	12.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	3.8
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119435	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.7;skeletal muscle: 126.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 90.3;monocytes: 42.3;Mucus-secreting cells: 71.1;Paneth cells: 95.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.1;neutrophil: 37.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in some"		"A549: 6.9;RPTEC TERT1: 20.3;SK-BR-3: 31.1;T-47d: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA					"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	1.4	16.2	5.0	25.1	10.9	19.2	3.3	25.6	2.7	41.4	76.7	1.3	1.6	1.4	1.3	3.8	2.3	1.8	1.1	21.9	15.6	5.5	1.3	2.2	1.4	36.8	13.6	1.1	1.7	1.3	1.5	1.6	45.6	2.3	43.4	4.6	21.1	1.8	126.4	2.8	3.6	3.9	69.6	4.2	2.1	1.3	26.0	0.0	1.2	14.8	1.6	2.1	0.7	0.0	4.2	37.2	5.1	0.0	0.0	1.7	0.0	6.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	2.9	0.1	0.9	0.3	0.1	0.9	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	2.2	0.3	0.8	1.0	2.3	0.0	0.0	0.0	0.2	20.3	0.0	1.2	0.1	0.0	31.1	0.0	1.8	8.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.4	5.1	15.1	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	37.2	0.0	0.1	0.1	0.0	1.7	16.2	25.1	3.3	22.0	21.9	15.6	36.8	13.6	45.6	26.0	0.0	2.2	0.0	0.2	0.2	2.2	0.3	0.0	0.0	2.3	1.8	90.3	0.1	10.0	0.5	5.7	0.0	25.6	0.0	0.0	0.4	0.4	0.3	16.2	0.0	7.6	0.0	3.5	1.3	6.8	8.5	0.3	4.8	27.0	42.3	71.1	30.6	0.0	95.1	0.7	0.2	29.3	0.0	1.0	0.2	0.3	0.4	0.1	0.0	21.7	0.1
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.5	0.0	1.3	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	16.2	0.0	0.0	0.0	2.4	0.1	0.1	12.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 5.9;granulocytes: 11.6;Kupffer cells: 4.7;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;HEL: 4.2;NB-4: 1.7;RPMI-8226: 4.9"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced					NA	NA		12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	0.0	4.2	0.1	0.4	0.0	0.4	0.6	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	1.7	0.2	0.0	0.2	0.2	0.0	4.9	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3	0.0	5.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.6	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.5	0.0	0.0
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"blood: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0		0.1		0.7	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.1	0.0	0.5			0.0		0.0	0.0		0.0	3.5	0.0	0.8	0.0	1.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	0.1	0.0	0.0	0.2	1.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 218.2;Spermatocytes: 187.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 61.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	61.3	20.0	19.7	12.5	1.9	3.5	8.3	28.2	13.4	29.0	24.5	6.9	11.4	32.7	10.0	10.8	32.3	16.3	18.9	9.5	31.9	8.0	10.2	7.8	14.2	10.1	0.1	5.1	11.7	0.9	7.8	13.4	7.2	5.2	14.6	16.2	11.5	22.0	34.2	6.9	19.3	6.0	3.5	16.6	17.4	12.1	27.4	8.8	10.9	9.5	7.8	12.2	10.5	12.4	15.8	5.7	13.0	7.8	8.5	19.1	46.0	24.2	29.9	3.1	8.7	15.1	11.6	9.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.9	7.9	0.0	0.3	5.1	0.0	2.3	0.0	0.0	3.1	0.0	0.5	218.2	0.0	1.3	46.7	0.0	40.6	2.9	0.7	0.0	1.0	4.2	0.0	0.0	7.4	1.9	37.5	7.8	0.6	0.0	0.0	4.3	0.0	0.2	0.0	2.8	0.0	0.0	6.5	0.5	187.0	31.0	2.0	5.6	0.0	5.3	0.7
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Group enriched"	"Detected in many"	9	"Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	82.8	38.8	0.1	4.3	48.0	0.0	0.1	11.5	0.0	0.1	0.1	33.4	0.1	0.1	3.3	0.0	0.0	0.4	0.1	0.1	0.1	0.2	28.0	0.0	0.0	70.4	0.0	5.5	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.7	0.0	0.1	0.0	0.3	0.1	0.0	0.1	15.2	0.5	16.6	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3	0.0	0.3	0.9	0.3	15.1	0.7	4.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	2.9	1.6	3.3	0.0	0.0	5.8	1.2	171.4	0.4	0.0	0.8	2.8	0.0	0.0	38.1	0.6	3.7	416.6	1.6	21.9	8.2	0.0	18.3	12.2	0.0	384.4	0.0	0.4	0.0	13.2	1.1	3.5	13.8	1.1	0.0	0.0	0.8
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Sertoli cells: 1267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 173.0;ASC TERT1: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	173.0	59.9	0.4	6.0	25.1	4.2	7.1	0.6	0.0	0.0	0.8	17.3	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.4	24.5	0.0	0.0	27.0	0.0	5.8	0.0	13.5	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.8	2.2	2.9	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7	0.0	0.6	0.0	0.5	21.3	5.0	13.4	0.0	1.4	0.0	1.8	3.9	0.6	0.0	0.0	0.8	16.2	0.0	0.0	0.0	1.0	68.8	0.6	0.0	1.5	1.4	0.0	0.0	6.7	0.0	4.7	153.1	2.2	23.6	1.0	0.0	74.9	0.1	0.0	191.6	0.0	1.1	1267.6	273.4	1.1	1.5	13.4	0.7	1.0	0.4	0.9
PEAK1	"KIAA2002, sgk269"	ENSG00000173517	"Pseudopodium enriched atypical kinase 1"	Q9H792	15	77100656-77420144	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026313, HPA026517"	Approved					NA	NA					"HPA026313: AB_1856801, HPA026517: AB_1856802"	"unprognostic (1.15e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.65e-3)"	21.5	6.0	14.3	8.7	13.2	9.7	12.4	8.4	14.1	15.1	9.3	12.3	6.2	7.2	16.1	8.7	6.6	7.5	12.2	18.5	12.3	7.5	6.6	4.9	20.5	7.5	13.8	8.8	9.8	5.8	7.6	4.2	19.5	9.8	8.4	10.2	13.7	7.0	9.5	8.8	8.4	9.1	14.8	10.1	41.8	6.7	11.5	15.9	2.7	8.3	9.0	5.7	10.0	12.2	0.9	0.6	1.1	0.6	5.5	1.4	0.4	2.6	3.8	9.2	2.1	17.3	18.7	3.2	14.2	9.8	7.6	7.6	3.0	2.3	2.0	2.5	20.4	2.9	1.3	7.3	2.2	8.7	2.0	3.8	3.7	5.7	1.8	6.3	2.2	2.0	14.3	2.2	14.6	2.4	8.3	21.1	3.3	4.8	2.0	8.1	1.0	1.2	2.4	4.2	1.8	1.0	2.5	5.5	1.4	2.2	4.7	2.0	2.5	5.5	1.2	9.5	10.5	0.8	1.5	25.8	16.2	7.8	6.7	6.0	3.2	4.4	2.9	2.8	5.2	8.6	0.4	0.6	1.1	0.7	0.2	1.4	0.9	0.2	0.2	0.3	0.8	0.3	0.3	0.6	5.5	0.2	0.6	0.2	0.4	14.3	13.2	8.4	14.1	12.3	7.5	13.8	8.8	9.8	15.9	137.0	38.5	5.6	7.4	19.5	17.0	40.3	10.2	56.2	45.5	1.8	11.8	2.8	0.0	5.6	12.1	29.4	16.1	0.0	4.7	1.6	38.5	5.2	16.3	3.2	15.1	19.1	2.9	33.2	19.7	10.8	18.4	17.1	11.8	5.4	10.3	31.5	8.3	8.6	15.2	3.1	20.6	12.9	25.0	10.6	11.7	15.7	5.3	5.1	9.7	8.1
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386498	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 27.5;NTERA-2: 17.8;SuSa: 19.0"	"Low region specificity"	"Detected in all"							"HPA011776, HPA012066"	Uncertain		Uncertain	"Nucleoli,Focal adhesion sites"		NA	NA			Nucleoli	"Focal adhesion sites"	"HPA011776: , HPA012066: AB_1847706"	"unprognostic (7.04e-3)"	"unprognostic (7.90e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.22e-3)"	7.6	0.2	6.4	8.8	4.9	0.1	5.4	30.4	7.0	2.4	5.7	1.8	3.2	9.8	0.8	1.7	2.6	5.0	4.0	1.8	2.1		1.3	0.9	4.3	9.1	0.0	1.4	1.7	1.0	2.2	0.0	5.4	1.2	1.5	3.4	0.0	1.7	5.7	5.6	2.8	9.4	0.9	1.4	5.7	3.9	0.7	1.2	1.8	15.4	4.7	6.2	1.5	0.2	3.1	4.6	2.2	1.6	1.3	3.9	0.4	3.3	27.5	3.1	0.4	0.0	0.2	7.8	7.0	1.5	2.8	1.1	13.6	8.0	5.5	4.8	3.3	7.6	12.0	0.5	8.4	0.6	0.2	0.8	0.0	3.3	7.6	3.0	0.8	8.7	0.7	5.5	0.4	1.2	1.6	5.7	0.8	0.0	0.0	2.1	4.6	0.7	2.6	17.8	10.5	7.1	3.5	3.3	1.3	4.1	9.5	1.5	1.0	2.7	7.7	2.7	19.0	6.0	3.4	7.5	0.2	7.4	0.0	1.7	0.4	0.6	7.5	1.7	1.8	4.1	0.0	0.5	2.2	1.2	0.1	0.9	3.1	1.5	0.4	0.7	2.6	3.9	3.2	0.0	1.3	1.6	4.6	0.2	0.4											8.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	6.4	0.0	6.6	0.0	0.0	0.0	0.0	2.7	5.5	0.0	0.0	2.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	5.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA		32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.5	23.1	32.1	11.5	13.5	14.5	20.7	14.4	20.0	13.4	13.2	10.1	12.0	8.8	32.6	18.3	18.9	17.1	18.8	32.8	20.4	0.1	8.8	19.5	12.8	13.9	18.5	0.0	9.2	9.8	16.2	16.8	23.7	35.4	39.6	12.5	19.6	0.2	17.9	25.2	0.2	0.1	12.4	31.5	25.8	12.9	17.6	0.4	28.4	33.1	12.7	15.9	22.4	7.2	14.5	29.6	17.0	0.3	23.9	13.3	25.0	15.6	16.1	0.0	0.1	0.9	17.2	0.1	17.9	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1	29.8	24.9	2.7	51.7	29.7	51.6	26.2	33.1	25.4	20.5	52.4	56.9	27.2	19.9	23.3	34.0	35.8	21.0	0.0	20.0	45.5	28.2	67.2	9.2	14.7	6.8	63.5	24.8	33.7	11.7	33.3	22.2	7.9	23.6	1.0	23.1	41.5	33.4	21.0	20.5	22.6	56.8	97.0	121.7	43.2	62.8	22.6	27.8	1.8	21.0	67.4
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.7;REH: 41.9"	"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	11.1	3.1	0.8	0.9	24.0	1.7	6.5	0.9	0.6	0.6	0.8	2.9	6.5	37.7	1.2	1.7	0.9	10.3	0.3	9.4	0.3	2.5	0.2	7.8	3.0	0.6	4.9	8.3	14.0	13.0	14.0	0.8	5.4	4.0	0.3	10.9	9.1	26.3	0.6	1.1	14.3	16.8	0.6	9.7	0.8	41.9	0.2	25.8	2.6	8.8	6.0	1.1	4.0	2.8	1.5	2.1	3.3	21.6	5.3	0.4	0.8	0.7	0.3	21.1	9.1	20.4	1.6	18.1	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7	3.0	30.9	54.0	32.1	33.5	4.1	3.1	12.7	13.4	13.6	14.0	0.0	2.4	0.0	6.4	1.1	7.5	48.3	0.0	7.0	23.9	3.8	16.5	27.7	21.8	20.9	7.9	7.5	3.1	73.4	0.8	1.4	42.5	8.5	34.3	18.6	3.4	9.4	35.1	0.7	14.7	4.0	0.0	1.6	4.2	5.5	26.3	1.6	39.9	14.9	14.8
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	10.6	1.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	20.4	0.0	3.6	0.0	0.0	16.6	0.0	0.0	0.0	2.6	0.2	0.0	4.3	0.0	0.0	0.0	3.4	0.0	22.5	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.1	5.9	0.0	0.1	0.1	27.4	7.7	0.0	0.6	0.2	0.0	13.0	0.1	1.1	1.2	4.0	0.0	0.0	12.5	0.8	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.2	0.2	0.5	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	11.9	34.1	0.0	2.8	5.3	2.0	0.4	12.7	9.4	17.0	0.0	2.0	0.2	0.0	1.4	0.0	0.3	90.1	0.0	1.4	0.1	0.4	1.3	9.2	1.5	0.7	0.0	5.2	0.6	4.1	0.0	0.3	2.8	0.0	0.0	39.1	2.4	10.3	65.1	0.0	0.1	3.9	0.0	0.4	0.2	0.2	13.6	0.1	0.0	18.8	13.8
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 314.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 13.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		10000000			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9.0	9.0	20.9	4.2	18.2	3.3	13.9	15.0	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0.0	13.8	0.3	0.0	0.7	1.5	0.8	2.1	0.6	21.1	35.0	22.7	23.3	30.0	22.6	36.5	19.8	25.4	19.0	7.6	0.0	17.9	26.3	14.4	24.5	9.4	21.5	12.6	0.1	11.7	2.0	4.3	25.5	34.5	0.0	0.1	33.3	19.5	26.1	8.3	34.6	2.5	8.5	1.3	0.0	9.0	1.6	7.6	3.0	9.8	0.2	1.7	7.7	30.0	0.0	15.3	10.5	12.1	23.0	3.6	0.3	11.7	23.2	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0.0	3.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	1.5	0.2	0.7	0.0	13.8	0.0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4	14.9	12.5	0.0	16.8	15.3	1.4	1.6	2.5	2.7	6.8	12.2	53.0	18.9	1.7	19.2	314.6	1.0	0.2	0.0	6.2	1.9	31.6	10.9	1.1	0.0	3.1	0.0	20.7	1.8	0.0	38.8	17.0	1.1	15.1	1.0	1.2	19.8	8.6	3.5	17.3	0.5	1.7	12.9	9.5	2.4	18.5	9.2	6.9	0.7	2.6	9.7
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase type IVA, member 1"	Q93096	6	63521748-63583587	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 135.1;skeletal muscle: 111.2"	"Cell type enhanced"	"Detected in many"	14	"Late spermatids: 2420.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA					"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	13.9	42.3	11.3	10.5	14.0	54.3	10.8	7.1	17.0	17.5	30.2	18.9	8.0	17.9	13.1	13.5	16.1	12.3	16.7	10.0	12.0	14.8	14.2	135.1	25.0	9.0	16.1	13.8	24.1	87.4	5.0	12.8	19.8	16.3	17.7	31.2	13.6	20.1	10.0	111.2	17.2	18.3	35.7	24.2	7.1	15.5	19.8	13.3	6.4	11.4	19.9	9.3	31.0	12.6	14.6	18.2	46.9	20.6	15.8	20.1	14.4	19.3	24.0	30.3	29.2	20.7	19.2	60.6	34.1	22.8	12.4	17.4	20.2	11.4	16.5	14.8	20.1	25.8	9.6	20.6	42.8	20.0	17.8	13.9	10.3	67.2	91.7	41.0	31.6	16.9	23.4	83.1	26.9	71.9	15.2	19.2	15.7	23.5	32.1	34.5	26.2	15.1	14.2	12.5	21.7	13.1	20.2	12.6	13.1	27.7	23.0	11.4	21.1	74.4	16.3	33.6	36.3	15.7	28.1	19.1	31.3	34.4	24.7	33.5	26.9	23.0	30.5	16.7	16.9	36.7	34.6	19.8	15.2	13.7	20.6	20.1	14.6	15.0	14.6	18.2	12.4	14.8	14.2	46.9	15.8	14.2	9.1	18.1	14.4	11.3	14.0	7.1	17.0	12.0	14.8	16.1	13.8	16.3	13.3	20.8	83.0	74.7	257.9	605.1	22.1	73.9	163.1	38.8	51.2	71.5	15.7	216.2	68.0	128.0	616.2	31.2	259.4	0.0	168.0	175.7	85.2	143.0	64.4	416.3	88.4	11.1	124.3	41.1	65.9	2420.5	26.4	64.7	161.9	36.1	129.4	17.8	159.8	140.8	22.6	85.2	23.2	6.5	110.2	32.8	21.3	560.3	384.3	37.0	97.1	110.7
PTP4A2	"HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2"	ENSG00000184007	"Protein tyrosine phosphatase type IVA, member 2"	Q12974	1	31906421-31944856	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Urothelial cells: 819.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003281, CAB011204"	Uncertain					NA	NA		440000			"CAB011204: AB_532271, HPA003281: AB_1855903"	"unprognostic (2.67e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (6.90e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.10e-11)"	"unprognostic (1.16e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.72e-5)"	51.6	22.4	41.1	39.6	57.3	74.6	48.8	12.0	34.6	26.3	37.1	68.9	24.9	31.9	23.4	20.8	25.3	23.9	31.6	64.8	50.6	31.4	26.7	36.3	34.6	44.0	56.3	29.5	34.6	28.5	17.1	19.2	25.8	40.9	28.6	36.9	21.1	28.0	27.5	82.8	16.5	29.1	32.7	58.5	40.9	31.3	44.6	48.7	110.5	48.0	20.0	47.2	49.0	40.3	14.7	14.8	50.0	44.6	18.2	29.0	18.2	42.3	24.7	24.2	45.2	48.6	52.1	16.6	41.6	58.1	34.2	35.6	21.7	61.4	75.3	32.8	56.5	38.5	17.3	24.7	24.2	63.5	67.7	14.0	52.3	43.8	22.5	52.2	42.4	53.0	47.8	20.2	48.2	47.6	34.2	34.6	60.6	67.2	30.9	43.8	20.6	135.8	20.8	32.4	32.5	36.1	23.6	40.7	31.3	22.9	78.4	23.8	17.1	44.3	28.9	47.1	44.1	82.5	23.5	35.7	40.3	34.0	60.0	45.8	32.2	50.2	38.4	39.0	34.8	39.1	50.0	17.2	27.4	25.4	32.6	20.3	14.7	22.6	29.0	14.8	11.3	14.5	24.9	18.0	18.2	44.6	10.7	17.8	18.2	41.1	57.3	12.0	34.6	50.6	31.4	56.3	29.5	40.9	48.7	113.2	107.0	105.7	413.0	172.4	53.2	156.4	145.2	36.1	85.3	191.9	56.9	42.6	162.5	131.4	33.4	86.3	153.7	46.7	159.0	99.5	130.0	535.6	85.4	139.5	112.1	93.8	123.2	81.0	165.5	29.0	163.7	193.7	109.6	162.3	177.6	142.6	155.3	178.2	164.8	128.3	51.1	129.4	116.1	95.6	88.0	171.8	133.9	143.0	162.7	819.0
PTP4A3	"PRL-3, PRL-R, PRL3"	ENSG00000184489	"Protein tyrosine phosphatase type IVA, member 3"	O75365	8	141391993-141432454	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 166.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 234.6;Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 210.7;Smooth muscle cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.3;non-classical monocyte: 27.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.3;monocytes: 27.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 70.2;Karpas-707: 21.4;REH: 12.0;RPMI-8226: 22.0;U-266/84: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003281	Uncertain					NA	NA					"HPA003281: AB_1855903"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.77e-1)"	5.9	2.4	2.8	3.9	6.5	1.7	4.1	3.9	10.9	5.5	6.2	2.6	2.5	3.4	7.6	5.4	5.5	6.1	3.0	48.0	2.7	3.0	5.1	1.7	5.5	7.9	2.8	5.0	4.8	13.6	2.4	22.0	4.1	4.6	7.2	2.0	15.7	8.2	3.8	166.4	3.4	3.3	7.6	1.5	5.6	9.9	3.5	0.6	1.7	3.3	15.9	5.1	5.5	3.3	2.8	4.3	30.3	27.8	0.8	3.5	2.5	0.1	0.5	0.8	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.0	0.0	6.5	0.1	0.0	0.0	0.1	0.0	0.0	70.2	0.5	5.0	0.0	1.1	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.6	2.7	21.4	0.0	5.4	0.6	0.1	1.3	0.5	0.3	12.0	0.0	22.0	0.0	0.1	9.0	2.1	0.4	0.0	1.8	0.6	1.0	0.3	0.1	0.0	1.3	0.0	0.0	6.7	23.3	0.2	0.0	2.0	0.2	0.4	1.6	6.6	1.6	14.8	1.1	2.8	3.5	1.6	1.2	0.8	3.4	1.9	30.3	0.8	27.8	4.3	2.5	2.5	2.8	6.5	3.9	10.9	2.7	3.0	2.8	5.0	4.6	0.6	3.0	45.2	18.2	3.6	8.9	90.4	234.6	5.1	0.0	5.7	7.0	115.8	0.2	8.3	6.5	9.8	29.7	0.0	0.0	53.0	0.2	11.8	9.7	1.1	0.2	3.2	14.3	9.8	9.2	2.8	3.6	3.4	6.0	20.3	10.8	2.4	25.7	16.3	0.0	1.8	4.2	210.7	32.3	93.8	1.8	22.8	8.9	0.2	8.7	2.3	2.5
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.3"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	7.0	12.0	7.6	4.4	32.3	1.5	6.4	4.7	16.4	4.7	4.9	25.3	1.4	3.1	6.2	4.9	4.4	4.4	4.7	10.0	12.1	6.9	5.1	2.4	6.8	3.7	13.9	8.9	6.3	12.2	6.8	8.9	3.7	19.9	5.6	5.9	4.1	4.3	4.4	7.0	6.2	3.6	8.3	20.5	3.0	7.1	15.0	13.0	1.6	5.1	1.3	3.9	4.9	3.6	1.1	0.3	0.0	0.2	0.0	2.0	0.1	6.1	2.7	4.9	6.3	6.1	8.5	6.5	4.5	3.2	4.6	3.9	2.6	5.2	5.2	3.1	3.4	10.6	4.9	5.0	2.9	4.5	7.0	1.4	1.2	7.2	2.8	8.0	1.4	4.0	8.4	10.5	7.0	9.8	2.8	4.9	8.6	3.0	0.0	8.6	3.3	5.2	2.2	3.4	5.0	5.1	5.6	9.7	0.0	2.6	1.5	4.3	5.5	6.2	5.8	9.7	6.8	3.1	2.5	6.9	6.2	3.8	9.5	5.4	7.6	8.4	0.7	4.6	2.5	8.6	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.1	0.0	0.3	1.1	2.0	0.7	0.0	0.0	0.2	0.2	0.0	0.1	7.6	32.3	4.7	16.4	12.1	6.9	13.9	8.9	19.9	13.0	0.0	7.7	1.9	2.6	4.2	10.5	8.4	2.5	1.4	1.2	5.2	9.8	0.3	3.3	2.9	8.0	5.7	0.9	0.0	2.5	1.6	5.0	1.9	5.7	0.8	2.7	4.8	3.4	6.2	0.3	3.8	3.4	2.7	3.3	0.0	2.4	2.3	5.0	1.1	13.4	1.0	9.8	19.4	4.8	12.0	15.9	3.8	0.2	2.5	2.3	1.7
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.2	12.6	1.5	10.1	11.7	9.0	4.3	13.1	12.4	13.1	12.5	20.9	11.9	16.0	14.5	9.8	12.2	19.1	10.4	13.6	14.0	19.5	31.3	7.4	25.8	26.3	17.2	14.3	9.8	8.9	15.5	6.1	18.8	10.1	9.3	15.9	18.8	12.3	9.6	42.0	12.2	18.5	9.4	3.8	23.4	22.4	8.5	13.7	15.8	14.3	9.4	11.5	19.9	7.3	11.8	6.6	33.8	15.4	10.0	9.7	15.0	15.7	19.7	18.7	12.5	10.9	7.6	12.4	5.9	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3	20.8	25.4	25.3	13.5	15.9	13.5	5.3	48.4	41.5	22.7	38.4	3.9	63.4	61.3	87.9	188.7	19.1	21.4	0.0	74.6	54.2	24.4	20.5	16.2	36.5	56.1	4.8	30.1	30.1	29.8	522.3	43.1	32.4	43.9	60.5	41.0	48.4	92.6	28.1	43.9	62.0	11.6	19.4	21.2	109.7	21.3	15.2	64.2	24.9	61.2	18.6
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase, non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;monocytes: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		11000	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	22.1	22.2	12.1	31.9	16.0	35.3	17.9	12.9	16.6	18.2	17.8	18.8	14.2	10.5	20.0	16.6	23.2	17.1	18.0	20.5	15.8	9.0	43.8	16.7	42.7	36.1	14.1	14.1	21.8	12.2	31.2	18.8	28.3	18.7	20.0	14.8	21.0	16.3	15.0	41.0	18.6	21.9	16.9	15.8	45.3	17.5	23.5	13.3	26.9	15.7	13.9	42.8	20.0	18.4	15.9	9.4	18.8	16.4	3.9	10.7	6.4	21.1	10.7	12.9	8.9	8.5	11.7	18.4	14.2	13.6	41.9	15.3	31.3	44.6	10.5	25.3	13.1	16.5	18.8	10.2	40.9	26.7	15.5	9.1	14.8	10.4	16.5	16.9	15.4	20.4	13.6	28.7	18.9	23.3	18.4	24.0	12.8	25.8	9.7	22.7	11.8	16.5	12.2	6.8	11.7	14.7	14.7	15.0	10.0	24.1	15.9	10.4	11.9	20.4	26.0	23.0	11.3	16.8	16.5	35.6	36.6	14.7	16.4	17.6	10.6	8.5	12.8	22.9	10.5	13.5	12.0	5.6	18.8	10.7	9.5	7.9	15.9	9.0	8.2	5.5	13.7	7.7	8.3	12.2	3.9	16.4	9.4	7.1	6.4	12.1	16.0	12.9	16.6	15.8	9.0	14.1	14.1	18.7	13.3	211.4	72.3	67.9	44.4	76.4	23.0	27.2	10.2	32.1	47.8	34.9	45.2	41.8	19.9	20.5	47.2	26.1	20.4	0.0	16.9	17.3	21.4	26.7	67.2	18.6	32.9	41.3	17.9	37.4	28.2	22.4	13.0	52.2	35.4	327.4	13.7	13.8	28.9	11.5	11.3	59.6	25.9	19.4	34.0	20.7	24.3	41.3	45.4	43.7	15.5	55.1
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		160000	"Nucleoli rim"	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	35.4	33.8	24.7	23.4	36.0	35.2	29.2	43.1	47.0	34.0	25.6	33.7	13.7	37.5	22.5	39.8	21.5	21.2	31.7	38.2	56.5	28.4	26.1	54.5	31.5	18.4	35.9	43.7	34.8	28.4	38.5	36.5	51.9	32.8	28.0	29.0	41.4	13.2	32.8	25.6	30.7	21.3	29.9	34.7	22.2	31.6	36.4	21.5	31.3	39.9	17.2	21.1	41.5	31.8	26.5	26.1	36.6	30.3	34.1	40.0	35.9	23.7	37.6	25.6	42.2	37.5	33.3	30.7	37.3	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1	56.6	53.2	13.4	22.8	22.8	27.6	136.3	30.6	20.1	50.0	34.9	15.7	20.0	28.2	34.0	65.9	35.8	17.2	0.0	36.7	21.0	25.9	57.9	26.7	93.6	22.8	12.7	12.6	27.0	32.4	19.0	47.8	23.7	13.5	16.2	19.6	59.0	45.4	20.4	75.0	29.8	21.4	32.3	31.9	7.7	5.3	24.0	29.4	19.8	18.7	65.6
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.2	10.6	25.2	12.8	17.7	18.5	13.5	18.0	23.0	14.2	20.3	5.2	27.0	2.0	5.8	21.0	31.1	12.3	8.4	18.0	28.7	5.0	4.7	10.8	10.7	21.2	17.4	6.1	7.2	15.1	20.1	30.9	39.9	25.5	30.0	0.5	12.9	3.0	45.2	11.8	0.8	17.1	20.3	23.5	12.2	3.6	20.2	1.0	24.4	9.3	3.1	16.7	22.1	20.3	17.5	45.3	9.8	22.5	21.8	30.8	18.6	11.2	33.9	3.1	1.7	5.3	18.1	15.9	53.3	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7	65.5	54.6	13.7	41.5	61.1	15.5	35.1	22.9	16.0	46.6	19.2	7.9	34.1	3.3	38.7	2.6	99.1	17.1	0.0	34.2	48.2	53.7	44.4	13.9	19.2	45.4	33.4	11.6	98.8	74.4	5.4	43.1	86.9	33.7	25.2	19.9	63.0	55.1	20.1	44.2	15.8	14.3	64.7	55.6	14.7	57.8	88.7	60.3	26.2	18.0	78.6
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase, non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 152.9;Basal keratinocytes: 97.1;Rod photoreceptor cells: 171.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"AF22: 45.2;RT4: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	10.3	5.9	10.8	2.7	16.9	0.7	9.9	5.7	11.6	15.9	4.1	13.0	7.6	1.2	10.8	21.2	18.7	11.4	6.5	5.3	10.4	5.7	22.1	1.6	18.0	4.3	16.9	7.9	24.1	4.3	26.6	38.3	3.0	14.2	12.0	2.4	39.0	5.9	9.4	1.0	43.0	2.3	8.7	10.3	3.5	3.6	12.2	17.6	1.9	16.9	12.4	11.8	15.7	17.6	0.0	0.5	0.1	4.9	0.1	2.3	0.1	5.1	2.6	45.2	4.4	19.1	16.7	0.0	9.5	19.4	3.6	4.6	0.0	2.6	0.0	2.1	10.5	1.3	17.0	7.8	14.3	7.0	0.1	5.8	4.3	5.6	0.0	2.3	7.5	0.0	10.7	4.6	2.6	8.7	7.6	0.0	0.0	0.0	7.4	0.0	2.3	0.6	2.7	10.3	0.0	1.9	1.5	0.0	0.0	13.8	21.5	2.6	3.8	2.8	6.3	5.2	7.6	3.7	0.2	0.0	3.5	2.7	0.0	1.2	7.7	0.0	0.0	3.7	0.0	1.5	0.0	0.2	0.0	0.2	3.0	2.3	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.1	0.1	10.8	16.9	5.7	11.6	10.4	5.7	16.9	7.9	14.2	17.6	44.7	152.9	0.0	21.0	97.1	9.8	1.7	10.2	32.1	75.1	45.4	86.4	0.2	3.3	4.3	20.2	2.2	0.0	0.0	3.0	0.1	20.2	12.1	4.7	0.0	0.2	1.6	4.6	1.8	2.2	14.8	42.3	5.7	18.6	0.0	0.5	14.1	4.3	3.5	30.8	9.2	171.6	12.9	12.5	24.4	21.6	86.9	0.2	4.4	0.2	45.5
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.8	3.9	3.2	4.7	5.6	9.6	9.5	10.1	9.4	7.7	6.5	7.9	4.6	0.0	11.2	23.4	4.4	7.9	4.4	11.2	13.2	0.1	3.3	0.8	11.3	1.5	10.2	0.1	0.4	7.1	11.8	13.4	21.6	12.7	14.9	0.3	0.0	0.1	18.6	0.9	0.1	0.1	7.0	1.6	4.3	0.1	16.2	0.0	13.9	4.5	0.0	0.7	12.5	8.2	5.1	11.9	8.1	0.3	26.5	18.1	7.1	6.4	14.2	0.5	0.0	0.0	9.7	0.1	15.0	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4	68.5	15.9	0.5	27.7	50.3	0.4	17.5	2.5	21.4	44.3	27.9	0.0	30.2	6.6	12.0	8.1	42.7	0.4	0.0	9.4	11.6	27.8	19.5	1.1	0.8	4.0	0.0	3.4	36.8	1.2	4.0	24.2	2.5	10.1	0.0	5.0	3.3	20.7	0.0	27.6	12.5	1.3	19.4	20.6	0.7	7.2	31.6	20.3	1.8	2.9	24.0
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase, non-receptor type 18"	Q99952	2	130356007-130375409	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		550000	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	12.8	7.1	11.0	16.7	13.5	18.9	22.3	26.8	13.7	15.3	22.8	6.6	25.7	16.6	9.3	11.0	11.3	13.3	21.3	7.5	9.8	8.5	13.9	19.2	16.9	29.2	8.4	9.5	7.8	28.9	6.4	11.0	9.4	6.9	17.8	19.3	7.9	18.5	24.0	11.0	6.9	28.8	10.5	9.1	37.7	16.0	3.3	9.1	1.6	13.0	7.1	35.5	11.0	10.7	7.6	7.4	6.2	17.1	2.8	6.6	10.2	5.8	3.9	1.6	7.9	9.9	6.8	16.4	3.0	2.7	3.9	4.4	7.8	9.0	21.9	3.0	7.3	1.8	6.7	6.9	6.8	3.8	9.9	3.8	7.9	4.7	9.2	5.1	7.7	21.5	8.0	5.6	4.3	5.9	0.8	7.4	4.9	7.4	16.7	7.4	11.4	1.4	13.4	1.6	12.6	4.3	13.3	4.6	29.6	7.7	3.6	10.1	2.6	5.3	19.0	8.7	1.6	6.6	11.4	6.9	5.6	6.3	3.0	2.8	2.6	0.7	21.1	8.5	7.0	6.0	6.2	7.8	6.1	6.6	10.8	4.1	7.6	4.4	6.3	6.7	4.5	2.7	5.4	4.9	2.8	17.1	7.4	5.6	10.2	11.0	13.5	26.8	13.7	9.8	8.5	8.4	9.5	6.9	9.1	26.8	22.9	49.5	26.1	5.8	13.5	8.1	20.4	18.7	12.5	34.9	3.9	12.1	46.4	16.6	0.7	21.5	49.1	0.0	39.9	25.3	13.3	43.8	35.7	18.1	76.6	9.5	46.7	17.2	79.3	0.9	17.5	52.8	32.1	16.2	50.4	12.4	23.4	56.1	10.6	25.1	10.0	19.4	19.8	3.0	4.1	5.1	9.6	39.8	38.3	27.6
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase, non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	16.7	12.5	12.6	27.0	14.3	33.7	19.9	32.6	19.2	14.7	15.0	7.8	17.8	12.9	12.2	14.9	17.0	13.7	15.7	12.8	13.1	6.8	13.6	20.5	21.6	30.3	15.3	10.3	22.1	28.2	10.4	27.2	13.3	13.8	14.4	17.1	7.9	26.3	16.0	13.1	16.0	15.3	11.8	24.7	24.2	13.1	9.4	15.9	61.3	14.7	11.7	28.9	16.5	15.8	29.1	32.8	19.9	28.0	31.7	29.2	19.6	12.0	7.4	8.6	2.8	9.9	17.8	8.4	8.1	18.0	17.4	15.6	16.0	17.5	19.0	13.7	8.3	19.5	7.3	14.0	22.2	22.9	7.3	8.4	13.4	6.4	16.6	13.6	31.5	12.8	14.9	21.1	15.8	31.4	10.7	8.8	20.8	13.0	25.9	13.9	13.8	31.4	26.0	10.3	49.8	8.6	10.6	13.6	21.5	14.6	19.4	15.5	8.0	16.4	9.7	14.0	9.6	8.1	18.1	6.7	22.1	21.3	16.4	17.4	8.3	8.3	27.5	10.4	17.3	9.2	11.5	28.0	19.9	21.0	24.6	28.2	29.1	24.8	23.1	32.8	20.3	18.3	20.0	10.2	31.7	22.8	28.0	29.2	19.6	12.6	14.3	32.6	19.2	13.1	6.8	15.3	10.3	13.8	15.9	32.8	62.4	68.6	84.1	53.1	42.4	13.2	38.2	33.5	60.3	14.0	98.2	46.3	11.6	47.9	16.6	28.1	29.6	23.3	59.5	44.8	31.3	89.2	55.4	27.0	47.0	14.3	31.0	16.5	81.8	19.2	27.0	82.9	21.9	111.8	30.9	14.8	39.1	38.6	24.1	17.3	84.6	19.4	21.1	15.4	50.3	43.8	67.9	68.2	36.2	140.6
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase, non-receptor type 21"	Q16825	14	88465778-88554733	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 53.6;Syncytiotrophoblasts: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 23.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus, Centriolar satellite"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.5	4.7	5.3	8.6	7.3	0.0	13.2	4.4	5.8	10.7	8.7	10.7	7.4	4.9	10.6	10.7	8.9	8.3	12.7	17.4	7.4	4.2	8.1	6.0	15.3	1.6	6.6	4.2	15.8	7.8	10.6	3.9	15.6	6.4	11.9	6.5	12.6	6.5	10.5	8.8	24.2	10.5	15.7	7.3	3.7	7.4	15.2	6.5	0.8	16.0	8.4	3.1	12.0	26.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	3.6	2.9	7.7	3.0	8.2	7.2	8.0	9.8	7.5	5.8	8.1	5.2	6.6	0.0	2.4	12.4	5.2	3.4	1.1	3.4	8.5	0.2	1.7	0.0	3.2	2.1	9.2	0.0	0.1	4.7	6.8	4.8	5.8	7.5	4.7	0.0	1.1	0.1	14.8	3.0	0.0	0.1	2.2	3.9	5.6	0.0	23.1	0.0	5.0	2.6	0.5	9.0	5.6	14.1	3.2	6.8	6.9	1.5	9.2	10.8	8.5	4.4	6.7	0.3	1.2	0.0	4.0	0.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.3	4.4	5.8	7.4	4.2	6.6	4.2	6.4	6.5	53.6	5.9	0.0	4.0	9.3	7.3	31.1	5.1	9.4	7.9	7.0	33.4	7.6	0.0	4.4	12.7	4.5	9.3	0.0	7.2	4.4	9.3	7.8	2.3	9.0	1.6	1.6	4.6	7.4	1.2	3.5	15.8	0.7	0.0	0.0	14.6	4.9	8.2	5.8	25.5	3.3	9.0	0.0	8.5	12.1	6.1	10.5	85.2	0.0	4.6	4.7
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6"	"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.1	0.0	4.7	0.0	0.0	0.1	13.3	10.5	3.0	0.0	1.4	0.1	2.7	5.2	8.4	0.0	7.7	5.1	0.1	9.4	7.5	0.0	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.4	8.0	0.1	0.1	0.2	14.4	3.0	18.0	5.5	13.6	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4	0.0	9.2	29.6	0.2	2.3	0.4	0.5	0.0	4.0	0.0	1.8	2.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.5	0.2	0.9	0.2	26.6	0.6	7.1	0.0	0.0	0.6	19.2	0.6	0.0	20.5	3.3	1.8	1.0	0.0	0.6	0.0	0.0	0.0	0.4	12.9	0.9	0.3	0.2	2.4	0.1	65.4	1.7	0.2
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase, non-receptor type 23"	Q9H3S7	3	47381011-47413441	"Enzymes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	15.9	18.5	23.1	17.4	22.3	19.2	21.6	22.8	25.0	18.1	12.5	21.4	14.6	20.7	20.0	15.1	17.2	17.2	12.8	13.2	17.9	11.7	16.4	13.0	16.8	17.8	24.6	23.7	23.4	19.4	53.4	29.9	17.1	20.5	16.9	10.4	15.2	20.8	19.0	25.7	25.9	16.0	16.0	20.3	19.2	17.9	17.8	22.7	9.7	24.8	9.7	11.1	17.7	18.1	1.4	1.1	3.7	1.2	0.9	1.5	0.8	13.0	18.6	10.4	13.4	13.6	10.5	10.0	11.9	11.9	11.2	9.5	15.7	12.9	9.3	11.0	13.5	19.9	11.7	8.9	12.9	5.4	8.6	9.6	12.8	13.6	14.6	15.0	7.5	17.4	13.9	13.3	14.5	14.9	7.9	13.7	7.9	9.5	12.8	11.9	18.3	7.1	6.3	11.1	9.1	13.1	4.4	5.0	11.2	8.4	25.3	5.5	13.0	10.5	22.4	8.7	6.6	12.8	7.2	13.7	17.1	14.5	23.7	16.8	18.4	12.0	5.4	18.6	7.1	12.1	3.7	1.2	0.0	0.8	0.5	0.6	1.4	0.6	1.3	0.4	0.7	0.6	0.8	1.4	0.9	0.5	1.1	1.5	0.8	23.1	22.3	22.8	25.0	17.9	11.7	24.6	23.7	20.5	22.7	8.9	6.5	1.5	4.4	7.1	11.3	6.2	10.2	10.7	7.9	5.2	13.7	8.5	1.7	9.1	1.4	11.1	14.2	0.0	7.6	6.5	6.1	7.9	2.3	9.6	11.6	15.9	7.0	12.3	11.1	2.1	17.8	7.8	11.8	9.0	15.6	9.2	11.8	8.6	12.7	8.2	13.8	6.5	6.2	7.4	10.9	9.5	7.8	4.3	11.5	6.3
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase, non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"OE19: 16.9;RPTEC TERT1: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA					"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	2.7	1.9	3.4	4.8	5.0	0.0	4.8	2.1	11.1	4.4	9.4	2.0	10.7	7.6	3.2	13.4	10.3	6.4	6.3	12.1	3.1	2.8	28.8	21.1	4.9	0.5	1.2	3.9	1.5	17.0	10.6	4.9	14.5	4.5	4.7	6.5	3.8	13.1	13.6	38.1	18.8	18.8	0.8	0.9	0.9	5.9	2.1	0.0	1.1	9.4	7.2	9.5	4.1	5.5	0.6	0.3	2.8	0.6	0.3	0.3	0.1	6.3	7.9	0.3	2.1	0.0	0.0	12.6	1.4	0.0	1.7	1.9	4.2	10.4	0.0	1.4	0.1	4.4	15.2	2.2	8.9	1.8	3.5	4.8	0.0	3.8	4.3	0.0	0.0	0.1	0.1	9.6	2.2	4.6	0.7	0.0	2.7	0.0	0.1	0.1	8.0	10.9	1.9	1.0	16.9	5.9	0.0	2.6	0.1	20.6	12.3	5.2	1.1	3.5	13.0	0.0	4.5	7.4	1.0	0.0	0.6	5.0	0.8	0.0	6.3	10.2	0.0	6.8	0.0	4.5	0.4	0.6	0.8	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.6	0.3	0.3	2.8	0.3	0.6	0.3	0.1	0.1	3.4	5.0	2.1	11.1	3.1	2.8	1.2	3.9	4.5	0.0	14.9	25.0	0.0	20.1	10.5	9.6	46.0	20.4	24.1	19.4	29.6	0.0	19.8	14.9	13.1	20.8	2.2	25.4	0.0	16.7	20.5	3.6	23.7	1.1	32.7	2.2	0.0	12.6	4.3	0.0	12.7	1.1	1.9	3.3	1.0	16.5	0.3	22.0	23.5	1.8	16.1	2.1	6.5	6.2	0.9	11.7	18.1	9.0	0.8	17.3	26.2
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase, non-receptor type 4"	P29074	2	119759631-119983818	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 53.9;Cone photoreceptor cells: 98.2;Horizontal cells: 152.6;Rod photoreceptor cells: 80.5;T-cells: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"NK-cells: 12.2;T-cells: 19.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	6.8	6.9	10.0	5.9	12.2	7.3	7.2	37.4	16.9	9.6	5.5	7.2	5.2	8.1	7.2	6.6	6.9	8.9	6.3	8.9	10.2	8.4	12.0	6.6	8.0	7.9	7.3	13.1	8.9	6.3	11.6	16.3	4.1	8.3	6.2	4.0	7.1	7.9	6.6	11.2	5.8	5.5	4.7	7.3	9.2	8.9	7.7	6.5	18.9	22.5	6.8	6.5	5.3	5.8	0.5	0.3	0.9	0.4	12.2	19.3	4.7	7.4	4.4	5.8	7.7	5.2	5.4	9.9	3.4	9.6	1.9	5.3	6.6	11.6	5.4	8.2	3.8	5.8	6.6	4.5	5.3	5.2	12.6	3.8	3.7	4.2	6.2	3.5	3.8	2.8	4.9	10.0	9.0	4.1	6.6	8.5	5.5	6.4	5.5	5.1	5.7	5.2	4.4	7.6	4.2	7.2	3.6	10.0	7.6	7.0	10.2	7.6	9.4	4.7	6.0	3.9	5.1	2.9	2.4	10.6	0.3	6.7	2.3	4.1	9.5	13.2	6.8	5.1	0.2	3.2	0.2	0.2	0.9	19.3	0.3	15.6	0.5	9.6	15.1	0.3	0.5	3.2	11.0	0.7	12.2	0.4	0.3	5.6	4.7	10.0	12.2	37.4	16.9	10.2	8.4	7.3	13.1	8.3	6.5	3.0	10.5	14.0	12.8	7.2	53.9	13.9	10.2	6.7	6.8	15.7	98.2	8.5	6.6	6.1	3.8	12.8	8.1	0.0	6.3	9.0	7.6	8.7	11.5	9.0	3.6	152.6	8.7	13.5	5.6	7.1	16.1	5.3	8.5	7.2	7.8	23.6	5.5	10.1	13.4	10.4	80.5	0.0	5.0	21.2	20.6	5.8	3.1	90.0	10.6	7.8
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.8	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3	0.0	0.0	0.0	0.0	0.1	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Group enriched"	"Detected in many"	5	"B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.9	5.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	3.0	6.6	2.0	1.5	0.0	0.0	3.4	0.0	3.9	0.0	1.2	1.2	28.7	0.6	2.4	0.0	25.5	112.6	0.0	2.8	0.0	1.2	0.0	0.0	10.3	0.0	0.2	0.0	6.1	9.2	14.9	1.5	6.8	0.9	8.4	0.0	14.5	3.1	5.5	0.5	0.0	0.9	4.6	0.0	4.1	1.4	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	11.2	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3	6.0	18.1	106.2	8.1	8.0	0.0	1.6	12.7	12.0	11.4	5.2	0.0	21.7	13.3	12.3	45.6	4.1	15.8	23.3	13.5	15.5	3.5	4.1	130.8	10.2	168.2	0.0	23.7	9.8	145.1	8.7	0.9	118.2	13.5	6.4	12.0	0.4	11.8	17.3	0.0	10.5	0.6	6.5	2.3	0.3	1.1	7.5	15.4	105.5	15.6	5.6
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase, non-receptor type 9"	P43378	15	75463251-75579289	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	16.8	12.8	15.0	11.8	17.7	9.2	15.7	11.1	20.0	17.4	22.4	10.5	12.0	17.0	18.9	16.4	10.9	16.4	13.5	12.2	13.1	14.6	17.9	14.0	16.0	12.6	11.6	12.4	16.0	12.3	16.6	12.5	18.9	13.2	16.9	19.5	18.4	14.6	21.9	6.8	11.8	30.6	17.6	15.6	15.6	13.4	8.7	7.5	16.3	34.4	8.0	13.9	14.7	15.3	3.3	5.9	4.6	5.7	6.7	7.2	2.9	9.2	11.2	17.5	11.6	13.1	14.5	5.7	14.0	21.7	17.7	16.1	6.7	14.1	15.0	11.3	23.7	14.2	14.1	37.6	16.0	17.9	18.6	9.5	8.4	8.0	7.1	19.7	12.8	13.0	18.7	16.8	14.1	22.2	18.1	14.8	10.0	5.6	5.5	19.9	6.1	9.0	12.0	16.0	8.4	5.7	17.8	8.7	4.1	22.3	15.1	6.9	14.3	19.8	11.0	21.4	17.5	5.7	22.0	17.0	17.0	5.5	11.1	14.8	8.1	8.4	14.0	9.9	19.4	16.6	4.6	4.3	4.2	7.2	5.7	5.7	3.3	5.0	6.1	5.9	2.3	2.1	3.9	0.7	6.7	5.4	3.9	3.1	2.9	15.0	17.7	11.1	20.0	13.1	14.6	11.6	12.4	13.2	7.5	6.0	12.0	13.4	6.8	3.0	11.0	3.1	10.2	8.1	9.1	10.4	7.9	13.9	13.3	9.2	2.4	8.0	20.3	0.0	8.6	3.5	11.9	8.9	15.0	9.9	16.4	3.2	6.9	22.1	18.1	3.5	11.5	20.8	6.8	16.2	12.2	5.4	14.2	10.5	25.8	8.4	17.5	12.9	8.6	5.2	7.0	2.9	8.5	12.9	12.1	12.7
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase, receptor type A"	P18433	20	2864184-3039076	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		21000	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	21.9	18.5	55.6	14.3	48.6	16.4	23.3	44.5	56.0	29.7	19.7	37.5	9.4	14.7	26.3	18.7	22.7	26.5	21.3	14.0	45.9	41.1	22.1	13.5	21.6	16.9	38.0	46.7	28.6	14.9	41.5	23.4	29.0	52.5	23.5	20.0	18.5	16.7	21.8	8.2	21.0	15.3	25.7	52.6	17.9	16.3	27.4	30.4	20.6	32.4	8.5	20.4	22.9	19.2	7.7	5.7	7.9	6.7	6.2	11.0	3.7	21.0	12.9	37.2	11.4	41.2	75.1	7.9	15.8	31.0	19.6	24.1	15.3	29.2	13.8	12.5	21.2	19.8	22.6	15.0	22.6	22.2	21.3	9.6	19.6	5.4	19.4	14.7	19.7	9.3	33.5	23.5	16.2	17.1	24.2	27.1	19.9	19.7	17.7	19.4	8.6	22.7	22.3	14.3	18.9	10.3	17.4	18.0	17.2	16.7	16.3	20.6	19.7	15.3	26.1	23.5	16.9	16.3	16.9	19.4	17.6	8.7	19.5	13.9	13.0	18.0	18.2	8.1	18.7	16.4	7.9	4.8	7.5	11.0	4.8	9.0	7.7	7.4	7.9	3.7	5.1	7.4	9.0	6.0	6.2	6.7	5.7	8.1	3.7	55.6	48.6	44.5	56.0	45.9	41.1	38.0	46.7	52.5	30.4	20.8	16.3	29.4	29.9	14.1	87.6	6.5	45.9	17.4	27.3	43.6	29.5	25.3	23.2	13.3	11.8	26.9	31.5	23.3	13.4	35.4	36.1	29.8	23.0	28.0	33.5	66.7	42.6	43.6	35.2	12.5	55.8	21.8	35.4	10.8	27.0	77.3	13.8	25.8	46.0	19.2	55.1	38.8	26.4	51.2	75.4	15.1	27.3	39.5	26.2	27.6
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 113.4;Ito cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.3	0.3	0.1	6.9	0.1	0.3	3.6	0.6	0.3	0.1	0.8	0.5	0.1	0.3	0.0	0.0	0.3	2.8	0.0	9.1	28.0	0.0	1.5	0.5	0.6	0.0	0.0	0.0	1.0	1.9	0.4	0.0	0.7	0.4	5.2	0.8	0.0	0.4	0.7	0.0	1.6	0.2	0.0	0.6	40.9	0.4	0.4	0.1	2.4	0.5	0.4	0.3	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3	0.0	19.9	13.7	0.8	3.3	5.4	9.2	17.8	0.0	1.2	3.5	0.0	0.0	0.0	1.4	4.3	113.4	4.3	46.7	0.8	0.0	1.9	0.6	23.3	2.0	0.3	4.8	0.0	448.7	26.3	2.5	1.1	2.0	5.0	0.0	4.8	0.3	7.2	14.4	0.0	0.0	0.8	0.0	0.9	0.7	0.5	1.4	0.0	1.7	5.2	0.6
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	26.6	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	61.5	0.5	0.7	0.0	0.0	35.5	14.5	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	0.0	19.7	0.3	0.0	0.2	0.1	0.1	22.0	20.0	28.2	0.0	21.5	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3	41.7	86.9	266.4	0.7	14.1	0.0	4.1	7.6	21.4	26.1	1.8	0.0	0.4	0.0	0.0	2.0	11.9	0.1	23.3	0.0	0.5	8.9	0.9	232.9	3.0	90.3	0.0	1.2	14.1	338.8	1.5	1.1	290.3	20.3	120.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	6.5	4.3	0.2	0.2	13.2	0.7	539.1	0.5	0.9
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2500000	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.5	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.6	4.8	0.6	0.0	0.0	0.0	0.2	8.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.7	0.0	1.5	2.9	8.7	0.0	2.1	0.0	4.0	0.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5	0.0	2.7	0.0	0.2	0.5	110.1	4.6	25.5	0.0	2.3	5.2	15.7	0.3	0.0	2.5	13.0	0.4	10.1	0.0	0.0	0.1	7.6	1.7	0.0	12.8	1.0	4.8	34.0	1.3	0.6	3.7	14.7	0.0	0.0	0.0	14.3	44.7	0.3	3.5	0.0	22.3	7.4	0.0	3.7	1.1	1.1	0.6	0.2	0.0	5.2	0.0
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase, receptor type E"	P23469	10	127907061-128085855	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 91.0"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 141.1;Macrophages: 249.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 91.0;plasmacytoid DC: 65.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	16.8	18.5	12.5	24.0	12.5	39.5	11.0	7.4	15.3	4.8	9.2	14.5	1.6	9.6	5.1	8.1	8.8	6.2	10.7	12.3	15.0	12.2	4.4	4.8	22.5	20.0	12.5	6.5	4.3	3.1	3.4	6.5	8.0	9.8	4.5	9.8	4.8	7.0	3.1	1.9	4.9	12.7	7.7	14.3	26.4	7.7	4.3	10.9	11.4	6.6	6.1	12.2	10.0	5.0	1.2	65.7	91.0	25.5	4.0	5.4	4.9	1.9	0.4	0.2	0.0	1.2	0.2	3.6	0.0	0.0	0.8	1.7	0.8	12.0	1.5	1.3	1.0	2.6	1.1	1.0	5.7	0.3	1.8	0.9	0.1	0.7	0.0	2.0	7.4	5.6	0.4	3.3	2.9	5.9	18.8	19.8	4.9	0.0	0.9	1.2	1.8	2.2	14.9	0.1	2.1	0.7	8.8	1.2	2.9	3.3	8.5	0.0	1.2	3.4	0.6	0.1	0.9	0.3	9.4	37.4	0.8	0.8	3.7	4.1	0.4	0.6	2.1	5.5	5.8	0.0	17.4	25.5	19.3	5.4	9.0	3.2	0.9	2.4	3.6	13.3	1.2	1.7	2.9	91.0	4.0	6.8	65.7	3.5	4.9	12.5	12.5	7.4	12.7	15.0	12.2	12.5	6.5	9.8	10.9	77.4	67.6	24.7	47.2	52.9	2.6	15.1	5.1	9.4	33.0	3.5	0.0	33.6	0.0	4.3	1.6	49.4	12.3	0.0	4.0	40.5	9.9	8.3	30.1	1.3	53.6	0.0	6.4	46.1	141.1	1.7	0.6	249.1	23.6	4.6	14.4	0.0	28.7	11.5	0.4	1.9	0.8	0.0	8.1	0.5	1.4	56.6	14.2	52.4	10.2	34.4
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase, receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 261.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.6;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		95000000	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	37.1	5.5	22.4	10.4	18.1	0.9	30.7	6.8	19.5	14.2	34.3	16.8	34.4	30.7	12.3	33.4	41.4	32.2	20.0	6.3	17.2	15.0	12.0	45.6	15.7	5.8	17.2	18.5	10.4	25.3	17.5	10.3	38.1	16.1	30.9	23.1	5.9	41.9	23.6	2.9	46.8	35.5	16.8	11.2	2.0	21.8	4.3	15.8	4.6	12.5	11.7	14.9	21.4	21.3	0.9	0.0	0.2	0.0	0.0	0.0	0.7	31.0	14.9	9.7	11.5	2.2	0.1	54.6	17.8	7.1	14.7	12.6	15.8	42.3	0.0	5.0	7.8	11.9	24.3	11.3	39.2	17.9	0.3	14.1	0.1	10.2	14.3	6.9	0.2	0.2	2.3	22.6	21.2	35.2	18.6	21.9	1.5	4.7	1.4	5.4	17.9	0.2	0.2	14.8	17.2	4.1	10.8	17.3	0.7	5.7	46.9	14.6	5.4	17.7	62.4	2.3	26.9	18.1	3.3	17.1	0.3	23.6	1.5	23.7	0.6	0.5	0.0	1.4	0.7	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	22.4	18.1	6.8	19.5	17.2	15.0	17.2	18.5	16.1	15.8	145.9	89.7	2.2	43.9	55.8	11.0	4.0	152.8	81.7	63.7	82.0	41.2	48.4	0.0	138.1	4.0	7.0	185.3	0.0	104.8	261.2	17.9	82.4	4.7	141.8	12.4	174.8	96.9	9.2	4.3	6.9	6.4	5.4	11.8	4.6	152.5	28.3	148.7	95.1	6.7	13.9	28.0	0.0	11.0	8.0	34.8	79.8	55.4	2.2	124.5	65.3
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase, receptor type G"	P23470	3	61561569-62297613	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.2;HSkMC: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	22.2	18.0	12.9	10.1	10.7	1.2	26.1	8.1	16.4	17.2	13.9	5.2	12.0	5.6	15.8	19.0	6.4	13.1	15.7	12.4	24.5	9.9	20.2	8.2	38.9	10.2	8.3	10.5	16.6	6.0	58.6	11.9	13.1	15.1	11.3	8.9	23.3	7.9	17.2	19.2	6.6	8.4	17.4	12.7	9.2	8.7	11.4	5.0	0.1	21.7	7.0	3.2	10.0	14.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	11.7	0.0	36.2	18.5	5.7	7.2	11.8	7.7	10.4	5.4	0.2	0.2	4.2	8.5	6.1	0.1	5.6	5.6	12.2	0.6	3.2	0.5	0.0	6.2	12.2	3.0	0.0	26.8	2.3	10.9	13.2	2.5	8.3	0.8	0.0	7.2	6.9	3.1	0.0	0.0	7.2	0.0	0.0	4.7	3.6	0.2	7.9	3.3	0.9	1.9	1.7	0.0	2.8	5.0	0.0	0.1	18.9	10.8	10.3	17.2	6.0	2.3	2.6	0.0	8.2	1.3	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.9	10.7	8.1	16.4	24.5	9.9	8.3	10.5	15.1	5.0	11.9	25.9	0.8	5.2	8.1	91.5	10.4	7.6	2.7	5.7	21.0	5.9	7.6	5.0	7.9	2.9	41.3	11.0	0.0	1.6	0.6	33.6	7.0	0.0	26.0	15.0	146.2	23.6	89.0	2.2	2.5	61.5	1.8	16.9	1.0	7.6	38.3	4.5	7.0	53.4	13.3	4.8	71.1	52.3	1.0	6.1	4.3	10.5	0.9	11.0	2.2
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase, receptor type H"	Q9HD43	19	55181248-55209506	"Enzymes, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 106.7;Paneth cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042300			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042300: AB_10796900"	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	0.5	8.9	0.5	5.2	0.7	0.0	0.5	0.5	1.0	0.7	39.9	0.6	0.5	30.1	0.5	0.5	0.6	0.0	29.6	0.5	1.3	1.6	0.6	7.8	0.6	0.5	3.0	0.5	0.6	2.8	0.0	3.0	0.6	0.5	1.0	9.6	0.6	0.5	0.5	0.5	0.0	84.3	0.7	6.9	21.2	10.2	0.5	0.5	0.5	0.5	1.0	0.8	1.1	2.4	0.0	0.7	0.0	1.5	0.0	0.0	0.0	4.9	3.0	0.0	1.2	1.0	2.7	0.0	0.1	2.7	0.5	1.1	1.3	7.0	0.0	0.2	0.5	6.2	0.0	0.0	0.0	0.6	0.0	0.1	0.4	0.1	3.5	9.1	0.0	3.6	0.7	2.2	1.7	2.7	0.3	0.1	0.0	10.6	0.5	0.0	0.0	0.0	0.2	0.0	22.4	7.2	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.0	3.1	15.9	0.0	0.0	1.4	0.0	0.7	1.1	0.3	0.0	0.0	2.6	0.0	0.8	0.1	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.7	0.5	0.5	1.3	1.6	3.0	0.5	0.5	0.5	0.0	0.0	0.0	2.4	1.5	0.0	0.6	20.4	0.0	0.0	1.8	0.0	0.0	0.0	11.7	0.0	0.2	106.7	0.0	22.9	0.0	0.2	3.1	0.0	5.1	0.2	15.9	4.6	1.3	0.0	0.0	0.0	0.8	0.0	1.0	14.0	0.2	20.1	38.6	0.0	0.0	0.3	0.0	0.4	0.0	0.2	1.0	0.1	0.0	15.6	17.9
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase, receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.2;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		840000000			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	5.6	3.7	10.4	17.7	13.9	22.6	5.6	4.9	9.5	6.1	9.0	8.8	12.3	8.4	3.9	7.6	2.9	5.0	6.7	5.2	9.5	9.2	13.3	12.2	12.2	22.6	10.8	9.4	3.0	9.1	21.1	14.5	20.3	8.3	7.8	8.1	12.9	12.9	9.0	4.6	4.3	13.4	5.5	6.7	33.0	13.8	3.1	9.9	6.7	18.8	0.9	9.7	6.0	3.9	1.0	1.8	12.2	5.3	1.2	2.1	0.9	3.5	13.5	5.9	3.2	0.9	2.1	2.0	3.6	2.7	6.4	4.8	0.8	20.0	3.3	25.5	9.2	9.6	2.7	9.3	0.9	7.8	21.9	2.5	0.9	16.7	1.2	5.8	1.2	20.8	1.5	0.3	1.7	0.5	15.3	3.9	0.2	1.2	2.2	2.2	7.7	0.0	7.5	4.6	11.5	2.1	0.8	0.7	1.7	24.8	5.3	4.0	1.2	10.1	5.7	9.1	4.5	6.4	9.2	12.5	5.0	5.3	10.0	11.0	0.5	0.7	5.5	5.8	3.8	18.3	0.9	1.5	3.4	2.1	2.5	1.4	1.0	1.2	1.5	1.0	0.7	1.0	1.3	12.2	1.2	5.3	1.8	1.1	0.9	10.4	13.9	4.9	9.4	9.5	9.2	10.8	9.4	8.3	9.9	8.9	21.3	8.0	8.8	0.2	11.1	3.1	17.8	8.1	22.7	36.6	5.9	1.5	0.0	6.5	4.2	2.2	28.4	0.0	4.3	0.6	3.0	20.5	12.8	14.0	26.2	9.5	12.1	2.5	67.6	4.0	0.3	20.6	1.7	10.8	8.5	11.5	8.7	28.1	0.4	10.9	1.0	0.0	3.9	0.2	3.2	0.3	1.6	13.8	5.7	5.4
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.5	4.9	2.9	0.2	6.2	8.3	3.0	12.3	23.8	5.1	4.6	8.1	3.8	0.0	3.7	11.3	14.8	12.9	3.1	9.7	7.2	13.6	4.9	0.1	7.5	11.2	7.6	0.0	0.4	6.1	9.0	10.6	14.5	13.3	13.8	4.4	0.0	0.2	12.4	9.1	6.9	0.0	3.1	8.3	6.3	24.8	6.3	0.8	12.6	9.3	15.5	0.0	12.7	14.2	0.7	3.5	3.9	0.3	23.4	8.0	5.6	15.5	11.1	0.1	1.6	0.0	10.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7	23.8	27.4	9.7	78.6	56.3	3.1	19.3	76.5	18.7	33.0	17.4	3.9	21.8	0.0	51.8	3.4	46.7	63.1	0.0	53.2	4.5	30.5	99.0	1.1	36.5	5.1	9.5	42.2	8.0	1.0	2.1	15.8	1.8	16.9	2.8	41.3	7.0	84.8	57.5	17.0	11.2	0.6	58.2	35.8	3.6	5.8	33.2	22.4	1.0	48.9	100.5
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase, receptor type M"	P28827	18	7566782-8406861	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Endothelial cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 7.2"	"Group enriched"	"Detected in many"	50	"dendritic cells: 2.7;T-cells: 7.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	NA		76000000	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	31.4	14.1	9.5	6.3	22.2	0.6	23.6	10.4	17.2	11.0	13.6	6.2	28.1	4.7	15.4	10.9	8.1	13.6	18.1	33.5	10.5	15.0	16.9	6.5	22.0	7.8	8.5	12.0	15.7	7.6	16.3	21.9	18.3	23.2	10.6	6.6	18.3	7.4	21.8	26.0	7.3	8.7	14.1	9.3	12.1	11.0	12.2	9.1	2.9	31.1	7.3	6.3	18.6	25.3	0.0	2.7	0.0	0.0	0.0	7.2	1.4	1.5	11.4	5.5	0.0	35.1	24.4	13.3	14.0	12.3	9.4	14.0	10.4	2.4	0.0	13.8	16.7	0.2	0.1	0.0	4.9	13.1	0.1	2.5	0.0	7.6	5.0	10.0	0.0	0.1	27.6	10.3	5.2	14.9	18.1	9.4	0.0	0.0	4.8	7.5	0.2	4.5	0.1	0.9	3.3	2.5	0.1	4.7	21.1	23.1	19.6	0.5	3.0	0.4	0.0	11.7	9.1	0.0	0.0	9.7	19.4	12.2	9.2	2.4	0.4	0.1	0.0	16.6	0.0	3.6	0.0	0.0	0.0	4.5	0.0	1.8	0.0	6.0	7.2	0.1	0.0	1.7	3.1	0.0	0.0	0.0	2.7	1.0	1.4	9.5	22.2	10.4	17.2	10.5	15.0	8.5	12.0	23.2	9.1	41.7	29.0	0.9	6.8	5.4	24.2	24.1	17.8	22.7	9.1	5.2	2.0	10.4	1.7	15.5	24.0	47.4	0.5	0.0	7.1	2.7	10.2	7.0	2.3	20.2	8.2	0.0	1.7	38.1	8.0	34.9	2.6	5.2	28.7	1.0	1.3	2.8	12.6	0.3	4.9	11.3	1.9	6.5	8.0	3.6	9.8	2.5	10.5	2.5	0.8	5.4
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 20.3;U-87 MG: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.5	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.2	75.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1	0.0	0.0	0.0	0.1	0.1	48.9	1.7	0.0	0.0	0.0	0.0	56.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	92.2	45.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	4.1	4.3	0.0	0.0	0.0	31.1	0.0	0.3	2.2	2.3	0.1	0.0	0.0	0.0	0.0
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 84.3;Intestinal endocrine cells: 126.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.6	1.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	3.7	0.0	0.4	0.0	0.0	22.0	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.0	0.2	6.5	22.6	3.1	5.5	0.8	0.0	0.7	0.1	0.0	0.0	12.5	12.7	0.0	0.0	0.0	0.0	0.0	11.1	3.3	5.1	1.9	0.0	0.4	0.1	0.0	0.0	15.4	9.2	3.7	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2	3.0	11.7	10.4	12.5	2.1	31.6	2.2	7.6	84.3	13.6	38.4	9.8	0.4	29.9	15.8	35.1	23.3	4.5	0.0	11.7	0.4	3.9	21.1	18.5	0.8	34.3	11.1	126.1	41.1	11.0	13.1	11.5	6.0	11.8	3.6	39.6	40.1	6.1	5.8	18.4	3.5	6.3	25.8	5.1	41.6	11.7	1.3	0.6	10.0	7.2	22.5
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase, receptor type O"	Q16827	12	15322397-15597399	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;intestine: 28.5;kidney: 21.6"	"Cell type enhanced"	"Detected in some"	7	"Bipolar cells: 16.3;Collecting duct cells: 15.7;Hofbauer cells: 22.6;Horizontal cells: 23.8;Kupffer cells: 17.2;monocytes: 19.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"GAMG: 13.0;NTERA-2: 8.2;SCLC-21H: 5.0;SH-SY5Y: 9.9;THP-1: 4.1"	"Region enhanced"	"Detected in many"		"olfactory region: 215.3"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA					"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	3.3	1.2	16.2	3.1	26.1	0.6	1.1	1.0	15.3	1.7	10.4	1.5	0.0	2.0	4.5	2.1	0.8	1.2	1.6	0.7	11.3	10.6	21.6	1.6	6.7	3.2	4.8	8.8	0.7	0.6	0.6	3.8	4.4	4.0	0.7	28.5	1.1	0.8	1.1	0.5	0.7	1.9	7.1	2.6	3.6	1.0	0.9	3.5	0.0	0.5	0.0	3.5	1.7	0.5	8.3	9.5	0.0	10.5	0.1	2.9	2.7	0.0	0.1	0.5	0.3	0.5	0.1	0.2	0.0	0.0	0.8	2.0	0.0	0.0	0.3	0.1	0.0	13.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	8.2	1.7	0.0	0.0	0.0	0.0	0.1	0.2	5.0	9.9	1.2	0.0	0.1	0.1	0.1	4.1	0.0	0.1	0.3	0.0	0.3	1.2	0.0	0.4	0.1	0.3	1.5	0.0	5.2	0.0	0.0	10.5	0.0	8.3	1.7	0.4	7.4	7.0	2.9	1.3	0.0	0.1	10.5	9.5	1.3	2.7	16.2	26.1	1.0	15.3	11.3	10.6	4.8	8.8	4.0	3.5	0.0	0.3	4.5	0.8	0.2	16.3	0.6	0.0	0.0	3.4	15.7	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	22.6	23.8	3.5	1.8	17.2	0.0	0.6	9.2	0.0	19.0	2.6	0.3	0.1	3.5	0.4	0.0	4.6	0.0	0.4	0.3	1.0	0.4	0.2	0.0	11.2	0.7
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 14.3;RT4: 27.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	27.4	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4	0.0	0.0	0.0	0.1	0.5	11.2	2.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.1	1.7	1.5	7.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.9	11.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.3
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
PTPRT	"KIAA0283, RPTPrho"	ENSG00000196090	"Protein tyrosine phosphatase, receptor type T"	O14522	20	42072752-43189970	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 23.5;fallopian tube: 17.0"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 40.8;Ciliated cells: 33.5;Early spermatids: 10.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017336, CAB069423"	Approved					NA	NA					"CAB069423: AB_1622602, HPA017336: AB_1855943"	"unprognostic (7.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	0.6	0.8	5.0	0.6	11.1	0.5	4.6	1.6	23.5	1.6	0.7	0.9	0.0	1.2	0.5	1.8	0.5	17.0	0.7	0.8	4.7	6.5	0.6	0.9	2.1	1.0	2.2	12.6	0.5	0.9	0.5	4.1	4.6	5.1	0.8	0.6	0.5	2.0	4.6	0.5	0.8	1.0	0.5	1.4	0.7	1.8	2.8	0.9	4.9	0.5	0.0	1.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	11.1	1.6	22.6	4.7	6.5	2.2	12.6	5.1	0.9	0.0	0.6	0.0	0.0	0.8	40.8	1.1	0.0	33.5	1.2	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	4.8	0.0	7.4	0.3	9.9	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase, receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved					NA	NA					"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (7.92e-4)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	6.0	3.2	3.1	1.7	5.8	0.6	16.0	6.7	12.7	24.8	3.7	2.6	6.1	1.3	9.5	4.7	3.9	14.5	7.0	8.9	4.5	5.1	3.9	7.0	11.4	1.2	5.2	5.3	12.2	12.0	12.1	8.1	14.3	21.4	11.0	2.3	18.7	11.3	17.9	14.7	7.3	1.7	6.5	6.6	2.4	4.5	4.4	0.9	0.3	4.9	2.1	2.0	12.2	17.6	0.4	0.0	0.0	0.5	0.0	0.2	0.0	3.2	4.4	0.2	0.6	12.4	0.4	40.5	3.4	3.1	0.1	0.2	3.8	14.4	0.5	6.9	0.6	0.4	17.5	16.1	11.2	0.0	0.2	8.1	0.6	5.0	16.0	5.2	0.0	0.7	5.7	6.1	0.0	1.0	4.8	0.1	2.0	0.1	0.5	3.2	5.3	0.2	0.1	6.6	6.4	2.0	0.0	4.7	0.2	5.0	16.2	13.7	17.8	3.5	11.0	2.4	2.9	6.5	0.7	2.9	0.6	4.0	1.1	0.4	0.3	0.4	0.0	8.0	0.7	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	5.8	6.7	12.7	4.5	5.1	5.2	5.3	21.4	0.9	8.9	12.8	0.0	6.2	1.3	3.6	3.4	0.0	6.7	11.4	5.2	11.8	16.4	0.0	5.6	0.5	0.7	0.0	0.0	2.3	9.3	5.1	5.4	1.1	4.5	2.1	0.0	0.0	1.8	1.2	1.1	4.4	0.3	8.5	0.0	0.0	17.4	5.3	0.0	6.7	0.2	40.7	6.5	3.8	1.2	6.1	0.5	7.6	0.0	0.0	8.6
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6	0.0	1.0	0.0	5.6	22.3	14.1	0.8	0.0	17.4	27.3	0.0	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.1	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.4	0.3	0.0	18.6	0.0	0.0	107.0	0.6	0.0	0.0	0.0	6.2	0.0	0.4	0.0	0.2	18.7	0.2	0.0	0.0	7.4
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell type enriched"	"Detected in some"	44	"Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		260000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	11.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	91.8	0.0	0.0	0.0	0.1	1.3	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0	0.0	0.3	0.0	0.5	0.2	0.1	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	1.7	1.0	1.2	1.1	0.8	0.1	74.7	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.4	1.1	0.5	0.0	0.0	0.0	0.1
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	NA	NA		2800000	Microtubules		"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.1	5.6	2.8	0.4	19.8	24.8	1.9	1.4	3.9	0.8	2.0	16.9	2.3	0.1	3.2	3.3	1.4	1.5	0.0	1.3	0.5	0.0	1.8	0.0	0.7	0.2	18.8	0.0	0.0	20.3	5.2	10.4	12.2	4.0	0.3	0.2	0.0	0.1	5.2	0.1	0.1	0.0	20.6	5.2	2.8	0.1	0.1	4.4	4.1	0.1	1.6	6.6	0.4	0.1	2.9	10.0	0.0	0.0	3.9	1.6	2.9	11.0	2.9	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9	47.6	8.0	0.0	1.8	3.4	1.7	8.5	2.5	1.4	2.3	1.8	0.0	0.2	0.0	5.3	7.8	1.3	0.0	0.0	13.4	0.7	7.6	1.5	0.0	0.0	5.8	0.0	20.6	1.3	0.0	4.7	25.6	0.0	3.3	0.0	2.3	4.9	10.7	0.0	13.8	2.8	0.0	6.5	12.0	0.7	1.2	4.0	0.2	0.0	2.6	0.9
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950162	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 9.7;Fibroblasts: 9.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 6.6"	"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 3.9"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.3;HHSteC: 32.4;HSkMC: 26.9;U-266/70: 18.7;U-266/84: 12.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 13.5"	HPA021868	Uncertain					NA	NA					"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	4.4	4.3	0.7	5.3	1.1	0.0	3.6	0.2	0.8	23.4	20.7	2.9	11.1	1.9	29.1	9.1	8.0	8.1	18.7	8.5	1.0	0.9	2.0	0.5	4.2	0.7	0.3	0.0	19.1	3.1	20.3	1.3	7.1	6.6	20.3	2.1	11.0	1.2	13.1	1.1	2.9	6.2	30.0	0.3	4.7	10.5	5.2	0.3	2.6	7.9	1.9	3.3	23.7	18.1	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	12.3	0.0	2.7	0.2	3.5	0.2	3.2	2.1	3.9	0.0	0.0	0.0	0.0	0.6	1.9	0.1	2.5	0.0	0.9	0.0	2.0	0.0	9.4	0.0	32.4	0.0	0.0	26.9	0.0	2.8	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.2	0.0	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.6	0.2	0.0	0.0	2.7	7.3	0.1	0.0	0.0	2.4	1.0	0.0	18.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.8	1.0	0.9	0.3	0.0	6.6	0.3	0.0	0.0	0.0	9.7	2.7	1.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	3.5	1.1	0.0	0.0	1.3	0.1	9.1	8.3	1.1	0.0	0.7	0.0	2.9	0.6	0.0	6.0	5.5	0.0	5.0	2.8	2.8	6.8	0.8	0.0	8.5	0.0	0.2	6.5	3.9	1.0	6.8	1.9	0.3	0.0	0.8	4.4
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.7	18.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	2.2	1.4	0.1	1.7	0.0	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0	14.9	56.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor-like tyrosine kinase"		3	134065303-134250744	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	23.8	13.2	8.5	12.1	9.3	6.3	27.5	10.6	9.5	26.5	19.3	12.7	18.2	8.8	25.8	19.1	21.1	16.7	15.8	17.1	8.1	6.7	12.9	12.7	12.4	9.1	10.8	7.3	39.7	17.7	14.1	17.9	18.8	8.6	26.9	12.1	16.4	15.2	21.5	15.3	15.5	13.3	28.6	8.4	13.8	14.3	20.3	10.0	13.6	23.2	11.4	15.2	27.5	31.9	2.8	0.7	6.7	1.6	3.1	4.3	1.1	26.0	6.9	21.9	16.7	28.2	30.1	16.9	17.3	40.2	23.1	26.0	21.9	20.0	5.1	28.8	21.2	22.2	24.4	15.5	21.8	33.1	8.5	7.0	13.5	7.5	14.0	22.1	6.5	11.9	19.9	25.7	14.3	28.8	25.3	19.3	9.0	4.7	2.5	22.6	12.4	9.1	8.5	18.4	21.7	8.3	4.5	16.8	10.7	18.9	19.3	10.7	15.9	21.0	15.3	26.2	14.7	19.1	11.9	14.2	19.2	17.4	20.0	13.9	1.1	1.3	2.8	12.2	11.0	13.5	6.7	1.6	3.1	2.5	1.6	2.9	1.5	4.2	3.0	0.7	2.8	4.3	3.4	0.6	3.1	1.6	0.0	1.0	1.1	8.5	9.3	10.6	9.5	8.1	6.7	10.8	7.3	8.6	10.0	11.9	24.7	11.9	30.3	36.7	18.8	28.1	22.9	5.3	22.7	41.8	27.5	16.4	0.0	14.3	7.9	26.0	12.7	0.0	18.1	11.9	35.7	30.8	17.3	17.4	9.7	12.7	13.4	39.9	17.7	4.0	30.8	14.0	13.5	10.0	21.0	26.7	18.6	17.3	30.8	8.1	37.2	45.3	26.4	27.0	33.8	33.2	9.0	12.5	20.0	36.3
SPRYD3	FLJ14800	ENSG00000167778	"SPRY domain containing 3"	Q8NCJ5	12	53064316-53079420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039426, HPA039685"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Vesicles, Plasma membrane, Actin filaments"	"HPA039426: AB_10673358, HPA039685: AB_2676623"	"unprognostic (7.73e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.27e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.78e-15)"	"unprognostic (9.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.41e-1)"	16.8	15.7	30.4	10.1	51.9	3.3	11.6	27.1	59.3	15.3	11.4	14.9	10.6	10.8	14.1	21.7	15.9	26.8	11.7	23.1	28.3	27.0	11.3	8.0	13.1	8.8	21.5	34.9	26.4	20.4	26.5	20.3	8.0	34.2	18.3	10.0	15.6	23.3	25.1	7.4	13.0	9.8	18.3	14.0	9.8	13.4	4.9	12.2	3.7	20.2	6.6	11.4	12.4	11.4	9.4	9.4	26.7	18.4	9.7	21.0	15.6	12.5	19.6	2.5	5.2	20.9	10.4	3.3	19.4	10.0	7.3	4.7	3.2	10.6	8.1	16.1	23.6	8.9	11.7	3.4	14.7	4.8	8.8	5.2	5.2	11.9	7.3	15.7	9.7	9.2	9.4	23.2	10.4	16.1	14.5	15.0	4.3	4.4	20.6	12.7	27.2	6.9	5.0	1.4	10.2	13.8	3.1	4.3	16.7	9.2	10.1	4.4	4.2	16.6	15.4	7.8	1.4	14.4	7.6	20.8	8.3	8.5	18.8	13.1	11.6	10.3	2.4	24.5	8.6	10.1	15.5	9.8	26.7	21.0	17.5	20.1	9.4	14.5	16.9	9.4	7.5	12.5	14.6	15.5	9.7	18.4	4.5	8.0	15.6	30.4	51.9	27.1	59.3	28.3	27.0	21.5	34.9	34.2	12.2	3.0	8.5	12.3	16.4	5.0	40.6	16.7	22.9	21.4	9.1	17.4	7.9	5.4	10.0	26.1	0.2	16.6	10.3	0.0	31.6	11.7	12.3	17.1	9.3	8.1	10.7	41.3	11.1	15.4	10.0	1.1	15.0	8.1	10.1	16.2	11.7	29.5	23.5	8.2	31.1	12.6	20.2	19.4	23.4	3.0	4.5	8.3	3.5	10.2	7.3	13.7
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		20000000	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.7	35.9	8.3	7.4	3.1	5.0	17.2	7.2	6.2	8.8	5.6	13.5	7.0	0.2	4.5	13.0	10.0	14.2	4.9	33.4	3.4	0.0	4.5	2.0	1.3	20.9	7.5	0.1	3.1	5.3	11.4	5.7	7.7	9.8	8.0	4.6	0.2	0.0	1.4	5.3	1.9	0.2	3.9	21.5	32.6	8.4	2.2	0.2	3.7	34.4	7.7	27.9	8.1	11.4	8.9	6.6	10.2	2.8	11.6	10.5	7.1	3.8	6.4	0.1	0.2	0.1	7.4	0.0	7.8	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8	3.0	1.7	4.4	10.8	7.2	5.4	1.6	15.3	1.4	0.0	12.2	2.0	1.6	1.7	9.7	1.3	1.4	30.0	0.0	16.2	7.0	8.2	11.2	0.0	0.9	5.8	3.2	16.1	1.3	6.9	1.5	10.0	12.1	1.7	7.2	25.9	4.1	29.0	18.1	16.3	9.5	4.7	12.9	6.4	0.2	0.7	8.0	1.9	0.0	14.9	27.7
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;MCF7: 4.7;OE19: 7.0;RT4: 9.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.3	0.0	0.3	0.5	0.3	0.0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0.0	0.3	0.3	0.3	0.0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0.0	0.3	0.3	0.3	2.2	0.0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	5.5	0.2	2.2	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	0.0	7.0	0.8	0.0	0.2	0.0	0.0	9.7	0.8	0.9	0.3	2.0	0.4	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSH1	KIAA1298	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778192-108857590	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	7.3	7.8	8.5	7.4	8.1	10.6	9.3	20.3	8.8	7.4	8.5	6.8	13.1	4.4	9.8	7.9	7.6	8.2	8.3	10.1	8.0	6.9	5.8	7.4	10.1	8.7	7.7	5.2	7.9	8.0	9.7	6.8	7.8	8.4	6.5	6.5	15.0	5.9	8.0	21.4	7.1	6.5	10.4	8.1	8.6	7.1	5.2	6.6	2.0	7.0	7.9	6.6	10.0	13.3	1.8	2.0	5.7	4.0	2.1	2.9	1.2	5.1	6.8	4.5	3.5	8.5	7.3	4.0	6.6	14.2	6.1	5.4	3.4	2.5	2.4	4.7	15.5	10.4	5.1	2.7	11.2	5.0	5.0	2.6	5.7	3.1	2.1	4.6	2.9	15.2	10.0	3.8	5.5	12.3	15.1	5.6	3.0	1.3	2.0	15.9	2.9	3.3	4.2	3.1	2.0	5.5	2.4	5.3	3.2	2.4	9.2	3.3	4.5	5.8	1.6	12.8	6.5	2.1	2.6	4.4	10.9	4.7	6.5	3.8	3.9	3.5	3.0	5.7	2.4	34.4	4.2	2.4	4.8	2.9	4.0	2.7	1.6	1.5	2.5	1.6	1.8	1.4	1.6	5.7	2.1	3.2	2.0	1.7	1.2	8.5	8.1	20.3	8.8	8.0	6.9	7.7	5.2	8.4	6.6	8.9	17.3	4.7	15.4	8.4	10.6	21.2	12.7	8.1	14.8	14.0	15.7	4.7	5.0	7.7	1.6	37.5	3.5	0.0	7.0	3.7	10.3	7.2	19.7	13.4	11.2	11.1	5.2	25.8	24.7	2.6	6.1	17.8	11.8	43.3	6.6	8.8	10.1	0.0	12.0	4.9	20.7	6.5	17.6	1.1	6.6	7.9	1.9	15.4	5.7	12.2
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 119.4;Late spermatids: 117.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 37.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 37.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain					NA	NA					"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	12.3	7.7	15.8	19.0	16.0	43.1	7.9	23.9	18.0	6.8	10.6	17.5	8.8	7.4	6.1	8.5	9.4	6.5	7.9	12.0	12.9	8.4	10.8	9.8	15.1	20.9	13.6	12.4	3.7	11.8	6.4	6.5	8.8	10.6	5.1	10.0	7.9	8.6	11.6	59.6	10.5	14.5	6.9	12.6	21.3	10.3	26.1	15.2	22.7	10.7	9.5	19.9	7.8	6.5	7.9	4.0	37.8	4.5	1.4	5.9	1.8	12.0	9.8	6.3	5.4	17.4	11.9	3.7	6.0	6.8	9.9	10.5	5.3	4.5	10.0	9.6	7.1	6.6	14.0	7.7	8.7	11.5	3.5	13.7	6.9	10.0	7.7	8.2	7.4	15.0	14.0	5.8	10.5	7.0	4.9	22.6	17.8	4.9	7.8	6.9	3.4	34.8	7.5	4.7	4.6	5.1	16.7	15.9	17.5	17.1	9.4	10.6	11.8	8.7	9.7	17.3	8.9	6.4	7.8	12.4	6.7	13.8	11.8	7.2	11.9	7.8	25.0	8.0	5.9	6.2	11.0	3.8	37.8	3.5	4.5	2.9	7.5	4.4	3.5	4.0	7.9	4.1	3.0	9.6	1.4	3.8	2.6	5.9	1.8	15.8	16.0	23.9	18.0	12.9	8.4	13.6	12.4	10.6	15.2	8.9	36.3	54.0	11.9	35.1	12.4	22.6	10.2	12.0	13.6	15.7	25.5	18.7	21.6	14.9	77.6	21.9	36.6	0.0	30.8	18.1	14.6	14.0	11.6	24.1	20.1	19.1	34.0	22.1	119.4	117.3	11.2	43.4	33.7	19.0	31.7	6.8	31.7	27.4	7.8	39.3	20.1	6.5	14.4	41.9	16.4	31.7	15.2	40.3	22.3	20.4
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.8;RT4: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.2	6.7	0.1	0.2	4.8	4.9	7.4	4.1	5.4	2.1	2.0	7.3	16.5	0.3	12.6	3.7	4.5	23.8	2.2	17.2	1.2	1.3	2.5	1.6	10.9	2.9	3.3	0.3	6.1	4.3	15.9	3.1	3.3	5.0	2.4	0.1	0.0	0.6	2.5	21.0	0.2	3.0	1.5	17.0	5.4	7.7	0.2	1.1	7.0	36.0	1.4	2.2	9.5	14.1	4.4	2.6	19.8	5.2	3.9	1.7	3.7	4.8	1.1	0.7	0.3	0.2	4.9	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7	3.0	5.4	0.0	20.7	6.3	1.1	3.4	15.3	8.1	10.3	15.7	0.0	12.6	3.3	16.4	0.0	3.9	17.2	0.0	19.0	20.2	6.2	13.1	3.5	4.3	6.8	1.6	3.5	4.3	8.6	0.0	12.0	2.9	8.5	12.6	14.7	4.6	16.4	17.5	11.3	6.3	0.4	0.0	8.3	0.3	0.0	9.2	13.2	4.3	18.5	22.9
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8;stomach 1: 16.0"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.6	0.3	2.6	2.3	10.6	1.0	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0.0	8.4	3.4	2.1	10.6	15.8	0.0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1.0	16.0	0.3	0.7	0.0	0.4	0.6	2.8	4.3	3.6	0.0	0.0	0.4	0.0	12.5	1.9	0.2	3.0	0.1	0.0	0.4	0.0	0.0	0.9	4.9	0.5	2.3	2.2	1.6	18.5	0.2	3.1	1.2	2.9	0.8	1.0	5.1	4.9	10.9	0.3	0.7	1.3	0.1	0.0	1.4	12.1	0.2	0.3	3.4	0.2	0.4	16.6	0.1	0.2	0.2	5.3	1.7	0.1	0.8	2.7	7.5	1.3	0.0	1.4	0.2	1.6	9.5	0.6	0.0	2.8	2.9	0.0	4.5	2.3	0.3	15.4	0.6	2.6	0.3	0.6	0.0	0.6	0.1	2.1	0.1	3.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.4	12.5	0.0	0.0	0.0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7	0.0	2.1	0.0	0.6	0.2	0.4	0.4	2.5	8.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	12.5	0.0	0.2	0.5	0.0	5.9	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	3.6	9.5	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.9	0.2	0.7	6.8	4.8
STYXL1	"DUSP24, MK-STYX"	ENSG00000127952	"Serine/threonine/tyrosine interacting like 1"	Q9Y6J8	7	75996338-76048004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050261	Uncertain					NA	No					"HPA050261: AB_2681066"	"unprognostic (6.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.88e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.77e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (8.22e-4)"	9.4	19.2	16.0	10.2	23.1	12.7	17.5	12.8	19.8	15.7	15.1	19.6	13.9	10.5	10.3	21.0	21.1	28.2	9.4	13.2	16.6	12.1	14.8	20.1	11.3	13.7	20.9	13.5	15.4	30.0	15.9	19.9	24.6	16.8	16.6	20.1	12.2	16.0	13.9	12.4	19.3	10.3	14.0	17.0	17.4	14.0	25.0	19.7	20.8	19.9	12.1	19.5	14.8	14.6	19.7	23.0	30.8	29.3	24.7	22.1	17.4	19.8	10.6	8.4	11.2	13.3	14.5	8.7	9.0	12.8	14.6	14.5	12.3	18.1	4.6	4.5	11.8	23.1	8.8	13.5	17.9	21.2	14.8	6.0	5.6	5.0	11.0	18.9	7.8	10.3	14.0	21.1	17.4	43.9	18.8	14.1	7.0	18.1	14.0	13.0	16.0	3.1	33.5	7.1	19.2	25.7	11.9	7.0	12.2	18.5	13.0	11.0	11.4	8.4	19.2	22.4	21.9	21.1	15.1	7.0	12.6	5.3	13.8	12.7	15.2	9.6	15.7	11.1	15.0	19.5	30.8	29.3	25.8	13.7	25.3	15.2	19.7	13.2	15.2	23.0	15.6	11.7	13.2	24.6	24.7	23.7	15.1	22.1	17.4	16.0	23.1	12.8	19.8	16.6	12.1	20.9	13.5	16.8	19.7	20.8	10.4	12.3	13.2	6.5	5.6	15.4	10.2	54.9	30.7	10.4	0.0	25.9	33.2	13.9	68.8	7.8	14.4	0.0	22.7	20.3	7.6	16.5	10.4	15.5	26.7	3.2	19.4	12.9	23.8	50.5	10.6	18.9	3.3	32.5	24.6	18.8	19.6	40.3	9.6	16.3	8.9	6.5	6.1	22.2	12.6	8.7	37.6	9.6	17.7	15.9
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	39.4	1.1	0.0	1.3	6.1	0.8	3.2	0.0	0.0	5.4	22.7	0.0	0.0	0.0	31.3	20.9	0.0	4.5	0.0	0.4	0.0	0.0	4.9	0.6	3.2	0.0	4.8	0.0	13.7	0.2	14.8	0.0	26.2	0.0	10.8	0.8	5.9	2.1	1.8	0.0	2.8	0.0	0.1	2.5	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.6	0.0	22.1	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9	11.9	22.7	53.8	3.7	3.1	0.9	1.6	12.7	12.0	17.0	14.0	0.0	1.2	13.3	12.6	5.5	1.1	18.4	0.0	10.9	1.3	1.1	1.8	40.6	0.9	63.0	0.0	9.9	4.9	79.3	4.7	0.6	66.0	11.8	24.4	23.8	0.0	15.3	28.1	0.0	0.3	0.1	6.5	1.0	0.7	0.7	5.0	1.1	5.3	24.7	6.5
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 12.7;granulocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in many"		"HEL: 10.6;HMC-1: 16.7;U-266/70: 16.7;U-266/84: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.1	2.3	0.0	1.8	1.5	1.7	0.0	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.6	0.8	0.1	0.0	1.7	16.7	0.0	0.2	1.4	0.0	1.1	0.0	0.5	5.8	0.4	3.3	0.8	1.0	3.8	0.3	1.1	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.3	0.4	0.9	0.6	3.4	0.0	0.0	0.0	2.3	0.0	16.7	11.9	2.1	0.0	2.4	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6	6.0	5.0	0.8	1.5	2.3	0.5	1.6	12.7	0.0	4.5	0.0	0.0	1.3	0.0	1.3	3.9	0.6	2.2	0.0	0.9	0.1	0.9	1.1	18.5	3.2	4.0	0.0	2.9	0.0	4.5	1.7	0.0	2.8	1.7	0.0	1.4	5.0	0.9	0.0	0.4	1.8	2.4	6.5	0.7	0.7	1.1	2.6	0.7	2.5	2.0	1.3
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
TESK1		ENSG00000107140	"Testis-specific kinase 1"	Q15569	9	35605305-35610041	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	30.9	19.4	13.5	10.8	20.5	5.6	25.4	13.4	26.4	14.3	15.2	15.0	9.7	13.7	15.3	13.4	11.0	12.0	13.0	12.8	13.7	13.1	10.5	10.0	11.5	10.7	14.1	10.3	17.0	16.0	13.1	15.7	12.3	12.6	15.1	8.8	14.2	14.6	21.0	47.2	13.7	12.7	16.9	7.3	11.0	12.9	28.4	12.9	9.2	13.0	12.3	9.0	16.6	20.9	1.0	2.3	0.3	1.8	2.1	4.9	1.5	9.5	8.9	6.1	10.2	24.6	10.3	7.0	10.9	9.8	10.2	6.5	5.2	2.7	17.4	6.2	10.9	27.1	3.3	3.9	7.9	1.9	11.2	5.2	2.5	8.5	4.5	14.4	2.1	8.4	10.0	12.5	7.9	10.9	10.9	7.1	8.6	2.9	6.3	10.1	10.5	4.8	10.6	3.8	8.8	10.5	7.5	3.7	4.1	7.5	4.4	5.0	6.1	6.2	7.6	4.6	4.4	9.0	3.2	6.2	22.6	9.7	16.2	6.5	3.8	5.4	6.5	16.4	2.5	5.1	0.0	1.8	0.3	3.4	0.4	3.0	0.8	1.4	4.9	2.1	1.0	1.5	1.6	0.0	2.1	0.8	2.3	0.3	1.5	13.5	20.5	13.4	26.4	13.7	13.1	14.1	10.3	12.6	12.9	6.0	7.7	5.9	5.6	12.8	10.4	1.9	5.1	4.0	3.4	7.0	7.9	3.2	1.7	5.6	33.3	8.7	14.2	0.0	9.0	7.2	8.9	13.5	1.1	9.3	13.1	12.7	9.1	4.9	4.1	27.1	11.2	8.4	13.5	2.8	12.4	11.3	8.3	8.2	13.4	6.1	12.2	6.5	7.8	13.0	5.9	12.2	2.7	6.9	6.1	6.8
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;RT4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.1	0.6	4.3	1.9	3.2	3.6	1.5	5.3	0.6	1.6	4.9	2.0	3.4	2.7	1.5	3.7	4.3	3.6	1.8	2.7	1.7	1.2	9.9	1.8	2.9	2.1	3.0	2.9	1.5	7.1	0.6	10.9	1.3	0.6	3.0	2.4	3.4	1.5	1.5	4.4	0.1	1.4	1.7	12.8	0.3	1.4	3.4	6.4	12.2	8.1	10.0	1.5	0.0	0.2	2.0	1.6	1.1	7.2	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8	0.0	3.2	2.4	6.5	6.9	2.3	1.1	5.1	1.4	3.4	0.0	13.7	6.5	0.0	1.0	18.1	2.9	12.4	0.0	2.3	2.5	2.2	12.9	6.9	5.5	5.9	0.0	4.1	1.3	4.6	5.2	2.6	4.5	3.3	2.8	5.3	1.1	1.0	7.4	1.8	0.6	2.8	6.5	4.7	26.8	5.7	7.4	12.4	4.4	4.9	7.3
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300993-43323108	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 81.7;Ito cells: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 3.4;NK-cell: 5.4"	"Group enriched"	"Detected in many"	22	"granulocytes: 3.4;NK-cells: 5.4"	"Group enriched"	"Detected in some"	5	"EFO-21: 28.5;HUVEC TERT2: 63.1;TIME: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		75000000				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	39.4	5.4	3.9	6.6	6.0	1.0	43.6	2.5	6.0	10.8	8.4	4.5	4.2	4.5	18.6	10.9	7.8	10.2	11.1	15.1	4.9	4.2	9.4	10.8	22.0	13.1	6.4	3.1	7.0	3.0	2.7	5.1	39.9	5.5	8.6	3.0	6.9	6.0	6.9	17.8	4.2	5.8	12.1	5.3	14.8	5.1	5.1	3.8	1.1	13.9	10.2	3.1	9.0	14.7	0.0	0.2	3.4	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	2.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	54.8	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	3.9	6.0	2.5	6.0	4.9	4.2	6.4	3.1	5.5	3.8	0.0	6.2	0.0	0.6	1.9	0.3	3.4	0.0	6.7	3.4	0.0	0.0	0.1	0.0	0.0	1.5	81.7	0.0	0.0	0.2	0.1	1.4	0.6	19.7	0.9	0.4	0.0	0.0	106.2	8.6	1.5	2.0	1.6	1.7	0.0	0.0	0.2	0.0	0.0	0.7	0.8	0.7	0.0	0.9	0.7	0.1	1.3	0.2	6.9	0.0	0.6
TNK1		ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 1.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HBEC3-KT: 7.0;hTCEpi: 7.9;T-47d: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.4	0.6	1.1	2.2	6.4	0.4	7.9	11.4	4.0	5.4	11.7	0.4	7.7	7.1	5.1	5.3	7.2	3.5	6.3	2.0	1.0	0.4	4.6	6.9	3.2	2.7	1.5	0.8	4.4	6.8	5.4	2.7	2.5	4.3	8.9	4.5	7.7	10.5	4.8	1.8	8.3	11.3	5.1	0.7	2.4	9.6	2.2	0.6	0.6	11.6	5.7	5.2	4.5	4.4	1.6	0.1	0.4	0.0	0.0	3.8	0.6	6.4	1.0	0.2	0.4	0.0	0.0	4.4	0.2	0.0	0.4	0.4	3.3	3.0	0.0	2.6	0.3	0.1	10.5	0.0	7.0	0.1	0.7	1.5	0.0	3.7	1.9	0.4	0.0	0.3	0.1	7.9	0.0	1.2	0.2	0.0	2.8	0.8	0.0	0.0	4.9	0.6	0.0	0.9	5.6	0.9	0.2	0.2	0.7	4.9	3.0	0.2	0.5	3.6	5.3	1.0	0.3	8.7	0.1	1.7	0.2	0.8	0.2	0.0	0.5	1.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	1.9	1.6	1.8	1.2	0.1	1.5	3.3	3.8	0.4	0.0	0.0	0.0	0.8	0.6	1.1	6.4	11.4	4.0	1.0	0.4	1.5	0.8	4.3	0.6	6.0	4.3	0.5	2.1	2.3	1.2	0.8	2.5	0.0	2.3	1.8	0.0	0.2	0.0	4.4	1.1	0.7	10.4	0.0	5.9	0.4	1.0	4.0	0.0	2.5	0.1	0.0	2.9	1.3	0.0	0.6	1.1	0.1	0.0	0.0	6.3	0.2	6.4	6.5	0.4	1.4	2.4	0.0	0.9	0.6	0.9	2.0	0.6	1.0	6.4	1.8
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 47.1;Horizontal cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041954	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041954: AB_10794164"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6.0	6.3	17.6	3.8	6.6	8.0	6.6	13.0	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20.0	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17.0	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.9	3.1	5.2	5.5	7.2	4.6	31.1	6.2	5.9	3.7	3.4	4.9	24.7	9.3	21.6	8.4	6.3	11.4	4.5	7.6	1.1	21.9	5.7	8.4	10.4	3.5	3.2	4.3	4.2	3.4	12.2	5.1	6.1	10.6	4.7	3.5	3.4	12.9	3.4	23.5	1.8	15.7	4.9	8.5	11.5	5.4	6.2	9.4	3.3	15.5	6.3	6.4	4.0	16.2	7.9	5.2	26.5	5.4	7.6	8.6	5.0	4.4	17.1	28.2	3.0	5.8	7.7	14.0	6.3	2.0	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1.0	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20.0	21.8	6.0	4.8	11.8	6.8	6.2	26.5	12.8	5.1	5.3	11.4	0.0	47.1	10.6	1.7	3.5	0.8	7.5	6.9	0.0	4.5	2.6	5.3	7.2	1.1	13.5	7.2	93.8	5.8	9.8	20.5	0.8	6.1	11.4	5.0	9.0	1.4	6.6	19.1	3.5	6.0	1.4	20.9	0.0	5.5	3.9	10.0	9.3	3.5	8.9	3.3	16.3
TPST1	TANGO13A	ENSG00000169902	"Tyrosylprotein sulfotransferase 1"	O60507	7	66205199-66420543	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 72.5;Spermatocytes: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3;neutrophil: 17.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047415, HPA061837"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA047415: AB_10964056, HPA061837: AB_2732672"	"unprognostic (7.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.59e-1)"	"unprognostic (9.25e-3)"	"unprognostic (4.12e-2)"	"unprognostic (4.98e-1)"	"prognostic unfavorable (8.16e-6)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.73e-5)"	15.4	12.8	16.7	9.8	28.2	5.6	11.2	12.2	19.2	34.0	7.7	8.8	3.4	3.4	20.2	13.8	10.8	10.9	34.2	6.6	26.1	22.2	13.4	38.9	9.0	5.9	15.3	12.2	11.5	7.1	8.1	19.6	23.2	28.1	15.5	7.9	9.7	5.4	15.8	2.9	6.2	5.9	35.7	27.5	9.0	10.0	19.6	11.4	0.3	10.7	3.2	5.2	27.2	19.9	6.3	0.1	21.3	1.1	3.9	2.0	0.8	4.3	2.6	6.8	8.6	20.7	16.6	2.1	8.2	19.0	10.2	14.4	8.3	2.5	0.5	6.6	16.8	16.2	3.4	6.3	9.3	13.5	1.2	3.6	0.9	6.4	6.3	24.5	0.7	0.7	23.5	7.4	19.4	8.6	11.3	12.3	1.1	0.4	3.9	15.5	2.3	0.0	1.1	6.1	0.1	3.5	3.0	5.5	4.4	10.5	4.6	3.9	16.8	10.4	0.8	22.1	14.1	3.3	1.7	23.4	13.0	8.3	9.3	14.9	3.5	4.8	1.7	11.5	2.6	18.3	21.3	1.1	10.7	0.4	0.0	0.3	2.4	0.2	0.3	0.1	6.3	1.1	2.0	17.3	3.9	0.0	0.0	0.0	0.8	16.7	28.2	12.2	19.2	26.1	22.2	15.3	12.2	28.1	11.4	0.0	6.2	6.2	7.4	9.6	9.4	1.2	2.5	18.7	5.7	29.6	2.0	1.7	8.3	19.8	7.2	17.9	0.0	0.0	42.8	3.7	72.5	4.4	4.6	28.0	14.3	6.4	7.5	12.9	5.1	9.1	44.5	5.6	13.5	27.1	0.7	4.9	20.9	0.0	35.0	3.1	3.7	6.5	26.4	81.4	24.5	6.6	3.2	0.0	0.4	7.0
TPST2	TANGO13B	ENSG00000128294	"Tyrosylprotein sulfotransferase 2"	O60704	22	26521983-26596717	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 71.0;pancreas: 192.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 157.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 57.1"	"Low region specificity"	"Detected in all"							HPA021054	Enhanced				"Intracellular and membrane"	NA	NA		33000			"HPA021054: AB_1858221"	"unprognostic (2.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.08e-5)"	"unprognostic (8.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (9.68e-2)"	"unprognostic (9.21e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	5.8	8.4	4.7	3.7	3.6	5.2	9.0	2.1	6.9	4.6	2.9	3.0	7.4	3.5	4.7	31.8	4.5	4.1	3.2	5.2	5.2	3.2	5.7	20.0	10.7	4.8	3.7	3.6	2.4	192.5	1.1	2.9	11.0	3.2	3.8	2.3	4.0	2.8	7.9	8.6	4.0	3.1	3.2	2.8	8.9	3.0	4.8	3.1	3.0	12.2	2.2	5.2	4.5	6.7	4.3	20.0	71.0	15.1	57.2	46.4	35.2	4.3	3.2	4.2	2.1	8.9	6.9	5.8	9.8	17.6	8.0	7.3	2.1	2.2	7.4	2.6	17.5	4.2	6.8	3.1	6.7	4.6	3.0	5.9	17.8	2.0	4.4	3.7	2.0	57.1	7.4	10.8	8.0	2.7	8.1	14.7	3.4	17.8	23.2	6.1	4.9	8.2	13.9	5.5	3.4	3.2	7.7	5.6	20.5	2.4	4.9	3.1	2.2	4.5	4.0	5.4	6.4	1.8	8.5	11.6	9.9	22.4	8.0	9.4	7.5	10.4	7.1	7.5	8.0	8.9	71.0	13.4	18.6	46.4	14.5	13.0	4.1	10.9	34.5	8.4	4.3	5.4	31.4	28.4	57.2	15.1	20.0	12.2	35.2	4.7	3.6	2.1	6.9	5.2	3.2	3.7	3.6	3.2	3.1	14.9	13.0	19.3	70.7	33.9	7.0	10.6	38.2	13.4	4.5	21.0	5.9	157.8	23.2	11.5	8.4	57.7	7.8	0.0	56.2	41.8	11.9	27.5	49.9	68.4	105.1	6.4	0.0	93.9	52.0	2.6	4.9	37.1	27.0	10.8	9.2	2.0	65.3	10.5	3.9	7.6	4.3	6.5	17.3	2.9	16.6	31.5	119.6	57.3	12.3	71.9
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Group enriched"	"Detected in some"	14	"Spermatocytes: 282.4;Spermatogonia: 73.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	7.0	0.0	5.1	0.0	0.0	1.2	0.0	5.2	0.0	0.0	9.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	8.9	0.0	0.0	0.0	2.0	4.6	2.4	0.0	8.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	12.9	0.0	282.4	73.0	0.0	0.9	0.0	0.0	0.0
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	"TXK tyrosine kinase"	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4"	"Cell type enriched"	"Detected in some"	9	"T-cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 43.5"	"Group enriched"	"Detected in many"	26	"NK-cells: 43.5;T-cells: 17.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062482			Approved	Vesicles		NA	NA			Vesicles		"HPA062482: AB_2684778"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.04e-2)"	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4.0	49.1	0.5	0.5	0.5	1.0	0.4	1.3	28.4	0.6	0.9	1.0	1.0	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1.0	1.7	0.2	14.0	1.9	0.2	19.3	2.4	1.4	0.0	0.1	1.1	0.0	43.5	17.5	10.6	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.8	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.1	2.4	0.0	0.0	0.0	0.3	11.3	0.0	0.0	0.1	0.0	0.8	0.1	0.4	0.2	0.0	0.7	0.0	0.0	2.1	0.0	0.6	0.8	0.3	0.0	0.0	1.4	1.3	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.1	5.5	6.8	0.4	0.0	0.4	25.4	1.1	0.0	0.3	13.2	0.0	17.4	0.0	6.8	6.4	0.0	0.0	17.5	11.9	0.8	43.5	0.0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2	0.0	2.6	0.8	0.5	0.3	0.0	0.2	2.5	0.0	0.0	0.0	3.9	0.2	1.7	1.3	4.3	0.1	0.0	0.0	0.0	0.1	0.5	0.4	1.1	1.0	1.2	0.0	0.0	4.3	5.1	1.3	0.3	0.5	1.7	0.0	0.0	2.3	0.2	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.2	1.0	0.5	43.1	0.2	0.6
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	16.8	19.0	22.9	36.0	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20.0	19.3	20.2	15.0	16.8	21.8	17.0	18.3	14.0	24.0	34.4	27.5	31.5	24.7	17.4	20.0	21.3	19.0	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.6	12.7	7.6	11.9	10.1	14.3	7.3	11.9	12.2	15.1	16.7	9.7	5.8	13.2	14.1	13.3	10.4	8.8	9.2	14.0	8.0	23.3	14.2	24.4	25.3	23.9	15.9	10.2	28.2	13.8	9.9	17.2	10.2	9.5	14.6	17.5	10.2	37.0	13.3	27.3	15.0	63.2	2.4	8.6	22.2	15.0	6.5	13.5	12.3	28.0	7.2	8.8	11.6	12.3	8.5	6.2	6.8	17.4	12.4	20.4	7.3	23.5	14.0	30.5	23.7	12.1	10.2	21.4	11.4	6.6	13.4	17.0	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9.0	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14.0	24.7	17.4	19.1	22.8	11.9	19.9	6.7	4.8	6.0	8.4	23.6	12.7	5.3	10.3	8.7	3.9	6.0	44.7	6.5	1.4	7.5	10.2	0.0	9.5	6.9	9.4	5.5	18.5	20.2	13.0	0.0	4.6	14.1	30.7	6.4	6.9	18.0	15.1	15.4	8.3	7.4	9.1	11.5	9.2	19.5	9.7	0.0	8.6	1.4	4.3	6.4	5.6	19.2	9.0	4.9
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583586	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.2;ovary: 48.2"	"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 41.1;Peritubular cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		6400000			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	18.3	4.1	18.7	2.1	16.6	1.5	7.7	27.3	39.2	2.3	1.8	25.6	1.2	2.3	5.0	4.2	12.7	11.7	3.1	2.5	15.1	7.8	6.4	1.6	3.2	1.9	19.6	18.2	48.2	9.5	1.3	0.8	5.9	14.0	3.3	1.7	1.7	2.4	6.7	1.4	13.0	2.9	4.8	23.1	5.4	3.6	17.9	16.6	0.0	1.8	2.2	4.1	2.9	2.8	1.2	1.0	5.0	0.9	1.0	0.8	0.2	4.8	3.2	10.1	11.0	9.5	6.4	33.9	7.0	4.5	7.0	6.5	17.8	1.6	0.1	9.0	5.6	9.8	11.4	11.2	1.7	3.2	2.7	7.5	1.4	10.1	8.5	6.6	2.4	0.2	2.0	3.6	5.3	1.8	2.8	5.1	4.7	8.8	2.1	3.8	4.6	1.1	0.4	23.2	7.5	3.2	14.9	9.1	1.8	0.6	9.3	12.1	3.4	6.5	10.5	7.8	15.3	8.6	2.8	4.0	13.9	6.1	10.2	10.5	0.8	1.6	1.4	8.4	16.0	8.3	2.6	0.9	0.8	0.6	0.5	0.6	0.7	0.6	0.8	0.3	1.2	0.7	0.7	5.0	1.0	0.5	1.0	0.5	0.2	18.7	16.6	27.3	32.7	15.1	7.8	19.6	18.2	14.0	16.6	3.0	1.4	0.9	6.2	6.1	1.2	3.7	2.5	0.0	0.0	3.5	5.9	2.4	0.0	3.4	2.7	4.9	0.9	0.0	3.1	8.9	5.6	4.8	0.0	0.2	1.0	0.0	1.7	12.3	0.6	4.0	41.1	1.1	8.5	0.0	0.1	6.5	3.7	0.0	44.2	1.5	3.9	0.0	2.8	2.4	5.4	9.5	15.8	0.0	1.6	4.7
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.4	7.2	22.8	17.8	13.7	17.0	26.8	9.6	19.7	11.4	15.7	17.1	10.7	0.0	10.3	16.3	14.6	8.5	21.3	17.1	22.4	0.0	7.2	4.3	7.1	11.9	11.1	3.3	7.7	13.0	18.4	17.2	19.2	14.2	38.4	2.4	18.7	6.4	16.2	9.9	2.0	4.3	14.4	8.8	9.2	2.5	17.9	1.2	16.6	17.2	4.6	5.4	19.9	15.1	12.6	15.7	10.4	6.9	33.0	28.1	31.2	21.2	25.9	5.6	2.7	0.8	10.6	4.7	16.6	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0	23.8	30.8	1.5	33.5	53.3	6.2	16.5	20.4	26.8	34.2	27.9	5.9	28.2	3.3	25.6	20.2	77.6	27.4	0.0	34.0	20.3	31.2	52.1	12.8	33.4	4.3	3.2	21.9	41.1	5.6	7.9	17.0	5.3	23.6	1.0	35.7	16.3	40.3	21.0	12.0	38.5	8.0	19.4	20.6	12.8	11.7	43.4	38.1	15.2	31.0	58.7
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713560-97739862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.4;lymphoid tissue: 107.1"	"Cell type enriched"	"Detected in many"	4	"T-cells: 96.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	41	"gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9"	"Group enriched"	"Detected in many"	53	"NK-cells: 26.4;T-cells: 37.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 39.8;MOLT-4: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002625, HPA003134"	Enhanced					NA	NA					"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	2.2	0.5	0.3	18.1	0.6	11.2	1.5	0.7	0.6	1.2	3.7	0.7	0.3	2.9	1.2	1.1	1.7	1.5	2.8	0.9	0.4	0.8	2.2	2.3	5.8	28.1	0.8	0.6	0.9	1.3	0.0	0.7	0.9	0.6	2.1	0.6	1.0	5.5	1.0	0.7	1.0	12.3	0.7	0.7	24.8	3.2	1.4	0.6	107.1	2.5	1.1	20.8	3.0	1.7	0.4	0.2	0.5	0.2	26.4	37.4	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.2	0.0	0.0	57.4	0.1	0.0	0.0	0.0	2.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	37.4	0.1	25.4	0.0	19.6	29.2	0.0	0.4	14.3	21.9	0.5	26.4	0.2	0.2	19.9	14.3	0.3	0.6	0.7	0.6	0.4	0.8	0.8	0.6	0.6	0.6	8.9	22.3	1.4	0.0	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.1	2.3	0.6	1.7	0.0	0.0	3.1	0.8	0.7	0.0	1.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.4	1.7	1.3	0.0	96.4	0.0	0.1
